Verordnung (EG) Nr. 1272/2008 des Europäischen Parlaments und des Rates vom 16. Dezember 2008 über die Einstufung, Kennzeichnung und Verpackung von Stoffen und Gemischen, zur Änderung und Aufhebung der Richtlinien 67/548/EWG und 1999/45/EG und zur Änderung der Verordnung (EG) Nr. 1907/2006 (Text von Bedeutung für den EWR)Text von Bedeutung für den EWR
Anhangteil
Anhang 6 32008R1272
ANHANG VI
Harmonisierte Einstufung und Kennzeichnung für bestimmte gefährliche Stoffe
In Teil 1 dieses Anhangs wird eine Einführung zur Liste der harmonisierten Einstufungen und Kennzeichnungen gegeben, die auch die in Tabelle 3 aufgeführten Informationen je Eintrag und entsprechenden Einstufungen und Gefahrenhinweise umfasst.
In Teil 2 dieses Anhangs werden allgemeine Grundsätze für die Vorbereitung der Dossiers festgelegt, mit denen eine harmonisierte Einstufung und Kennzeichnung von Stoffen auf Unionsebene vorgeschlagen und begründet wird.
In Teil 3 dieses Anhangs sind gefährliche Stoffe aufgeführt, für die eine harmonisierte Einstufung und Kennzeichnung auf Unionsebene erstellt wurde. Die Einstufungen und Kennzeichnungen in Tabelle 3 beruhen auf den Kriterien in Anhang I dieser Verordnung.
- 1.
TEIL 1: EINFÜHRUNG ZUR LISTE DER HARMONISIERTEN EINSTUFUNGEN UND KENNZEICHNUNGEN
- 1.1.
Informationen je Eintrag
- 1.1.1.
Nummerierung der Einträge und Identifizierung eines Stoffes
- 1.1.1.1.
Indexnummern
Die Einträge in Teil 3 sind nach der Ordnungszahl des Elements geordnet, das für die Eigenschaften des jeweiligen Stoffes am kennzeichnendsten ist. Organische Stoffe wurden aufgrund ihrer Vielfältigkeit in Klassen eingeordnet. Die Indexnummer der einzelnen Stoffe besteht aus einer Zeichensequenz nach dem Muster ABC-RST-VW-Y. ABC entspricht der Ordnungszahl des Elements bzw. der organischen Gruppe, das bzw. die am kennzeichnendsten für das Molekül ist. RST ist die laufende Nummer des Stoffes in der ABC-Reihe. VW gibt die Form an, in der der Stoff hergestellt oder in den Verkehr gebracht wird. Y ist die Kontrollziffer, die nach der zehnstelligen ISBN-Methode berechnet wird. Diese Nummer ist in der Spalte "Index No" angegeben.
- 1.1.1.2.
EG-Nummer
Die EG-Nummer, d. h. die EINECS-, ELINCS- oder NLP-Nummer, ist die offizielle Nummer des Stoffes in der Europäischen Union. Die EINECS-Nummer kann dem Europäischen Verzeichnis der auf dem Markt vorhandenen chemischen Stoffe (EINECS)(1) entnommen werden. Die ELINCS-Nummer kann der Europäischen Liste der angemeldeten chemischen Stoffe (in der aktuellen Ausgabe) entnommen werden (EUR 22543 EN, Amt für Amtliche Veröffentlichungen der Europäischen Gemeinschaften, 1997, ISBN 1018-5593). Die NLP-Nummer kann der Liste "No-longer-polymers" (in der aktuellen Ausgabe) entnommen werden (Amt für Amtliche Veröffentlichungen der Europäischen Gemeinschaften, 1997, ISBN 92-827-8995-0). Bei der EG-Nummer handelt es sich um ein System siebenstelliger Nummern nach dem Muster XXX-XXX-X, das bei 200-001-8 (EINECS), 400-010-9 (ELINCS) und 500-001-0 (NLP) beginnt. Diese Nummer ist in der Spalte "EC No" angegeben.
- 1.1.1.3.
CAS-Nummer
Ferner wird die CAS-Nummer (Chemical Abstracts Service) angegeben, um den Eintrag leichter identifizieren zu können. Es sei darauf hingewiesen, dass ein und dieselbe EINECS-Nummer Stoffe sowohl in ihrer wasserfreien Form als auch in ihrer Hydratform beinhaltet, während es dafür häufig unterschiedliche CAS-Nummern gibt. Die angegebene CAS-Nummer bezeichnet lediglich die wasserfreie Form und beschreibt deshalb den Eintrag nicht immer mit der gleichen Genauigkeit wie die EINECS-Nummer. Diese Nummer ist in der Spalte "CAS No" angegeben.
- 1.1.1.4.
Internationale chemische Bezeichnung
Gefährliche Stoffe werden nach Möglichkeit mit ihren IUPAC-Namen bezeichnet. In EINECS, ELINCS oder in der Liste "No-longer-polymers" aufgeführte Stoffe werden mit den dort verwendeten Namen bezeichnet. In einigen Fällen sind auch andere Namen, wie z. B. der Trivialname oder der gebräuchliche Name, angegeben. Pflanzenschutzmittel und Biozidwirkstoffe werden nach Möglichkeit mit ihren ISO-Namen bezeichnet.
Verunreinigungen, Zusatzstoffe und unbedeutende Bestandteile werden normalerweise nicht angegeben, es sei denn, sie haben einen wesentlichen Einfluss auf die Einstufung des Stoffes.
Bei einigen Stoffen wird der spezifische Reinheitsgrad prozentual angegeben. Stoffe mit einem höheren Gehalt an Wirkstoffen (z. B. organische Peroxide) als dieser Prozentanteil werden nicht in den Eintrag in Teil 3 aufgenommen und können andere gefährliche Eigenschaften haben (z. B. Explosionsgefahr); sie sollten entsprechend eingestuft und gekennzeichnet werden.
Stoffspezifische Konzentrationsgrenzen beziehen sich auf den Stoff bzw. die Stoffe des Eintrags. Insbesondere bei Einträgen, bei denen es sich um Mischungen von Stoffen oder um Stoffe mit prozentualer Angabe des spezifischen Reinheitsgrades handelt, beziehen sich die Konzentrationsgrenzen nicht auf den reinen, sondern auf den in Teil 3 beschriebenen Stoff.
Für in Teil 3 aufgeführte Stoffe hat der auf dem Kennzeichnungsetikett zu verwendende Stoffname einer der Bezeichnungen zu entsprechen, die dort angegeben sind. Bei bestimmten Stoffen wurden zur leichteren Identifizierung des Stoffes zusätzliche Angaben in eckigen Klammern angefügt. Diese zusätzlichen Informationen brauchen nicht in das Kennzeichnungsetikett aufgenommen zu werden.
Bestimmte Einträge enthalten einen Verweis auf Verunreinigungen; in diesen Fällen steht hinter dem Namen des Stoffes folgender Wortlaut: "(enthält ≥xx % Verunreinigungen)". Der Verweis in Klammern gilt dann als Bestandteil des Namens und muss in das Kennzeichnungsetikett aufgenommen werden.
- 1.1.1.5.
Einträge für Stoffgruppen
Es werden eine Reihe von Gruppeneinträgen in Teil 3 aufgenommen. In diesen Fällen gelten die Vorschriften für die Einstufung und Kennzeichnung für alle von der Beschreibung erfassten Stoffe.
In einigen Fällen gibt es Einstufungs- und Kennzeichnungsanforderungen für bestimmte Stoffe eines Gruppeneintrags. Dann erfolgt für diesen Stoff ein eigener Eintrag in Anhang VI Teil 3, und beim Gruppeneintrag wird der Vermerk "mit Ausnahme der an einer anderen Stelle dieses Anhangs genannten Stoffe" hinzugefügt.
In einigen Fällen können bestimmte Stoffe in verschiedenen Gruppeneinträgen erwähnt sein. In diesen Fällen entspricht die Einstufung des Stoffes derjenigen beider Gruppeneinträge. Sind für dieselbe Gefahr verschiedene Einstufungen angegeben, so ist die strengere Einstufung zu verwenden.
Einträge in Teil 3 für Salze (unter jeder Bezeichnung) gelten sowohl für Salze in wasserfreier Form als auch in Hydratform, sofern nicht etwas anderes festgelegt ist.
Bei Einträgen, die mehr als vier einzelne Stoffe umfassen, werden die EG- oder CAS-Nummern in der Regel nicht angegeben.
- 1.1.2.
Informationen über die Einstufung und Kennzeichnung der einzelnen Einträge in Tabelle 3
- 1.1.2.1.
Einstufungskodierungen
- 1.1.2.1.1.
Kodierungender Gefahrenklassen und Gefahrenkategorien
Die Einstufung für die einzelnen Einträge basiert auf den Kriterien des Anhangs I gemäß Artikel 13 Buchstabe a und wird in Form von Abkürzungen dargestellt, die für die Gefahrenklasse und die Gefahrenkategorie oder Gefahrenkategorien/-unterklassen/-typen innerhalb dieser Gefahrenklasse stehen.
Die Gefahrenklassen und die für die einzelnen Gefahrenkategorien einer Klasse verwendeten Abkürzungen sind in Tabelle 1.1 angegeben.
Tabelle 1.1 Gefahrenklasse Kodierungen der Gefahrenklassen und Gefahrenkategorien Explosive Stoffe/Gemische und Erzeugnisse mit Explosivstoff Unst. Expl.
Expl. 1.1
Expl. 1.2
Expl. 1.3
Expl. 1.4
Expl. 1.5
Expl. 1.6
Entzündbare Gase Flam. Gas 1
Flam. Gas 2
Chem. Unst. Gas A
Chem. Unst. Gas B
Aerosole Aerosol 1
Aerosol 2
Aerosol 3
Oxidierende Gase Ox. Gas 1 Gase unter Druck Press. Gas(2) Entzündbare Flüssigkeiten Flam. Liq. 1
Flam. Liq. 2
Flam. Liq. 3
Entzündbare Feststoffe Flam. Sol. 1
Flam. Sol. 2
Selbstzersetzliche Stoffe oder Gemische Self-react. A
Self-react. B
Self-react. CD
Self-react. EF
Self-react. G
Pyrophore Flüssigkeiten Pyr. Liq. 1 Pyrophore Feststoffe Pyr. Sol. 1 Selbsterhitzungsfähige Stoffe oder Gemische Self-heat. 1
Self-heat. 2
Stoffe oder Gemische, die in Berührung mit Wasser entzündbare Gase entwickeln Water-react. 1
Water-react. 2
Water-react. 3
Oxidierende Flüssigkeiten Ox. Liq. 1
Ox. Liq. 2
Ox. Liq. 3
Oxidierende Feststoffe Ox. Sol. 1
Ox. Sol. 2
Ox. Sol. 3
Organische Peroxide Org. Perox. A
Org. Perox. B
Org. Perox. CD
Org. Perox. EF
Org. Perox. G
Korrosiv gegenüber Metallen Met. Corr. 1 Akute Toxizität Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 4
Ätzwirkung auf die Haut/Hautreizung Skin Corr. 1
Skin Corr. 1A
Skin Corr. 1 B
Skin Corr. 1C
Skin Irrit. 2
Schwere Augenschädigung/Augenreizung; Eye Dam. 1
Eye Irrit. 2
Sensibilisierung der Atemwege/Haut Resp. Sens. 1, 1A, 1B
Skin Sens. 1, 1A, 1B
Keimzell-Mutagenität Muta. 1A
Muta. 1B
Muta. 2
Karzinogenität Carc. 1A
Carc. 1B
Carc. 2
Reproduktionstoxizität Repr. 1A
Repr. 1B
Repr. 2
Lact.
Spezifische Zielorgan-Toxizität (einmalige Exposition) STOT SE 1
STOT SE 2
STOT SE 3
Spezifische Zielorgan-Toxizität (wiederholte Exposition) STOT RE 1
STOT RE 2
Aspirationsgefahr Asp. Tox. 1 Gewässergefährdend Aquatic Acute 1
Aquatic Chronic 1
Aquatic Chronic 2
Aquatic Chronic 3
Aquatic Chronic 4
Schädigt die Ozonschicht Ozone 1
- 1.1.2.1.2.
Kodierungender Gefahrenhinweise
Die gemäß Artikel 13 Buchstabe b zugeordneten Gefahrenhinweise werden gemäß Anhang III angegeben. Darüber hinaus werden dem dreistelligen Gefahrenhinweis-Code bei bestimmten Gefahrenhinweisen Buchstaben zur weiteren Differenzierung angefügt. Es werden die nachstehenden zusätzlichen Codes verwendet:
H350i Kann bei Einatmen Krebs erzeugen. H360F Kann die Fruchtbarkeit beeinträchtigen. H360D Kann das Kind im Mutterleib schädigen. H361f Kann vermutlich die Fruchtbarkeit beeinträchtigen. H361d Kann vermutlich das Kind im Mutterleib schädigen. H360FD Kann die Fruchtbarkeit beeinträchtigen. Kann das Kind im Mutterleib schädigen. H361fd Kann vermutlich die Fruchtbarkeit beeinträchtigen. Kann vermutlich das Kind im Mutterleib schädigen. H360Fd Kann die Fruchtbarkeit beeinträchtigen. Kann vermutlich das Kind im Mutterleib schädigen. H360Df Kann das Kind im Mutterleib schädigen. Kann vermutlich die Fruchtbarkeit beeinträchtigen.
- 1.1.2.2.
Kennzeichnungskodierungen
In der Kennzeichnungsspalte werden die folgenden Elemente aufgeführt:
- i)
die Kodierungen der Gefahrenpiktogramme gemäß Anhang V und in Übereinstimmung mit den Rangfolgevorschriften in Artikel 26;
- ii)
die Signalwortkodierung "Gef." für "Gefahr" oder "Achtg." für "Achtung" in Übereinstimmung mit den Rangfolgevorschriften in Artikel 20 Absatz 3;
- iii)
die Kodierungen der Gefahrenhinweise gemäß Anhang III und entsprechend der Einstufung;
- iv)
die Kodierungen für die ergänzenden Hinweise gemäß Anhang II Teil 1, die in Übereinstimmung mit Artikel 25 Absatz 1 und den Vorschriften in Anhang II Teil 1 zugeordnet werden.
- 1.1.2.3.
Spezifische Konzentrationsgrenzwerte, Multiplikationsfaktoren und Schätzwerte Akuter Toxizität (ATE)
Im Falle einer Abweichung von den allgemeinen Konzentrationsgrenzwerten des Anhangs I werden für eine bestimmte Kategorie spezifische Konzentrationsgrenzwerte in einer eigenen Spalte zusammen mit der betreffenden Einstufung unter Verwendung der Codes nach Abschnitt 1.1.2.1.1 aufgeführt. In derselben Spalte der Tabelle 3 sind auch harmonisierte ATE angegeben. Hersteller, Einführer oder nachgeschaltete Anwender müssen die spezifischen Konzentrationsgrenzwerte und die harmonisierten ATE für die Einstufung eines diesen Stoff enthaltenden Gemisches verwenden. Wenn ein ATE angewandt wird, ist die Additivitätsformel gemäß Anhang I Abschnitt 3.1.3.6 zu verwenden. Sind für eine bestimmte Kategorie in diesem Anhang keine spezifischen Konzentrationsgrenzwerte angegeben, gelten für die Einstufung von Stoffen, die Verunreinigungen, Zusatzstoffe und einzelne Bestandteile enthalten, und für Gemische die allgemeinen Konzentrationsgrenzwerte von Anhang I. Wenn harmonisierte ATE-Werte für akute Toxizität fehlen, ist der korrekte Wert anhand der verfügbaren Daten festzustellen.
Sofern nicht anders angegeben, sind die aufgeführten Konzentrationsgrenzwerte als Gewichtsprozent, bezogen auf das Gesamtgewicht des Gemisches, zu verstehen.
Für den Fall, dass ein Multiplikationsfaktor (M-Faktor) für Stoffe harmonisiert wurde, die als gewässergefährdend in die Kategorie "Aquatic Acute 1" oder "Aquatic Chronic 1" eingestuft sind, wird dieser M-Faktor in Tabelle 3 in derselben Spalte wie die spezifischen Konzentrationsgrenzwerte angegeben. Falls ein M-Faktor für die Kategorie "Aquatic Acute 1" oder für die Kategorie "Aquatic Chronic 1" harmonisiert wurde, ist jeder M-Faktor in derselben Zeile aufzuführen wie seine entsprechende Differenzierung. Wird in Tabelle 3 ein einziger M-Faktor angegeben und ist der Stoff in die Kategorien "Aquatic Acute 1" und "Aquatic Chronic 1" eingestuft, so ist dieser M-Faktor vom Hersteller, Einführer oder nachgeschalteten Anwender für die Einstufung eines diesen Stoff enthaltenden Gemisches aufgrund seiner akuten und langfristigen Gewässergefährdung mithilfe der Summierungsmethode zu verwenden. Ist in Tabelle 3 kein M-Faktor angegeben, wird er auf der Grundlage der für den Stoff verfügbaren Daten vom Hersteller, Einführer oder nachgeschalteten Anwender festgelegt. Zur Festlegung und Verwendung des M-Faktors siehe Anhang I Abschnitt 4.1.3.5.5.5.
- 1.1.3.
Einem Eintrag zugeordnete Anmerkungen
Die Anmerkung/-en, die einem Eintrag zugeordnet ist/sind, ist/sind in der Spalte "Notes" aufgeführt. Der Inhalt der Anmerkungen lautet wie folgt:
- 1.1.3.1.
Anmerkungen zur Identifizierung, Einstufung und Kennzeichnung von Stoffen
Anmerkung A:
Der Name des Stoffes muss auf dem Kennzeichnungsetikett mit einer der in der Liste des Teils 3 aufgeführten Bezeichnungen angegeben werden.
In einigen Fällen wird in Teil 3 eine allgemeine Beschreibung wie "…verbindungen" oder "…salze" verwendet. In diesem Fall muss der Lieferant auf dem Kennzeichnungsetikett den korrekten Namen angeben und dabei Abschnitt 1.1.1.4. gebührend beachten.
Anmerkung B:
Manche Stoffe (Säuren, Basen usw.) werden als wässrige Lösungen in unterschiedlichen Konzentrationen in Verkehr gebracht; dies erfordert auch eine unterschiedliche Einstufung und Kennzeichnung, da von den verschiedenen Konzentrationen unterschiedliche Gefahren ausgehen können.
In Teil 3 haben Einträge mit der Anmerkung B allgemeine Bezeichnungen wie "Salpetersäure ... %".
In diesem Fall muss der Lieferant die Konzentration in Prozent auf dem Kennzeichnungsetikett angeben. Unter % ist ohne anderslautende Angabe stets der Gewichtsprozentsatz zu verstehen.
Anmerkung C:
Manche organischen Stoffe können entweder in einer genau definierten isomeren Form oder als Gemisch mehrerer Isomere in Verkehr gebracht werden.
In diesem Fall muss der Lieferant auf dem Kennzeichnungsetikett angeben, ob es sich um ein bestimmtes Isomer oder um ein Isomerengemisch handelt.
Anmerkung D:
Bestimmte Stoffe, die spontan polymerisieren oder sich zersetzen können, werden normalerweise in stabilisierter Form in Verkehr gebracht. Sie werden in dieser Form in Teil 3 aufgeführt.
Allerdings werden solche Stoffe manchmal auch in nicht stabilisierter Form in Verkehr gebracht. In diesem Fall muss der Lieferant auf dem Kennzeichnungsetikett nach dem Namen des Stoffes die Bezeichnung "nicht stabilisiert" anfügen.
Anmerkung E (Tabelle 3.2):
Stoffe mit spezifischen Auswirkungen auf die menschliche Gesundheit (siehe Kapitel 4 des Anhangs VI der Richtlinie 67/548/EWG), die als karzinogen, keimzellmutagen und/oder reproduktionstoxisch der Kategorie 1 oder 2 eingestuft sind, werden mit der Anmerkung E versehen, wenn sie darüber hinaus als sehr toxisch (T+), toxisch (T) oder gesundheitsschädlich (Xn) eingestuft sind. Bei diesen Stoffen ist den Gefahrensätzen R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (gesundheitsschädlich), R48 und R65 sowie vor alle Kombinationen dieser Gefahrensätze das Wort "auch" voranzustellen.
Anmerkung F:
Dieser Stoff kann einen Stabilisator enthalten. Wenn dieser Stabilisator die mit der Einstufung in Teil 3 angegebenen gefährlichen Eigenschaften des Stoffes verändert, so sollten die Einstufung und die Kennzeichnung des Stoffes in Übereinstimmung mit den Vorschriften für die Einstufung und Kennzeichnung gefährlicher Gemische vorgenommen werden.
Anmerkung G:
Diese Stoffe können in einer explosionsgefährlichen Form in Verkehr gebracht werden. In diesem Fall müssen die explosiven Eigenschaften durch entsprechende Prüfmethoden bestimmt werden. Die Einstufung und die Kennzeichnung müssen einen entsprechenden Hinweis auf diese Eigenschaften enthalten.
Anmerkung H (Tabelle 3.1):
Die für diesen Stoff aufgeführte Einstufung und Kennzeichnung gilt für die gefährliche/-n Eigenschaft/-en, auf die der/die Gefahrenhinweis/-e im Zusammenhang mit der/den betreffenden Gefahrenklasse/-n und -kategorie/-n verweist/-en. Die Vorschriften von Artikel 4 für Hersteller, Importeure oder nachgeschaltete Anwender dieses Stoffes gelten für alle anderen Gefahrenklassen und -kategorien. Für Gefahrenklassen, bei denen der Expositionsweg oder die Art der Wirkungen zu einer Differenzierung der Einstufung der Gefahrenklasse führt, muss der Hersteller, Importeur oder nachgeschaltete Anwender diejenigen Expositionswege oder Wirkungsarten berücksichtigen, die noch nicht berücksichtigt worden sind.
Das endgültige Kennzeichnungsetikett hat den Anforderungen von Anhang I Kapitel 1.2 zu entsprechen.
Anmerkung H (Tabelle 3.2):
Die für diesen Stoff anzuwendende Einstufung und das entsprechende Kennzeichnungsetikett gelten für die in dem/den R-Satz/R-Sätzen im Zusammenhang mit den betreffenden Gefahrenkategorien erwähnte/-n gefährliche/-n Eigenschaft/-en. Die Hersteller, Importeure und nachgeschalteten Anwender sind verpflichtet, Nachforschungen anzustellen, um sich für die Einstufung und Kennzeichnung des Stoffes die einschlägigen und zugänglichen Daten zu allen anderen Eigenschaften zu verschaffen. Das endgültige Kennzeichnungsetikett muss den Anforderungen von Teil 7 des Anhangs VI der Richtlinie 67/548/EWG entsprechen.
Anmerkung J:
Die Einstufung als karzinogen oder keimzellmutagen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff weniger als 0,1 Gewichtsprozent Benzol (EINECS-Nr. 200-753-7) enthält. Diese Anmerkung gilt nur für bestimmte komplexe Kohlen- und Ölderivate in Teil 3.
Anmerkung K:
Die Einstufung als karzinogen oder keimzellmutagen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff weniger als 0,1 Gewichtsprozent 1,3-Butadien (Einecs-Nr. 203-450-8) enthält. Wird der Stoff nicht als karzinogen oder keimzellmutagen eingestuft, so sind zumindest die Sicherheitshinweise (P102-)P210-P403 anzuwenden. Diese Anmerkung gilt nur für bestimmte komplexe Ölderivate in Teil 3.
Anmerkung L:
Die Einstufung als karzinogen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff weniger als 3 % DMSO-Extrakt, gemessen nach dem Verfahren IP 346 ("Bestimmung der polyzyklischen Aromate in nicht verwendeten Schmierölen und asphaltenfreien Erdölfraktionen — Dimethylsulfoxid-Extraktion-Brechungsindex-Methode", Institute of Petroleum, London), enthält. Diese Anmerkung gilt nur für bestimmte komplexe Ölderivate in Teil 3.
Anmerkung M:
Die Einstufung als karzinogen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff weniger als 0,005 Gewichtsprozent Benzo[a]pyren (EINECS-Nr. 200-028-5) enthält. Diese Anmerkung gilt nur für bestimmte komplexe Kohlenderivate in Teil 3.
Anmerkung N:
Die Einstufung als karzinogen ist nicht zwingend, wenn der ganze Raffinationsprozess bekannt ist und nachgewiesen werden kann, dass der Ausgangsstoff nicht karzinogen ist. Diese Anmerkung gilt nur für bestimmte komplexe Ölderivate in Teil 3.
Anmerkung P:
Die Einstufung als karzinogen oder keimzellmutagen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff weniger als 0,1 Gewichtsprozent Benzol (Einecs-Nr. 200-753-7) enthält.
Ist der Stoff nicht als karzinogen eingestuft, so sind zumindest die Sicherheitshinweise (P102-)P260-P262-P301 + P310-P331 anzuwenden.
Diese Anmerkung gilt nur für bestimmte komplexe Ölderivate in Teil 3.
Anmerkung Q:
Die Einstufung als karzinogen ist nicht zwingend, wenn nachgewiesen werden kann, dass der Stoff eine der nachstehenden Bedingungen erfüllt:
Mit einem Kurzzeit-Inhalationsbiopersistenztest wurde nachgewiesen, dass die gewichtete Halbwertszeit der Fasern mit einer Länge von über 20 μm weniger als 10 Tage beträgt.
Mit einem Kurzzeit-Intratrachealbiopersistenztest wurde nachgewiesen, dass die gewichtete Halbwertszeit der Fasern mit einer Länge von über 20 μm weniger als 40 Tage beträgt.
Bei einem geeigneten Intraperitonealtest ergaben sich keine Belege für übermäßige Karzinogenität.
Bei einem geeigneten Langzeit-Inhalationstest blieben eine relevante Pathogenität oder neoplastische Veränderungen aus.
Anmerkung R:
Die Einstufung als karzinogen ist nicht zwingend für Fasern, bei denen der längengewichtete mittlere geometrische Durchmesser abzüglich der zweifachen geometrischen Standardabweichung größer ist als 6 μm.
Anmerkung S:
Für diesen Stoff ist gegebenenfalls kein Kennzeichnungsetikett gemäß Artikel 17 erforderlich (siehe Anhang I Abschnitt 1.3) (Tabelle 3).
Anmerkung T:
Dieser Stoff kann in einer Form in Verkehr gebracht werden, die nicht die physikalischen Eigenschaften aufweist, wie im Einstufungseintrag in Teil 3 angegeben. Wenn die Ergebnisse der einschlägigen Methode/-n gemäß der Verordnung (EG) Nr. 440/2008 zeigen, dass die betreffende Form des in Verkehr gebrachten Stoffes diese physikalische/-n Eigenschaft/-en nicht aufweist, ist der Stoff gemäß den Ergebnissen dieser Prüfung/-en einzustufen. In das Sicherheitsdatenblatt sind die betreffenden Informationen aufzunehmen, einschließlich der Nennung der einschlägigen Prüfmethode/-n.
Anmerkung U (Tabelle 3):
Beim Inverkehrbringen müssen die Gase als "Gase unter Druck" in eine der Gruppen der verdichteten Gase, der verflüssigten Gase, der tiefgekühlten Gase oder der gelösten Gase eingestuft werden. Die Zuordnung zu einer Gruppe hängt vom Aggregatzustand ab, in dem das Gas verpackt wird, und muss deshalb von Fall zu Fall entschieden werden. Folgende Kodierungen werden zugewiesen:
Press. Gas (Comp.)
Press. Gas (Liq.)
Press. Gas (Ref. Liq.)
Press. Gas (Diss.)
Aerosole dürfen nicht als Gase unter Druck eingestuft werden (vgl. Anhang I Teil 2 Abschnitt 2.3.2.1 Anmerkung 2).
- 1.1.3.2.
Anmerkungen zur Einstufung und Kennzeichnung von Gemischen
Anmerkung 1:
Die angegebenen Konzentrationen oder — bei Fehlen einer entsprechenden Angabe — die in dieser Verordnung festgelegten allgemeinen Konzentrationen sind als Gewichtsprozent des Metalls, bezogen auf das Gesamtgewicht des Gemisches, zu verstehen.
Anmerkung 2:
Die angegebenen Konzentrationen der Isocyanate sind als Gewichtsprozent des freien Monomers, bezogen auf das Gesamtgewicht des Gemisches, zu verstehen.
Anmerkung 3:
Die angegebenen Konzentrationen sind als Gewichtsprozent der in Wasser gelösten Chromationen, bezogen auf das Gesamtgewicht des Gemisches, zu verstehen.
Anmerkung 5:
Die Konzentrationsgrenzwerte für gasförmige Gemische werden in Volumenprozent angegeben.
Anmerkung 7:
Legierungen, die Nickel enthalten, werden als hautsensibilisierend eingestuft, wenn die Freisetzung 0,5 μg Ni/cm2/Woche, gemessen mit Hilfe des Europäischen Standardreferenzprüfverfahrens EN 1811, übersteigt.
Anmerkung 8:
Die Einstufung als karzinogen ist nicht zwingend, wenn nachgewiesen werden kann, dass die theoretische Höchstkonzentration an freisetzbarem Formaldehyd, unabhängig von der Quelle, in dem in Verkehr gebrachten Gemisch weniger als 0,1 % beträgt.
Anmerkung 9:
Die Einstufung als keimzellmutagen ist nicht zwingend, wenn nachgewiesen werden kann, dass die theoretische Höchstkonzentration an freisetzbarem Formaldehyd, unabhängig von der Quelle, in dem in Verkehr gebrachten Gemisch weniger als 1 % beträgt.
- 1.1.4.
Informationen über die Einstufung und Kennzeichnung der einzelnen Einträge in Tabelle 3.2
- 1.1.4.1.
Einstufungskodierungen
Die Einstufung für jedes Gefährlichkeitsmerkmal (wie in Artikel 2 Absatz 2 der Richtlinie 67/548/EWG festgelegt) wird in der Regel in Form von Abkürzungen dargestellt, die dem jeweiligen Gefährlichkeitsmerkmal entsprechen, unter Angabe des/der entsprechenden R-Satzes/-Sätze. In bestimmten Fällen (z. B. bei Stoffen, die als entzündbar, sensibilisierend oder umweltgefährlich eingestuft wurden) wird jedoch lediglich der R-Satz angegeben.
Abkürzungen der einzelnen Gefährlichkeitsmerkmale:
explosionsgefährlich: E
brandfördernd: O
hochentzündlich: F+
leichtentzündlich: F
entzündlich: R10
sehr giftig: T+
giftig: T
gesundheitsschädlich: Xn
ätzend: C
reizend: Xi
sensibilisierend: R42 und/oder R43
krebserzeugend: Carc. Cat. (1, 2 oder 3)
erbgutverändernd: Muta. Cat. (1, 2 oder 3)
fortpflanzungsgefährdend: Repr. Cat. (1, 2 oder 3)
umweltgefährlich: N oder R52 und/oder R53;
- 1.1.4.2.
Kennzeichnungskodierungen
- i)
Buchstabe, der dem Stoff gemäß Anhang II der Richtlinie 67/548/EWG (siehe Artikel 23 Absatz 2 Buchstabe c der Richtlinie 67/548/EWG) zugeordnet ist. Dieser dient als Abkürzung des Symbols und der Gefahrenbezeichnung (falls diese zugeordnet wurden).
- ii)
Hinweise auf besondere Gefahren gemäß Anhang III der Richtlinie 67/548/EWG (siehe Artikel 23 Absatz 2 Buchstabe d der Richtlinie 67/548/EWG), die als eine Reihe von Ziffern mit vorangestelltem "R" zur Bezeichnung der Art der besonderen Gefahren dargestellt werden. Zwischen den Ziffern steht ein Bindestrich (-) zur getrennten Angabe der besonderen Gefahren (R) oderein Schrägstrich (/) zur kombinierten Angabe der besonderen Gefahren in einem einzigen Satz gemäß Anhang III.
- iii)
Sicherheitsratschläge gemäß Anhang IV der Richtlinie 67/548/EWG (siehe Artikel 23 Absatz 2 Buchstabe e der Richtlinie 67/548/EWG), die als eine Reihe von Ziffern mit vorangestelltem "S" dargestellt werden und die empfohlenen Sicherheitsvorkehrungen wiedergeben. Auch hier werden die Ziffern entweder durch einen Bindestrich oder durch einen Schrägstrich getrennt. Die Bedeutung der empfohlenen Sicherheitsratschläge ist in Anhang IV der Richtlinie 67/548/EWG dargelegt. Die angegebenen Sicherheitsratschläge beziehen sich ausschließlich auf Stoffe; bei Zubereitungen werden die Sätze nach dem üblichen Verfahren ausgewählt.
Bei bestimmten im Einzelhandel erhältlichen gefährlichen Stoffen und Gemischen ist die Angabe bestimmter S-Sätze vorgeschrieben.
Die Angabe von S1, S2 und S45 ist bei allen sehr giftigen, giftigen und ätzenden Stoffen und Gemischen, die im Einzelhandel erhältlich sind, vorgeschrieben.
Die Angabe von S2 und S46 ist bei allen anderen Stoffen und Gemischen, die im Einzelhandel erhältlich sind, vorgeschrieben, mit Ausnahme der nur als umweltgefährlich eingestuften Stoffe und Zubereitungen.
Die Sicherheitssätze S1 und S2 sind in Anhang I in Klammern angegeben und können nur dann bei der Kennzeichnung weggelassen werden, wenn die Stoffe und Gemische ausschließlich für industrielle Zwecke verkauft werden.
- 1.1.4.3.
Spezifische Konzentrationsgrenzwerte
Konzentrationsgrenzwerte und die entsprechenden toxikologischen Einstufungen, die für eine Einstufung der den entsprechenden Stoff enthaltenden gefährlichen Gemische gemäß der Richtlinie 1999/45/EG erforderlich sind.
Sofern nicht anders angegeben, sind die aufgeführten Konzentrationsgrenzwerte als Gewichtsprozent, bezogen auf das Gesamtgewicht des Gemisches, zu verstehen.
Wenn keine Konzentrationsgrenzwerte angegeben sind, gelten bei Anwendung der konventionellen Methode zur Bewertung des Gesundheitsrisikos die Konzentrationsgrenzwerte des Anhangs II und bei Anwendung der konventionellen Methode zur Bewertung des Umweltrisikos die Konzentrationsgrenzwerte des Anhangs III der Richtlinie 1999/45/EWG des Europäischen Parlaments und des Rates.
- 1.1.4.4.
Nichtübereinstimmung mit Tabelle 3.1 bei physikalischen Gefahren
Es wird empfohlen, die physikalischen Gefahren einiger Einträge in Tabelle 3.2 im Rahmen einer künftigen Anpassung an den technischen Fortschritt zu aktualisieren.
Solange diese Einträge nicht aktualisiert sind, stimmen die physikalischen Gefahren der entsprechenden Einträge in den beiden Tabellen nicht miteinander überein. Diese Einträge sind in Tabelle 3.2 durch ""gekennzeichnet.
- 1.2.
Einstufungen und Gefahrenhinweise in Tabelle 3 infolge der Umwandlung von Einstufungen gemäß Anhang I der Richtlinie 67/548/EWG
- 1.2.1.
Mindesteinstufung
Für bestimmte Gefahrenklassen, darunter akute Toxizität und spezifische Zielorgan-Toxizität (wiederholte Exposition), entspricht die Einstufung gemäß den Kriterien der Richtlinie 67/548/EWG nicht direkt der Einstufung in eine Gefahrenklasse und -kategorie gemäß dieser Verordnung. In diesen Fällen gilt die Einstufung in diesem Anhang als Mindesteinstufung. Diese Einstufung gilt, wenn keine der nachstehenden Bedingungen gegeben ist:
Der Hersteller oder Einführer hat Zugang zu in Anhang I Teil 1 genannten Daten oder anderen Informationen, die zur Einstufung in eine im Vergleich zur Mindesteinstufung strengere Kategorie führen. Dann gilt die strengere Einstufung in die höhere Kategorie.
Die Mindesteinstufung kann auf der Grundlage der Umwandlungstabelle in Anhang VII weiter verfeinert werden, wenn dem Hersteller oder Importeur der Aggregatzustand des bei der Prüfung auf akute Inhalationstoxizität verwendeten Stoffes bekannt ist. Die sich aus Anhang VII ergebende Einstufung tritt dann an die Stelle der in diesem Anhang angegebenen Mindesteinstufung, falls sie von dieser abweicht.
Die Mindesteinstufung in Bezug auf eine Kategorie ist in Tabelle 3 in der Spalte "Einstufung" durch "*" gekennzeichnet.
Das Zeichen "*" ist auch in der Spalte "Spezifische Konzentrationsgrenzwerte und M-Faktoren und ATE" zu finden, wo es anzeigt, dass für den betreffenden Eintrag bestimmte Konzentrationsgrenzwerte für akute Toxizität gemäß der Richtlinie 67/548/EWG gelten. Die Konzentrationsgrenzwerte können allerdings nicht in Konzentrationsgrenzwerte dieser Verordnung umgewandelt werden, was insbesondere im Fall einer Mindesteinstufung ausgeschlossen ist. Wenn das Zeichen "*" angegeben wird, ist der Einstufung dieses Eintrags als akut toxisch dennoch besondere Beachtung beizumessen.
- 1.2.2.
Expositionsweg kann nicht ausgeschlossen werden
Für bestimmte Gefahrenklassen, z. B. STOT, sollte der Expositionsweg im Gefahrenhinweis nur dann angegeben werden, wenn schlüssig belegt ist, dass diese Gefahr gemäß den Kriterien des Anhangs I bei keinem anderen Expositionsweg besteht. Gemäß der Richtlinie 67/548/EWG wurde der Expositionsweg für Einstufungen als R48 angegeben, wenn Daten vorlagen, die eine Einstufung für diesen Expositionsweg rechtfertigten. Die Einstufung gemäß der Richtlinie 67/548/EWG, bei der der Expositionsweg angegeben ist, wurde in die entsprechende Klasse und Kategorie gemäß dieser Verordnung umgewandelt, jedoch mit einem allgemeinen Gefahrenhinweis ohne Angabe des Expositionswegs, da die erforderlichen Informationen nicht verfügbar sind.
Diese Gefahrenhinweise sind in Tabelle 3 durch "**" gekennzeichnet.
- 1.2.3.
Gefahrenhinweise für die Reproduktionstoxizität
Die Gefahrenhinweise H360 und H361 zeigen an, dass aufgrund von Wirkungen auf die Fruchtbarkeit und/oder die Entwicklung allgemeiner Anlass zur Besorgnis besteht: "Kann/Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen." Den Kriterien zufolge kann der allgemeine Gefahrenhinweis ersetzt werden durch den Gefahrenhinweis gemäß Abschnitt 1.1.2.1.2, der die konkrete Wirkung anzeigt, aufgrund deren Anlass zu Besorgnis besteht. Wenn die andere Differenzierung nicht erwähnt wird, so ist das darauf zurückzuführen, dass die Nachweise eine diesbezügliche Wirkung nicht belegen oder keine bzw. keine schlüssigen Daten vorliegen; für diese Differenzierung gelten die Verpflichtungen gemäß Artikel 4 Absatz 3.
Damit keine Informationen aus den harmonisierten Einstufungen für Wirkungen auf Fruchtbarkeit oder Entwicklung gemäß der Richtlinie 67/548/EWG verlorengehen, wurden die Einstufungen nur für Wirkungen übertragen, die bereits im Rahmen dieser Richtlinie eingestuft sind.
Diese Gefahrenhinweise sind in Tabelle 3 durch "***" gekennzeichnet.
- 1.2.4.
Ordnungsgemäße Einstufung nach physikalischen Gefahren konnte nicht vorgenommen werden
Für einige Einträge konnte eine ordnungsgemäße Einstufung nach physikalischen Gefahren nicht vorgenommen werden, da keine ausreichenden Daten für die Anwendung der Einstufungskriterien dieser Verordnung zur Verfügung stehen. Der betreffende Eintrag kann einer anderen (auch höheren) Kategorie oder sogar einer anderen Gefahrenklasse als den angegebenen Kategorien oder Gefahrenklassen zugeordnet werden. Die ordnungsgemäße Einstufung ist durch Prüfungen zu bestätigen.
Die Einträge mit physikalischen Gefahren, die durch Prüfungen bestätigt werden müssen, werden in Tabelle 3 mit "****" gekennzeichnet.
- 2.
TEIL 2: DOSSIERS FÜR HARMONISIERTE EINSTUFUNG UND KENNZEICHNUNG
In diesem Teil werden allgemeine Grundsätze für die Vorbereitung der Dossiers festgelegt, mit denen eine harmonisierte Einstufung und Kennzeichnung vorgeschlagen und begründet wird.
Für Methodik und Format der Dossiers sind die einschlägigen Teile der Abschnitte 1, 2 und 3 des Anhangs I der Verordnung (EG) Nr. 1907/2006 zugrunde zu legen.
Für sämtliche Dossiers sind alle einschlägigen Informationen aus Registrierungsdossiers zu berücksichtigen und es können weitere verfügbare Informationen verwendet werden. Für Gefahrenmerkmale, die der Agentur noch nicht unterbreitet wurden, ist dem Dossier eine qualifizierte Studienzusammenfassung beizulegen.
Ein Dossier für die harmonisierte Einstufung und Kennzeichnung muss Folgendes enthalten:
Vorschlag
Der Vorschlag umfasst die Identität des/der betreffenden Stoffe/-s und die vorgeschlagene harmonisierte Einstufung und Kennzeichnung.
Begründung der vorgeschlagenen Einstufung und Kennzeichnung
Die verfügbaren Informationen sind mit den Kriterien des Anhangs I Teile 2 bis 5 unter besonderer Berücksichtigung der allgemeinen Grundsätze in Teil 1 zu vergleichen und in dem Format, das in Teil B des Stoffsicherheitsberichts des Anhangs I der Verordnung (EG) Nr. 1907/2006 festgelegt ist, zu dokumentieren.
Begründung für andere Wirkungen auf Gemeinschaftsebene
Für andere Wirkungen als karzinogene, keinzellmutagene, reproduktionstoxische und die Atemwege sensibilisierende Wirkungen muss begründet werden, dass ein Handeln auf Gemeinschaftsebene erforderlich ist. Dies gilt nicht für Wirkstoffe im Sinne der Richtlinie 91/414/EWG oder der Richtlinie 98/8/EG.
- 3.
TEIL 3: TABELLE ZUR HARMONISIERTEN EINSTUFUNG UND KENNZEICHNUNG
Tabelle 3.1: Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe
Tabelle 3.2: Die Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe aus Anhang I der Richtlinie 67/548/EWG
Tabelle 3 Liste der harmonisierten Einstufungen und Kennzeichnungen gefährlicher Stoffe Index-Nr. Internationale chemische Bezeichnung EG-Nr. CAS-Nr. Einstufung Kennzeichnung Spezifische Konzentrationsgrenzen, M-Faktoren und ATE Anmerkungen Kodierung der Gefahrenklassen und -kategorien Kodierung der Gefahrenhinweise Piktogramm, Kodierung der Signalworte Kodierung der Gefahrenhinweise Kodierung der ergänzenden Gefahrenmerkmale 001-001-00-9 hydrogen 215-605-7 1333-74-0 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314
001-003-00-X sodium hydride 231-587-3 7646-69-7 Water-react. 1 H260 GHS02
Gef.
H260 001-004-00-5 calcium hydride 232-189-2 7789-78-8 Water-react. 1 H260 GHS02
Gef.
H260 003-001-00-4 lithium 231-102-5 7439-93-2 Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Gef.
H260
H314
EUH014 003-002-00-X n-hexyllithium 404-950-0 21369-64-2 Water-react. 1
Pyr. Sol. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Gef.
H260
H250
H314
EUH014 003-003-00-5 (2-methylpropyl)lithium;
isobutyllithium
440-620-2 920-36-5 Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H314
H336
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H260
H250
H314
H336
H410
EUH014 004-001-00-7 beryllium 231-150-7 7440-41-7 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Gef.
H350i
H330
H301
H372 **
H319
H335
H315
H317
004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex — — Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411
GHS06
GHS08
GHS09
Gef.
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411
A 004-003-00-8 beryllium oxide 215-133-1 1304-56-9 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Gef.
H350i
H330
H301
H372 **
H319
H335
H315
H317
005-001-00-X boron trifluoride 231-569-5 7637-07-2 Press. Gas
Acute Tox. 2 *
Skin Corr. 1A
H330
H314
GHS04
GHS06
GHS05
Gef.
H330
H314
EUH014 U 005-002-00-5 boron trichloride 233-658-4 10294-34-5 Press. Gas
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1B
H330
H300
H314
GHS04
GHS06
GHS05
Gef.
H330
H300
H314
EUH014 U 005-003-00-0 boron tribromide 233-657-9 10294-33-4 Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
H330
H300
H314
GHS06
GHS05
Gef.
H330
H300
H314
EUH014 005-004-00-6 trialkylboranes, solid — — Pyr. Sol. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Gef.
H250
H314
A 005-004-01-3 trialkylboranes, liquid — — Pyr. Liq. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Gef.
H250
H314
A 005-005-00-1 trimethyl borate 204-468-9 121-43-7 Flam. Liq. 3
Acute Tox. 4 *
H226
H312
GHS02
GHS07
Achtg.
H226
H312
005-006-00-7 dibutyltin hydrogen borate 401-040-5 75113-37-0 Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H341
H372**
H312
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H360FD
H341
H372**
H312
H302
H318
H317
H410
005-007-00-2 boric acid; [1]
boric acid; [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. 1B H360FD GHS08
Dgr
H360FD Repr. 1B; H360FD: C ≥ 5,5 % 005-008-00-8 diboron trioxide;
boric oxide
215-125-8 1303-86-2 Repr. 1B H360FD GHS08
Dgr
H360FD Repr. 1B; H360FD: C ≥ 3,1 % 005-009-00-3 tetrabutylammonium butyltriphenylborate 418-080-4 120307-06-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 422-050-6 118612-00-3 Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H351
H302
H315
H318
GHS08
GHS05
GHS07
Gef.
H351
H302
H315
H318
005-011-00-4 disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]
215-540-4 [1]
235-541-3 [2]
237-560-2 [3]
1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]
Repr. 1B H360FD GHS08
Dgr
H360FD Repr. 1B; H360FD: C ≥ 4,5 % 005-011-01-1 disodium tetraborate decahydrate;
borax decahydrate
215-540-4 1303-96-4 Repr. 1B H360FD GHS08
Dgr
H360FD Repr. 1B; H360FD: C ≥ 8,5 % 005-011-02-9 disodium tetraborate pentahydrate;
borax pentahydrate
215-540-4 12179-04-3 Repr. 1B H360FD GHS08
Dgr
H360FD Repr. 1B; H360FD: C ≥ 6,5 % 005-012-00-X diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate 418-070-1 141714-54-7 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
005-013-00-5 diethylmethoxyborane 425-380-9 7397-46-8 Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H250
H332
H312
H302
H373**
H314
H317
H413
GHS02
GHS05
GHS08
GHS07
Dgr
H250
H332
H312
H302
H373**
H314
H317
H413
005-014-00-0 4-formylphenylboronic acid 438-670-5 87199-17-5 Skin Sens. 1 H317 GHS07
Wng
H317 005-015-00-6 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 414-380-4 140681-55-6 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
005-016-00-1 tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate 431-370-5 — Aquatic Chronic 4 H413 — H413 005-017-00-7 sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-017-01-4 sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
STOT SE 3
Eye Dam. 1
H360Df
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H335
H318
Repr. 1B; H360Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H360Df
H332
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H332
H335
H318
Repr. 1B; H360Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-019-00-8 perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-019-01-5 perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate [3]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-020-00-3 Dinatriumoctaborat wasserfrei; [1]
Dinatriumoctaborat Tetrahydrat [2]
234-541-0 [1]
234-541-0 [2]
12008-41-2 [1]
12280-03-4 [2]
Repr. 1B H360FD GHS08
Dgr
H360FD 006-001-00-2 carbon monoxide 211-128-3 630-08-0 Flam. Gas 1
Press. Gas
Repr. 1A
Acute Tox. 3 *
STOT RE 1
H220
H360D ***
H331
H372 **
GHS02
GHS04
GHS06
GHS08
Gef.
H220
H360D ***
H331
H372 **
U 006-002-00-8 phosgene;
carbonyl chloride
200-870-3 75-44-5 Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
H330
H314
GHS04
GHS06
GHS05
Gef.
H330
H314
U 006-003-00-3 carbon disulphide 200-843-6 75-15-0 Flam. Liq. 2
Repr. 2
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
H225
H361fd
H372 **
H319
H315
GHS02
GHS08
GHS07
Gef.
H225
H361fd
H372 **
H319
H315
Repr. 2; H361fd: C ≥ 1 %
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0.2 % ≤C < 1 %
006-004-00-9 calcium carbide 200-848-3 75-20-7 Water-react. 1 H260 GHS02
Gef.
H260 T 006-005-00-4 thiram (ISO);
tetramethylthiuram disulphide
205-286-2 137-26-8 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 **
H319
H315
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H332
H302
H373 **
H319
H315
H317
H410
M=10 006-006-00-X hydrogen cyanide;
hydrocyanic acid
200-821-6 74-90-8 Flam. Liq. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H224
H330
H400
H410
GHS02
GHS06
GHS09
Gef.
H224
H330
H410
006-006-01-7 hydrogen cyanide … %;
hydrocyanic acid … %
200-821-6 74-90-8 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Gef.
H330
H310
H300
H410
B 006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
EUH032 A 006-008-00-0 antu (ISO);
1-(1-naphthyl)-2-thiourea
201-706-3 86-88-4 Acute Tox. 2 *
Carc. 2
H300
H351
GHS06
GHS08
Gef.
H300
H351
006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan
204-318-2 119-38-0 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan
204-525-8 122-15-6 Acute Tox. 3 * H301 GHS06
Gef.
H301 006-011-00-7 carbaryl (ISO);
1-naphthyl methylcarbamate
200-555-0 63-25-2 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H351
H332
H302
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H302
H400
M=100 006-012-00-2 ziram (ISO);
zinc bis dimethyldithiocarbamate
205-288-3 137-30-4 Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H373 **
H335
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H330
H302
H373 **
H335
H318
H317
H410
M=100 006-013-00-8 metam-sodium (ISO);
sodium methyldithiocarbamate
205-293-0 137-42-8 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H314
H317
H410
EUH031 006-014-00-3 nabam (ISO);
disodium ethylenebis(N, N'-dithiocarbamate)
205-547-0 142-59-6 Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H317
H410
GHS07
GHS09
Achtg.
H302
H335
H317
H410
006-015-00-9 diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4 330-54-1 Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H373**
H410
M = 10 006-016-00-4 propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate
204-043-8 114-26-1 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
006-017-00-X aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2 116-06-3 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Gef.
H330
H300
H311
H410
006-018-00-5 aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate
217-990-7 2032-59-9 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
006-019-00-0 di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-1 2303-16-4 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H302
H410
006-020-00-6 barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4 101-27-9 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Achtg.
H302
H317
H410
006-021-00-1 linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5 330-55-2 Repr. 1B
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H351
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Gef.
H360Df
H351
H302
H373 **
H410
006-022-00-7 decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
— 1563-67-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
006-023-00-2 mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-2 2032-65-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
006-024-00-8 proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate
205-443-5 140-93-2 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Achtg.
H302
H315
H411
006-025-00-3 allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]
249-013-5 [2]
[3]
584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H302
H410
C 006-026-00-9 carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-0 1563-66-2 Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Gef.
H330
H300
H410
006-028-00-X dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1 973-21-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
006-029-00-5 dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-4 6988-21-2 Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Gef.
H301
H411
006-030-00-0 EPTC (ISO);
S-ethyl dipropylthiocarbamate
212-073-8 759-94-4 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-031-00-6 formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-0 22259-30-9 Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Gef.
H330
H300
H317
H410
006-032-00-1 monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-5 1746-81-2 Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Achtg.
H302
H373 **
H410
006-033-00-7 metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-2 19937-59-8 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 006-034-00-2 pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate
214-215-4 1114-71-2 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
006-035-00-8 Pirimicarb (ISO); 2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat 245-430-1 23103-98-2 Carc. 2
Acute Tox. 3
Acute Tox. 3
Skin Sens. 1
Aquatic Acute 1 Aquatic Chronic 1
H351
H331
H301
H317
H400
H410
GHS08
GHS06
GHS09
Dgr
H351
H331
H301
H317
H410
M = 10
M = 100
006-036-00-3 benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea
217-685-9 1929-88-0 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-037-00-9 promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-0 2631-37-0 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
006-038-00-4 sulfallate (ISO);
2-chloroallyl N,N-dimethyldithiocarbamate
202-388-9 95-06-7 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H302
H410
006-039-00-X tri-allate (ISO);
S—2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-7 2303-17-5 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H302
H373 **
H317
H410
006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan
— 2532-43-6 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
006-041-00-0 dimethylcarbamoyl chloride 201-208-6 79-44-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H331
H302
H319
H335
H315
GHS06
GHS08
Gef.
H350
H331
H302
H319
H335
H315
Carc. 1B; H350: C ≥ 0,001 % 006-042-00-6 monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1 150-68-5 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H302
H410
006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA
— 140-41-0 Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H315
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H319
H315
H410
006-044-00-7 isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-4 34123-59-6 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Achtg.
H351
H410
M=10 006-045-00-2 methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate
240-815-0 16752-77-5 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410
M=100 006-046-00-8 Bendiocarb (ISO);
2,2-Dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamat;
2,2-Dimethyl-1,3-benzodioxol-4-yl-methylcarbamat
245-216-8 22781-23-3 Acute Tox. 3
Acute Tox. 3
Acute Tox. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H300
H400
H410
GHS06
GHS09
Dgr
H331
H311
H300
H410
M = 10
M = 100
006-047-00-3 bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
— 8065-36-9 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
006-048-00-9 ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-9 29973-13-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
006-049-00-4 dixanthogen;
O,O-diethyl dithiobis(thioformate)
207-944-4 502-55-6 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA
— 4482-55-7 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Achtg.
H315
H410
006-051-00-5 ferbam (ISO);
iron tris(dimethyldithiocarbamate)
238-484-2 14484-64-1 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H335
H315
H410
006-052-00-0 formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-0 23422-53-9 Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Gef.
H330
H300
H317
H410
006-053-00-6 isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate
220-114-6 2631-40-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
006-054-00-1 mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3 315-18-4 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Gef.
H300
H312
H410
006-055-00-7 xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC
219-364-9 2425-10-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
006-056-00-2 metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC
214-446-0 1129-41-5 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
006-057-00-8 nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine
217-682-2 1929-82-4 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
006-058-00-3 noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
— 2163-79-3 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-059-00-9 oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-3 23135-22-0 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Chronic 2
H330
H300
H312
H411
GHS06
GHS09
Gef.
H330
H300
H312
H411
006-060-00-4 oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-2 5259-88-1 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride
243-193-9 19622-19-6 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
006-062-00-5 methyl 3,4-dichlorophenylcarbanilate;
SWEP.
— 1918-18-9 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-063-00-0 thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate
248-924-5 28249-77-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
006-064-00-6 thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime
254-346-4 39196-18-4 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid
— 15271-41-7 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Chronic 2
H300
H311
H411
GHS06
GHS09
Gef.
H300
H311
H411
006-066-00-7 vernolate (ISO);
S-propyl dipropylthiocarbamate
217-681-7 1929-77-7 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
006-067-00-2 XMC;
3,5-xylyl methylcarbamate
— 2655-14-3 Acute Tox. 4 * H302 GHS07
Achtg.
H302 006-068-00-8 diazomethane 206-382-7 334-88-3 Carc. 1B H350 GHS08
Gef.
H350 006-069-00-3 thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-7 23564-05-8 Muta. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H332
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H341
H332
H317
H410
006-070-00-9 furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide
262-302-0 60568-05-0 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Achtg.
H351
H410
006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 401-620-8 87731-18-8 Skin Sens. 1 H317 GHS07
Achtg.
H317 006-072-00-X prosulfocarb (ISO);
S-benzyl N,N-dipropylthiocarbamate
401-730-6 52888-80-9 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Achtg.
H302
H317
H411
006-073-00-5 3-(dimethylamino)propylurea 401-950-2 31506-43-1 Eye Dam. 1 H318 GHS05
Gef.
H318 006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 402-440-2 2094-99-7 Acute Tox. 2 *
Skin Corr. 1B
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H314
H373 **
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H330
H314
H373 **
H334
H317
H410
006-076-00-1 mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
— 8018-01-7 Repr. 2
Skin Sens. 1
Aquatic Acute 1
H361d***
H317
H400
GHS08
GHS07
GHS09
Wng
H361d***
H317
H400
M=10 006-077-00-7 maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)
235-654-8 12427-38-2 Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H332
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d***
H332
H319
H317
H410
M=10 006-078-00-2 zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-1 12122-67-7 STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Achtg.
H335
H317
006-079-00-8 disulfiram;
tetraethylthiuramdisulfide
202-607-8 97-77-8 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H302
H373 **
H317
H410
006-080-00-3 tetramethylthiuram monosulphide 202-605-7 97-74-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Achtg.
H302
H317
H411
006-081-00-9 zinc bis(dibutyldithiocarbamate) 205-232-8 136-23-2 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H319
H335
H315
H317
H410
006-082-00-4 zinc bis(diethyldithiocarbamate) 238-270-9 14324-55-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H335
H315
H317
H410
006-083-00-X butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-3 34681-10-2 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H226
H331
H311
H301
H319
H400
H410
GHS02
GHS06
GHS09
Gef.
H226
H331
H311
H301
H319
H410
006-084-00-5 carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-9 55285-14-8 Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H317
H400
H410
GHS06
GHS09
Dgr
H330
H301
H317
H410
006-085-00-0 fenobucarb (ISO);
2-butylphenyl methylcarbamate
223-188-8 3766-81-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
006-086-00-6 fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate 276-696-7 72490-01-8 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
M = 1
M = 10000
006-087-00-1 furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate
265-974-3 65907-30-4 Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H373**
H319
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H301
H373**
H319
H315
H317
H410
M = 100 006-088-00-7 benfuracarb (ISO);
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
— 82560-54-1 Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H331
H302
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f***
H331
H302
H410
006-089-00-2 chlorine dioxide 233-162-8 10049-04-4 Ox. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H270
H330
H314
H400
GHS03
GHS04
GHS06
GHS05
GHS09
Dgr
H270
H330
H314
H400
EUH006 M=1000 U 006-089-01-X chlorine dioxide . . . % 233-162-8 10049-04-4 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 10 %
STOT SE 3; H335: C ≥ 3 %
M=10
B 006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 408-010-0 88558-41-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H332
H318
H412
GHS05
GHS07
Gef.
H332
H318
H412
006-091-00-3 propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)
— 9016-72-2 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H332
H373**
H317
H400
GHS08
GHS07
GHS09
Wng
H332
H373**
H317
H400
006-092-00-9 tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate 425-420-5 98737-29-2 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 006-093-00-4 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) 427-180-7 — Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
006-094-00-X O-isobutyl-N-ethoxy carbonylthiocarbamate 434-350-4 103122-66-3 Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H226
H350
H340
H302
H373**
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H350
H340
H302
H373**
H317
H411
006-095-00-5 fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate
254-320-2 39148-24-8 Eye Dam. 1 H318 GHS05
Dgr
H318 006-096-00-0 chlorpropham (ISO);
isopropyl 3-chlorocarbanilate
202-925-7 101-21-3 Carc. 2
STOT RE 2 *
Aquatic Chronic 2
H351
H373**
H411
GHS08
GHS09
Wng
H351
H373**
H411
006-097-00-6 1-phenyl-3-(p-toluenesulfonyl)urea 424-620-1 13909-63-2 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate 429-170-8 134575-17-0 Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
006-099-00-7 N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate
432-520-2 232938-43-1 Aquatic Chronic 2 H411 GHS09 H411 006-101-00-6 reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
423-070-8 — Aquatic Chronic 4 H413 — H413 006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate 432-750-3 — Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H340
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H302
H373**
H317
H411
006-103-00-7 N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea 445-760-8 — Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H400
H410
GHS05
GHS08
GHS09
Dgr
H318
H334
H410
M=100 007-001-00-5 ammonia, anhydrous 231-635-3 7664-41-7 Flam. Gas 2
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H221
H331
H314
H400
GHS04
GHS06
GHS05
GHS09
Gef.
H221
H331
H314
H400
U 007-001-01-2 ammonia ….% 215-647-6 1336-21-6 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
STOT SE 3; H335: C ≥ 5 % B 007-002-00-0 nitrogen dioxide; [1]
dinitrogen tetraoxide [2]
233-272-6 [1]
234-126-4 [2]
10102-44-0 [1]
10544-72-6 [2]
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314
*
STOT SE 3; H335: C ≥ 0,5 %
5 007-003-00-6 chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride
213-666-4 999-81-5 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
007-004-00-1 Salpetersäure … % 231-714-2 7697-37-2 Ox. Liq. 2
Skin Corr. 1A
H272
H314
GHS03
GHS05
Dgr
H272
H314
EUH071 Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Ox. Liq. 2; H272: C ≥ 99 %
Ox. Liq. 3; H272: 99 % > C ≥ 65 %
B 007-006-00-2 ethyl nitrite 203-722-6 109-95-5 Flam. Gas 1
Press. Gas
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H220
H332
H312
H302
GHS02
GHS04
GHS07
Gef.
H220
H332
H312
H302
U 007-007-00-8 ethyl nitrate 210-903-3 625-58-1 Unst. Expl. H200 GHS01
Dgr
H200 007-008-00-3 hydrazine 206-114-9 302-01-2 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H350
H331
H311
H301
H314
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Gef.
H226
H350
H331
H311
H301
H314
H317
H410
Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 3 % ≤ C < 10 %
007-009-00-9 dicyclohexylammonium nitrite 221-515-9 3129-91-7 Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Achtg.
H332
H302
* 007-010-00-4 sodium nitrite 231-555-9 7632-00-0 Ox. Sol. 3
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Gef.
H272
H301
H400
* 007-011-00-X potassium nitrite 231-832-4 7758-09-0 Ox. Sol. 2
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Gef.
H272
H301
H400
* 007-012-00-5 N,N-dimethylhydrazine 200-316-0 57-14-7 Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H331
H301
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Gef.
H225
H350
H331
H301
H314
H411
007-013-00-0 1,2-dimethylhydrazine — 540-73-8 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Gef.
H350
H331
H311
H301
H411
Carc. 1B; H350: C ≥ 0.01 % 007-014-00-6 salts of hydrazine — — Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H311
H301
H317
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H331
H311
H301
H317
H410
A 007-015-00-1 O-ethylhydroxylamine 402-030-3 624-86-2 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H225
H331
H311
H301
H372 **
H319
H317
H400
GHS02
GHS06
GHS08
GHS09
Gef.
H225
H331
H311
H301
H372 **
H319
H317
H400
007-016-00-7 butyl nitrite 208-862-1 544-16-1 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
H225
H331
H301
GHS02
GHS06
Gef.
H225
H331
H301
007-017-00-2 isobutyl nitrite 208-819-7 542-56-3 Flam. Liq. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H350
H341
H332
H302
GHS02
GHS08
GHS07
Gef.
H225
H350
H341
H332
H302
007-018-00-8 sec-butyl nitrite 213-104-8 924-43-6 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Gef.
H225
H332
H302
007-019-00-3 tert-butyl nitrite 208-757-0 540-80-7 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Gef.
H225
H332
H302
007-020-00-9 pentyl nitrite; [1]
"amyl nitrite", mixed isomers [2]
207-332-7 [1]
203-770-8 [2]
463-04-7 [1]
110-46-3 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Gef.
H225
H332
H302
007-021-00-4 hydrazobenzene;
1,2-diphenylhydrazine
204-563-5 122-66-7 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H302
H410
007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) 405-030-1 — Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H302
H314
H317
H412
GHS08
GHS05
GHS07
Gef.
H350
H302
H314
H317
H412
007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate 405-510-0 — Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Achtg.
H315
H317
007-024-00-0 2-(decylthio)ethylammonium chloride 405-640-8 36362-09-1 STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H315
H318
H400
H410
GHS08
GHS05
GHS09
Gef.
H373 **
H315
H318
H410
007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 406-090-1 81880-96-8 Muta. 2
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H301
H372 **
H317
H400
H410
GHS06
GHS08
GHS09
Gef.
H341
H301
H372 **
H317
H410
007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 413-230-5 122035-71-6 Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Gef.
H318
H317
007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 420-190-2 771478-66-1 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Gef.
H312
H302
H373 **
H314
H317
H410
007-028-00-2 hydroxylammonium nitrate 236-691-2 13465-08-2 Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H311
H302
H373**
H319
H315
H317
H400
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H351
H311
H302
H373**
H319
H315
H317
H400
007-029-00-8 diethyldimethylammonium hydroxide 419-400-5 95500-19-9 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
008-001-00-8 oxygen 231-956-9 7782-44-7 Ox. Gas 1
Press. Gas
H270 GHS03
GHS04
Gef.
H270 U 008-003-00-9 hydrogen peroxide solution ... % 231-765-0 7722-84-1 Ox. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H271
H332
H302
H314
GHS03
GHS05
GHS07
Gef.
H271
H332
H302
H314
Ox. Liq. 1; H271: C ≥ 70 %****
Ox. Liq. 2; H272: 50 % ≤ C < 70 %****
*
Skin Corr. 1A; H314: C ≥ 70 %
Skin Corr. 1B; H314: 50 % ≤ C < 70 %
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 8 %
STOT SE 3; H335; C ≥ 35 %
B 009-001-00-0 fluorine 231-954-8 7782-41-4 Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1A
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314
009-002-00-6 hydrogen fluoride 231-634-8 7664-39-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Gef.
H330
H310
H300
H314
009-003-00-1 hydrofluoric acid ... % 231-634-8 7664-39-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Gef.
H330
H310
H300
H314
Skin Corr. 1A; H314: C ≥ 7 %
Skin Corr. 1B; H314: 1 % ≤ C < 7 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
B 009-004-00-7 sodium fluoride 231-667-8 7681-49-4 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Gef.
H301
H319
H315
EUH032 009-005-00-2 potassium fluoride 232-151-5 7789-23-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
009-006-00-8 ammonium fluoride 235-185-9 12125-01-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
009-007-00-3 sodium bifluoride;
sodium hydrogen difluoride
215-608-3 1333-83-1 Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Gef.
H301
H314
*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-008-00-9 potassium bifluoride;
potassium hydrogen difluoride
232-156-2 7789-29-9 Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Gef.
H301
H314
*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-009-00-4 ammonium bifluoride;
ammonium hydrogen difluoride
215-676-4 1341-49-7 Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Gef.
H301
H314
*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-010-00-X fluoroboric acid ... % 240-898-3 16872-11-0 Skin Corr. 1B H314 GHS05
Gef.
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B 009-011-00-5 fluorosilicic acid ... % 241-034-8 16961-83-4 Skin Corr. 1B H314 GHS05
Gef.
H314 B 009-012-00-0 alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3]
240-934-8 [1]
240-896-2 [2]
240-968-3 [3]
16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
* A 009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 * H302 GHS07
Achtg.
H302 * A 009-014-00-1 lead hexafluorosilicate 247-278-1 25808-74-6 Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Gef.
H360Df
H332
H302
H373 **
H410
1 009-015-00-7 sulphuryl difluoride 220-281-5 2699-79-8 Press. Gas
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H373 **
H400
GHS04
GHS06
GHS08
GHS09
Gef.
H331
H373 **
H400
U 009-016-00-2 trisodium hexafluoroaluminate [1] 237-410-6 [1] 13775-53-6 [1] STOT RE 1
Acute Tox. 4
Aquatic Chronic 2
H372
H332
H411
GHS07
GHS08
GHS09
Dgr
H372
H332
H411
trisodium hexafluoroaluminate (cryolite) [2] 239-148-8 [2] 15096-52-3 [2] 009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 400-040-2 12091-08-6 Flam. Sol. 1
Water-react. 1
Skin Corr. 1A
Acute Tox. 4 *
H228
H270
H314
H332
GHS02
GHS05
GHS07
Gef.
H228
H270
H314
H332
EUH014 T 009-018-00-3 magnesium hexafluorosilicate 241-022-2 16949-65-8 Acute Tox. 3 * H301 GHS06
Gef.
H301 * 011-001-00-0 sodium 231-132-9 7440-23-5 Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Gef.
H260
H314
EUH014 011-002-00-6 sodium hydroxide;
caustic soda
215-185-5 1310-73-2 Skin Corr. 1A H314 GHS05
Gef.
H314 Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
011-003-00-1 sodium peroxide 215-209-4 1313-60-6 Ox. Sol. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Gef.
H271
H314
011-004-00-7 sodium azide 247-852-1 26628-22-8 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Gef.
H300
H400
H410
EUH032 011-005-00-2 sodium carbonate 207-838-8 497-19-8 Eye Irrit. 2 H319 GHS07
Achtg.
H319 011-006-00-8 sodium cyanate 213-030-6 917-61-3 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
011-007-00-3 propoxycarbazone-sodium — 181274-15-7 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 M=10 012-001-00-3 magnesium powder (pyrophoric) 231-104-6 7439-95-4 Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Gef.
H260
H250
T 012-002-00-9 magnesium, powder or turnings 231-104-6 — Flam. Sol. 1
Water-react. 2
Self-heat. 1
H228
H261
H252
GHS02
Gef.
H228
H261
H252
T 012-003-00-4 magnesium alkyls — — Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Gef.
H250
H260
H314
EUH014 A 012-004-00-X aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate 422-150-1 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 013-001-00-6 aluminium powder (pyrophoric) 231-072-3 7429-90-5 Water-react. 2
Pyr. Sol. 1
H261
H250
GHS02
Gef.
H261
H250
T 013-002-00-1 aluminium powder (stabilised) 231-072-3 7429-90-5 Water-react. 2
Flam. Sol. 1
H261
H228
GHS02
Dgr
H261
H228
T 013-003-00-7 aluminium chloride, anhydrous 231-208-1 7446-70-0 Skin Corr. 1B H314 GHS05
Gef.
H314 013-004-00-2 aluminium alkyls — — Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Gef.
H250
H260
H314
EUH014 A 013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 401-160-8 55426-95-4 Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Gef.
H260
H250
H314
EUH014 013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised 402-370-2 — Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Gef.
H226
H318
013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) 403-430-0 — Eye Dam. 1 H318 GHS05
Gef.
H318 013-008-00-4 di-n-octylaluminium iodide 408-190-0 7585-14-0 Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H314
H400
H410
GHS02
GHS05
GHS09
Gef.
H250
H314
H410
EUH014 013-009-00-X sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0.5 y = 1.5 418-720-2 — Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A
H228
H260
H250
H332
H314
GHS02
GHS05
GHS07
Gef.
H228
H260
H250
H332
H314
EUH014 T 013-010-00-5 hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide) 430-650-4 151841-65-5 Aquatic Chronic 2 H411 GHS09 H411 014-001-00-9 trichlorosilane 233-042-5 10025-78-2 Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H224
H250
H332
H302
H314
GHS02
GHS05
GHS07
Gef.
H224
H250
H332
H302
H314
EUH014
EUH029
*
STOT SE 3; H335: C ≥ 1 %
T 014-002-00-4 silicon tetrachloride 233-054-0 10026-04-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Achtg.
H319
H335
H315
EUH014 014-003-00-X dimethyldichlorosilane 200-901-0 75-78-5 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Gef.
H225
H319
H335
H315
014-004-00-5 trichloro(methyl)silane;
methyltrichlorosilane
200-902-6 75-79-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Gef.
H225
H319
H335
H315
EUH014 Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %
014-005-00-0 tetraethyl silicate;
ethyl silicate
201-083-8 78-10-4 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H319
H335
GHS02
GHS07
Achtg.
H226
H332
H319
H335
014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride 401-380-4 — Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Achtg.
H319
H411
014-007-00-1 triethoxyisobutylsilane 402-810-3 17980-47-1 Skin Irrit. 2 H315 GHS07
Achtg.
H315 014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 401-200-4 85491-26-5 Aquatic Chronic 2 H411 GHS09 H411 014-009-00-2 isobutylisopropyldimethoxysilane 402-580-4 111439-76-0 Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H315
GHS02
GHS07
Achtg.
H226
H332
H315
014-010-00-8 disodium metasilicate 229-912-9 6834-92-0 Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
014-011-00-3 cyclohexyldimethoxymethylsilane 402-140-1 17865-32-6 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine 403-480-3 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
014-013-00-4 α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) 404-920-7 — Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H312
H302
H314
H411
GHS05
GHS07
GHS09
Gef.
H312
H302
H314
H411
014-014-00-X etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane
253-704-7 37894-46-5 Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
H360D ***
H302
H373 **
GHS08
GHS07
Gef.
H360D ***
H302
H373 **
014-015-00-5 α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane)) 406-420-4 69430-40-6 Aquatic Chronic 4 H413 — H413 014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6 — Aquatic Chronic 2 H411 GHS09 H411 014-017-00-6 flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H—1,2,4-triazol-1-ylmethyl)silane
— 85509-19-9 Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Gef.
H351
H360D ***
H302
H411
014-018-00-1 octamethylcyclotetrasiloxane 209-136-7 556-67-2 Repr. 2
Aquatic Chronic 4
H361f ***
H413
GHS08
Achtg.
H361f ***
H413
014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H—1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H—1,2,4-triazole
403-250-2 — Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Gef.
H351
H360D ***
H302
H411
014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 414-960-7 53863-99-3 Acute Tox. 4 * H332 GHS07
Achtg.
H332 014-021-00-8 tris(isopropenyloxy)phenyl silane 411-340-8 52301-18-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H400
H410
014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) 401-530-9 — Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H228
H370 **
H332
H312
H302
GHS02
GHS08
GHS07
Gef.
H228
H370 **
H332
H312
H302
T 014-023-00-9 α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 408-160-7 125613-45-8 Aquatic Chronic 2 H411 GHS09 H411 014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 412-620-2 121626-74-2 Aquatic Chronic 2 H411 GHS09 H411 014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 411-400-3 102089-33-8 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H373 **
H315
H318
H412
GHS08
GHS05
GHS07
Gef.
H302
H373 **
H315
H318
H412
014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 407-180-3 770722-36-6 Skin Corr. 1A H314 GHS05
Gef.
H314 014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 410-270-5 770722-46-8 Skin Corr. 1A H314 GHS05
Gef.
H314 014-028-00-6 α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 415-290-8 193159-06-7 Skin Sens. 1 H317 GHS07
Achtg.
H317 014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 421-870-1 156145-66-3 Repr. 2
Acute Tox. 4 *
STOT RE 2 *
H361f ***
H302
H373 **
GHS08
GHS07
Achtg.
H361f ***
H302
H373 **
014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium 422-060-0 137390-08-0 Acute Tox. 2 * H300 GHS06
Gef.
H300 014-031-00-2 bis(1-methylethyl)-dimethoxysilane 421-540-7 18230-61-0 Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H226
H315
H317
H412
GHS02
GHS07
Achtg.
H226
H315
H317
H412
014-032-00-8 dicyclopentyldimethoxysilane 404-370-8 126990-35-0 Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Gef.
H315
H318
H410
014-033-00-3 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica 419-030-4 125804-20-8 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
014-034-00-9 3-hexylheptamethyltrisiloxane 428-700-5 1873-90-1 Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
014-035-00-4 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane 425-050-4 10217-34-2 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
014-036-00-X (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane 405-020-7 105024-66-6 Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H400
H410
GHS08
GHS09
Dgr
H360F***
H410
M=1000 014-037-00-5 2-butanone-O,O',O''-(phenylsilylidyne)trioxime 433-360-6 34036-80-1 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412
014-038-00-0 S-(3-(triethoxysilyl)propyl) octanethioate 436-690-9 220727-26-4 Skin Sens. 1 H317 GHS07
Wng
H317 014-039-00-6 (2,3-dimethylbut-2-yl)-trimethoxysilane 439-360-2 142877-45-0 Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane 445-890-5 201290-01-9 Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
014-042-00-2 reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) 423-010-0 — Eye Dam. 1 H318 GHS05
Dgr
H318 014-043-00-8 reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) 432-200-2 — STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H335
H315
H318
H412
GHS05
GHS07
Dgr
H335
H315
H318
H412
014-044-00-3 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane 433-050-0 — Aquatic Chronic 2 H411 GHS09 H411 014-045-00-9 magnesium sodium fluoride silicate 442-650-1 — STOT RE 2 * H373** GHS08
Wng
H373** 014-046-00-4 E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] — — Carc. 1B H350i GHS08
Dgr
H350i A 014-047-00-X Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).] — — Carc. 2 H351 (Einatmen) GHS08
Wng
H351 (Einatmen) A 015-001-00-1 white phosphorus 231-768-7 12185-10-3 Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H250
H330
H300
H314
H400
GHS02
GHS06
GHS05
GHS09
Gef.
H250
H330
H300
H314
H400
015-002-00-7 red phosphorus 231-768-7 7723-14-0 Flam. Sol. 1
Aquatic Chronic 3
H228
H412
GHS02
Gef.
H228
H412
015-003-00-2 Calciumphosphid; Tricalciumdiphosphid 215-142-0 1305-99-3 Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Eye Dam. 1
Aquatic Acute 1
H260
H300
H311
H330
H318
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H260
H300
H311
H330
H318
H400
EUH029
EUH032
M = 100 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-005-00-3 magnesium phosphide;
trimagnesium
diphosphide
235-023-7 12057-74-8 Water-react. 1 H260 GHS02 H260 EUH029 M = 100 Acute Tox. 2 H300 GHS06 H300 EUH032 Acute Tox. 3 H311 GHS09 H311 Acute Tox. 1 H330 Dgr H330 Aquatic Acute 1 H400 H400 015-006-00-9 trizinc diphosphide;
zinc phosphide
215-244-5 1314-84-7 Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H260
H300
H400
H410
GHS02
GHS06
GHS09
Dgr
H260
H300
H410
EUH029
EUH032
M=100 T 015-007-00-4 phosphorus trichloride 231-749-3 7719-12-2 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A
H330
H300
H373 **
H314
GHS06
GHS08
GHS05
Gef.
H330
H300
H373 **
H314
EUH014
EUH029
015-008-00-X phosphorus pentachloride 233-060-3 10026-13-8 Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H330
H302
H373 **
H314
GHS06
GHS08
GHS05
Gef.
H330
H302
H373 **
H314
EUH014
EUH029
015-009-00-5 phosphoryl trichloride 233-046-7 10025-87-3 Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A
H330
H372 **
H302
H314
GHS06
GHS08
GHS05
Gef.
H330
H372 **
H302
H314
EUH014
EUH029
015-010-00-0 phosphorus pentoxide 215-236-1 1314-56-3 Skin Corr. 1A H314 GHS05
Gef.
H314 015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 231-633-2 7664-38-2 Skin Corr. 1B H314 GHS05
Gef.
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B 015-012-00-1 tetraphosphorus trisulphide;
phosphorus sesquisulphid
215-245-0 1314-85-8 Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H302
H400
GHS02
GHS07
GHS09
Gef.
H228
H260
H302
H400
T 015-013-00-7 triethyl phosphate 201-114-5 78-40-0 Acute Tox. 4 * H302 GHS07
Achtg.
H302 015-014-00-2 tributyl phosphate 204-800-2 126-73-8 Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
H351
H302
H315
GHS08
GHS07
Achtg.
H351
H302
H315
015-015-00-8 tricresyl phosphate (o—o—o-, o—o—m-, o—o—p-, o—m—m-, o—m—p-, o—p—p-);
tritolyl phosphate (o—o—o-, o—o—m-, o—o—p-, o—m—m-, o—m—p-, o—p—p-);
201-103-5 78-30-8 STOT SE 1
Aquatic Chronic 2
H370 **
H411
GHS08
GHS09
Gef.
H370 **
H411
STOT SE 1; H370: C ≥ 1 %
STOT SE 2; H371: 0,2 % ≤ C < 1 %
C 015-016-00-3 tricresyl phosphate (m—m—m-, m—m—p-, m—p—p-,p—p—p-);
tritolyl phosphate (m—m—m-, m—m—p-, m—p—p-, p—p—p-);
201-105-6 78-32-0 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Achtg.
H312
H302
H411
* C 015-019-00-X dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate
200-547-7 62-73-7 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
H330
H311
H301
H317
H400
GHS06
GHS09
Dgr
H330
H311
H301
H317
H400
M=1000 015-020-00-5 mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-1 7786-34-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
M=10000 015-021-00-0 trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-3 52-68-6 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Achtg.
H302
H317
H400
H410
M=1000 015-022-00-6 phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-5 13171-21-6 Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H300
H311
H400
H410
GHS06
GHS08
GHS09
Gef.
H341
H300
H311
H410
015-023-00-1 pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate
— 108-34-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Gef.
H330
H310
H300
015-024-00-7 triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide
— 1031-47-6 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-025-00-2 TEPP (ISO);
tetraethyl pyrophosphate
203-495-3 107-49-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Gef.
H310
H300
H400
015-026-00-8 schradan (ISO);
octamethylpyrophosphoramide
205-801-0 152-16-9 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-027-00-3 sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate
222-995-2 3689-24-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
M=1000 015-028-00-9 demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8 298-03-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Gef.
H310
H300
H400
015-029-00-4 demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8 126-75-0 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-030-00-X demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1 867-27-6 Acute Tox. 3 * H301 GHS06
Gef.
H301 015-031-00-5 demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6 919-86-8 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H311
H301
H411
GHS06
GHS09
Gef.
H311
H301
H411
015-032-00-0 prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-2 2275-18-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 3
H310
H300
H412
GHS06
Gef.
H310
H300
H412
015-033-00-6 phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2 298-02-2 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
M=1000 015-034-00-1 parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-7 56-38-2 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H300
H311
H372 **
H410
M=100 015-035-00-7 parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1 298-00-0 Flam. Liq. 3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H330
H300
H311
H373 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Gef.
H226
H330
H300
H311
H373 **
H410
M=100 015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN
218-276-8 2104-64-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
015-037-00-8 phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate
218-892-7 2275-14-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Gef.
H331
H311
H301
H410
015-038-00-3 coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-3 56-72-4 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Gef.
H300
H312
H410
015-039-00-9 azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-1 86-50-0 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H317
H400
H410
GHS06
GHS09
Gef.
H330
H300
H311
H317
H410
015-040-00-4 diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8 333-41-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H400
H410
015-041-00-X malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]
204-497-7 121-75-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=1000 015-042-00-5 chlorthion
O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate
207-902-5 500-28-7 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
M=100 015-043-00-0 phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate
— 5826-76-6 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Achtg.
H332
H312
H302
015-044-00-6 carbophenothion (ISO);
4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate
212-324-1 786-19-6 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
015-045-00-1 mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate
219-993-9 2595-54-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H400
H410
015-046-00-7 oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7 301-12-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
H311
H301
H400
GHS06
GHS09
Gef.
H311
H301
H400
015-047-00-2 ethion (ISO);
O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);
diethion
209-242-3 563-12-2 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Gef.
H301
H312
H410
M=10000 015-048-00-8 fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-9 55-38-9 Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H312
H302
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H312
H302
H372**
H410
M=100 015-049-00-3 endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-3 2778-04-3 Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Gef.
H311
H301
015-050-00-9 thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6 640-15-3 Acute Tox. 3 *
Acute Tox. 4 *
H301
H312
GHS06
Gef.
H301
H312
015-051-00-4 dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-3 60-51-5 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
015-052-00-X fenchlorphos (ISO);
O,O-dimethyl O—2,4,5-trichlorophenyl phosphorothioate
206-082-6 299-84-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
015-053-00-5 menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate
201-123-4 78-57-9 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
015-054-00-0 fenitrothion (ISO);
O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2 122-14-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
015-055-00-6 naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3 300-76-5 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H312
H302
H319
H315
H400
GHS07
GHS09
Achtg.
H312
H302
H319
H315
H400
M=1000 015-056-00-1 azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-6 2642-71-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M=100 015-057-00-7 formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate
219-818-6 2540-82-1 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
015-058-00-2 morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0 144-41-2 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Gef.
H331
H311
H301
H410
015-059-00-8 vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-8 2275-23-2 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Gef.
H301
H312
H400
015-060-00-3 disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3 298-04-4 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
015-061-00-9 dimefox (ISO);
tetramethylphosphorodiamidic fluoride
204-076-8 115-26-4 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-062-00-4 mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride
206-742-3 371-86-8 STOT SE 1 H370 ** GHS08
Gef.
H370 ** 015-063-00-X dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-7 78-34-2 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Gef.
H330
H300
H311
H410
M=1000 015-064-00-5 bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate
225-399-0 4824-78-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Gef.
H301
H312
H410
015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate — 2703-37-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Gef.
H330
H310
H300
H411
015-066-00-6 omethoate (ISO);
O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-8 1113-02-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Gef.
H301
H312
H400
015-067-00-1 phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate
218-996-2 2310-17-0 Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H317
H400
H410
GHS06
GHS09
Dgr
H301
H332
H312
H317
H410
M=1000 015-068-00-7 dichlofenthion (ISO);
O—2,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-5 97-17-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H400
H410
015-069-00-2 methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4 950-37-8 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Gef.
H300
H312
H410
015-070-00-8 cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-4 3734-95-0 Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Gef.
H300
H311
015-071-00-3 chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate
207-432-0 470-90-6 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H410
015-072-00-9 monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-7 6923-22-4 Muta. 2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H330
H300
H311
H400
H410
GHS06
GHS08
GHS09
Gef.
H341
H330
H300
H311
H410
015-073-00-4 dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3 141-66-2 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H410
015-074-00-X crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1 299-86-5 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate — 2635-50-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
015-076-00-0 potasan;
O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
— 299-45-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Gef.
H330
H310
H300
H410
M=1000 015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate — 7076-53-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Gef.
H331
H311
H301
015-078-00-1 demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-5 17040-19-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2
H301
H312
H411
GHS06
GHS09
Gef.
H301
H312
H411
015-079-00-7 acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate
250-241-2 30560-19-1 Acute Tox. 4 * H302 GHS07
Achtg.
H302 015-080-00-2 amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
— 919-76-6 Acute Tox. 4 * H302 GHS07
Achtg.
H302 015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 221-817-0 3244-90-4 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
015-082-00-3 azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-3 5834-96-8 Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Achtg.
H332
H302
015-083-00-9 bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4 741-58-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
015-084-00-4 chlorpyrifos (ISO);
O,O-diethyl O—3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-4 2921-88-2 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H400
H410
M=10000 015-085-00-X chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4 115-78-6 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H301
H312
H319
H315
GHS06
Gef.
H301
H312
H319
H315
015-086-00-5 coumithoate (ISO);
O,O-diethyl O—7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
— 572-48-5 Acute Tox. 3 * H301 GHS06
Gef.
H301 015-087-00-0 cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-3 2636-26-2 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
015-088-00-6 dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-3 10311-84-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H400
H410
015-089-00-1 ethoate-methyl (ISO);
ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1 116-01-8 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
015-090-00-7 fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3 115-90-2 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
015-091-00-2 fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate
213-408-0 944-22-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
015-092-00-8 phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-7 4104-14-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
015-093-00-3 leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-8 21609-90-5 Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H370 **
H312
H400
H410
GHS06
GHS08
GHS09
Gef.
H301
H370 **
H312
H410
015-094-00-9 mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3 950-10-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H310
H300
H411
GHS06
GHS09
Gef.
H310
H300
H411
015-095-00-4 methamidophos (ISO);
O,S-dimethyl phosphoramidothioate
233-606-0 10265-92-6 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
H330
H300
H311
H400
GHS06
GHS09
Gef.
H330
H300
H311
H400
015-096-00-X oxydisulfoton (ISO);
O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-1 2497-07-6 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H410
M=10 015-097-00-5 phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-0 2597-03-7 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
M=100 015-098-00-0 trichloronate (ISO);
O-ethyl O—2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1 327-98-0 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H410
015-099-00-6 pirimiphos-ethyl (ISO);
O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-0 23505-41-1 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Gef.
H301
H312
H410
015-100-00-X phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-3 14816-18-3 Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f***
H302
H317
H410
M=1000 015-101-00-5 phosmet (ISO);
O,O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4 732-11-6 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
M=100 015-102-00-0 tris(2-chloroethyl)phosphate 204-118-5 115-96-8 Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360F***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360F***
H302
H411
015-103-00-6 phosphorus tribromide 232-178-2 7789-60-8 Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
EUH014 015-104-00-1 diphosphorus pentasulphide;
phosphorus pentasulphide
215-242-4 1314-80-3 Flam. Sol. 1
Water-react. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H332
H302
H400
GHS02
GHS07
GHS09
Gef.
H228
H260
H332
H302
H400
EUH029 T 015-105-00-7 triphenyl phosphite 202-908-4 101-02-0 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H315
H410
Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %
015-106-00-2 hexamethylphosphoric triamide;
hexamethylphosphoramide
211-653-8 680-31-9 Carc. 1B
Muta. 1B
H350
H340
GHS08
Gef.
H350
H340
Carc. 1B; H350: C ≥ 0.01 % 015-107-00-8 ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate
236-152-1 13194-48-4 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H301
H317
H400
H410
GHS06
GHS09
Gef.
H330
H310
H301
H317
H410
015-108-00-3 bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-3 2104-96-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
M=100 015-109-00-9 crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-5 7700-17-6 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
M=10 015-110-00-4 cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate
— 13067-93-1 Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H301
H370 **
H312
H319
H411
GHS06
GHS08
GHS09
Gef.
H301
H370 **
H312
H319
H411
015-111-00-X phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2 947-02-4 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-112-00-5 thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6 297-97-2 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-113-00-0 tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
260-515-3 57018-04-9 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-114-00-6 chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate
246-538-1 24934-91-6 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 10 015-115-00-1 chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]
244-663-6 21923-23-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M = 1000 015-116-00-7 demephion-O (ISO);
O,O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9 682-80-4 Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Gef.
H300
H311
015-117-00-2 demephion-S (ISO);
O,O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-9 2587-90-8 Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Gef.
H300
H311
015-118-00-8 demeton — 8065-48-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Gef.
H310
H300
H400
015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate — 3254-63-5 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-120-00-9 ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate
225-875-8 5131-24-8 Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Achtg.
H315
H317
015-121-00-4 edifenphos (ISO);
O-ethyl S,S-diphenyl phosphorodithioate
241-178-1 17109-49-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Gef.
H331
H301
H312
H317
H410
015-122-00-X etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate
253-855-9 38260-54-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
M=10 015-123-00-5 fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1 22224-92-6 Acute Tox. 2 H300 GHS06 H300 M = 100 Acute Tox. 2 H310 GHS09 H310 M = 100 Acute Tox. 2 H330 Dgr H330 Eye Irrit. 2 H319 H319 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 H410 015-124-00-0 fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate
244-437-7 21548-32-3 Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Gef.
H310
H300
015-125-00-6 glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine
219-468-4 2439-99-8 Eye Dam. 1 H318 GHS05
Gef.
H318 015-126-00-1 heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-0 23560-59-0 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
M=100 015-127-00-7 iprobenfos(ISO);
S-benzyl diisopropyl phosphorothioate
247-449-0 26087-47-8 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
015-128-00-2 IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
— 5827-05-4 Acute Tox. 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H301
H400
H410
GHS06
GHS09
Gef.
H310
H301
H410
M=100 015-129-00-8 isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-1 25311-71-1 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
M=100 015-130-00-3 isothioate (ISO);
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
— 36614-38-7 Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Gef.
H311
H301
015-131-00-9 isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-8 18854-01-8 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;
methylcarbophenothione
— 953-17-3 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
M=1000 015-133-00-X piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate
— 24151-93-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
M=10 015-134-00-5 pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate
249-528-5 29232-93-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
015-135-00-0 profenofos (ISO)
O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;
255-255-2 41198-08-7 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
M=1000 015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO)
250-517-2 31218-83-4 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Gef.
H301
H410
M=100 015-137-00-1 pyrazophos (ISO);
O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-1 13457-18-6 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H302
H410
015-138-00-7 quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-6 13593-03-8 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Gef.
H301
H312
H410
M=1000 015-139-00-2 terbufos (ISO);
S—tert-butylthiomethyl O, O-diethylphosphorodithioate;
235-963-8 13071-79-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Gef.
H310
H300
H410
M=1000 015-140-00-8 triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate
245-986-5 24017-47-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H410
M=100 015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers 400-520-1 — Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H400
H410
GHS05
GHS07
GHS09
Gef.
H314
H302
H410
015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate 401-100-0 — Flam. Liq. 2
Eye Irrit. 2
Aquatic Chronic 2
H225
H319
H411
GHS02
GHS07
GHS09
Gef.
H225
H319
H411
T 015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,
reaction mass of isomers
401-740-0 — Acute Tox. 4 * H302 GHS07
Achtg.
H302 015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 402-090-0 87025-52-3 Skin Corr. 1B H314 GHS05
Gef.
H314 015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate 401-520-4 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate 401-850-9 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) 400-930-0 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H315
H318
H317
H411
015-148-00-1 2-(diphosphonomethyl)succinic acid 403-070-4 51395-42-7 Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Gef.
H314
H317
015-149-00-7 reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide
403-470-9 — Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Gef.
H314
H410
015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 404-940-6 86608-70-0 Acute Tox. 4 *
Eye Dam. 1
STOT RE 2 *
Aquatic Chronic 3
H302
H318
H373 **
H412
GHS08
GHS05
GHS07
Gef.
H302
H318
H373 **
H412
015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate 405-010-2 — Aquatic Chronic 2 H411 GHS09 H411 015-152-00-3 dioxabenzofos (ISO);
2-methoxy-4H—1,3,2-benzodioxaphosphorin 2-sulphide
223-292-3 3811-49-2 Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
Aquatic Chronic 2
H311
H301
H370 **
H411
GHS06
GHS08
GHS09
Gef.
H311
H301
H370 **
H411
015-153-00-9 isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate
255-863-8 42509-80-8 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H311
H301
H373 **
H317
H410
015-154-00-4 ethephon; 2-chloroethylphosphonic acid 240-718-3 16672-87-0 Acute Tox. 3
Acute Tox. 4
Acute Tox. 4
Skin Corr. 1C
Aquatic Chronic 2
H311
H332
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H332
H302
H314
H411
EUH071 015-155-00-X glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
278-636-5 77182-82-2 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H360Fd
H332
H312
H302
H373**
GHS08
GHS07
Dgr
H360Fd
H332
H312
H302
H373**
015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]
[2]
30864-28-9 [1]
62610-77-9 [2]
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Achtg.
H302
H317
H410
015-157-00-0 phosphonic acid; [1]
phosphorous acid [2]
237-066-7 [1]
233-663-1
[2]
13598-36-2 [1]
10294-56-1 [2]
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Gef.
H302
H314
015-158-00-6 (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) 402-340-9 32760-80-8 Aquatic Chronic 3 H412 — H412 015-159-00-1 hydroxyphosphonoacetic acid 405-710-8 23783-26-8 Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
H302
H373 **
H314
H317
GHS08
GHS05
GHS07
Gef.
H302
H373 **
H314
H317
015-160-00-7 vanadyl pyrophosphate 406-260-5 58834-75-6 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Achtg.
H319
H317
H412
015-161-00-2 divanadyl pyrophosphate 407-130-0 65232-89-5 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H317
H411
015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped 407-350-7 — Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H332
H373 **
H318
H411
GHS08
GHS05
GHS07
GHS09
Gef.
H332
H373 **
H318
H411
015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 412-010-6 145052-34-2 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 400-480-5 36669-85-9 Aquatic Chronic 3 H412 — H412 015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Gef.
H318
H410
015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 410-290-4 80693-00-1 Aquatic Chronic 4 H413 — H413 015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 411-200-6 14657-64-8 Eye Dam. 1 H318 GHS05
Gef.
H318 015-168-00-0 fosthiazate (ISO);
(RS)-S—sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
— 98886-44-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Gef.
H331
H301
H312
H317
H410
EUH070 015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate 413-520-1 — Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Gef.
H302
H373 **
H314
H317
H410
015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate
407-490-9 — Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Gef.
H312
H302
H314
015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate 406-940-1 — Aquatic Chronic 2 H411 GHS09 H411 015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6 — Flam. Liq. 3
Skin Corr. 1B
Aquatic Chronic 2
H226
H314
H411
GHS02
GHS05
GHS09
Gef.
H226
H314
H411
015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 414-080-3 117291-73-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 411-370-1 82857-68-9 Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 2
H301
H318
H411
GHS06
GHS05
GHS09
Gef.
H301
H318
H411
015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 412-880-7 35000-38-5 Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H301
H373 **
H319
H317
H411
GHS06
GHS08
GHS09
Gef.
H301
H373 **
H319
H317
H411
015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 413-430-2 116163-96-3 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 412-170-7 83623-61-4 STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373 **
H318
H317
GHS08
GHS05
Gef.
H373 **
H318
H317
015-178-00-5 (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 418-570-8 25383-07-7 Repr. 2
Aquatic Chronic 2
H361f ***
H411
GHS08
GHS09
Achtg.
H361f ***
H411
015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 422-720-8 166242-53-1 Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Gef.
H351
H302
H373 **
H314
H317
H410
015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 415-820-8 137590-32-0 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Gef.
H318
H317
H412
015-181-00-1 phosphine 232-260-8 7803-51-2 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H220
H330
H314
H400
GHS02
GHS04
GHS06
GHS05
GHS09
Gef.
H220
H330
H314
H400
U 015-182-00-7 tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate) 430-630-5 10596-22-2 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
015-183-00-2 (1-hydroxydodecylidene)diphosphonic acid 425-230-2 16610-63-2 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex — — Aquatic Chronic 2 H411 GHS09 H411 A 015-186-00-9 chlorpyrifos-methyl (ISO)
O, O-dimethyl O—3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-5 5598-13-0 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
M=10000 015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H—1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
015-188-00-X (1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate 425-220-8 5945-33-5 Aquatic Chronic 4 H413 — H413 015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Achtg.
H317
H413
015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2 154862-43-8 Aquatic Chronic 4 H413 — H413 015-191-00-6 dodecyldiphenyl phosphate 431-760-5 27460-02-2 Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate 432-770-2 139189-30-3 Skin Sens. 1 H317 GHS07
Wng
H317 015-193-00-7 triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) 442-960-7 332350-93-3 Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H400
H410
GHS05
GHS06
GHS09
Dgr
H301
H318
H410
015-194-00-2 tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate 444-440-5 220689-12-3 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
015-195-00-8 reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate
433-860-4 — Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
015-196-00-3 reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3 — Carc. 1B
Muta. 1B
Skin Sens. 1
H350
H340
H317
GHS08
GHS07
Dgr
H350
H340
H317
015-197-00-9 bis(2,4,4-trimethylpentyl)dithiophosphonic acid 420-160-9 107667-02-7 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H302
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H302
H314
H411
015-198-00-4 (4-phenylbutyl)phosphinic acid 420-450-5 86552-32-1 Carc. 2
Eye Dam. 1
H351
H318
GHS05
GHS08
Dgr
H351
H318
015-199-00-X tris[2-chloro-1-chloromethyl)ethyl] phosphate 237-159-2 13674-87-8 Carc. 2 H351 GSH08
Wng
H351 015-200-00-3 indium phosphide 244-959-5 22398-80-7 Carc. 1B
Repr. 2
STOT RE 1
H350
H361f
H372 (Lunge)
GHS08
Dgr
H350
H361f
H372 (Lunge)
STOT RE 1;
H372: C ≥ 0,1 %
Carc 1B;
H350: C ≥ 0,01 %
STOT RE 2;
H373: 0,01 % ≤ C < 0,1 %
015-201-00-9 trixylyl phosphate 246-677-8 25155-23-1 Repr. 1B H360F GHS08
Dgr
H360F 015-202-00-4 tris(nonylphenyl) phosphite 247-759-6 26523-78-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-203-00-X diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide 278-355-8 75980-60-8 Repr. 2 H361f (verursacht Hodenatrophie) GHS08
Wng
H361f (verursacht Hodenatrophie) 016-001-00-4 hydrogen sulphide 231-977-3 7783-06-4 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Aquatic Acute 1
H220
H330
H400
GHS02
GHS04
GHS06
GHS09
Gef.
H220
H330
H400
U 016-002-00-X barium sulphide 244-214-4 21109-95-5 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Achtg.
H332
H302
H400
EUH031 016-003-00-5 barium polysulphides 256-814-3 50864-67-0 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Achtg.
H319
H335
H315
H400
EUH031 016-004-00-0 calcium sulphide 243-873-5 20548-54-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Achtg.
H319
H335
H315
H400
EUH031 016-005-00-6 calcium polysulphides 215-709-2 1344-81-6 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Achtg.
H319
H335
H315
H400
EUH031 016-006-00-1 dipotassium sulphide;
potassium sulphide
215-197-0 1312-73-8 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
EUH031 016-007-00-7 potassium polysulphides 253-390-1 37199-66-9 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
EUH031 016-008-00-2 ammonium polysulphides 232-989-1 9080-17-5 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
EUH031 EUH031: C ≥ 1 % 016-009-00-8 disodium sulfide;
sodium sulfide
215-211-5 1313-82-2 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H311
H302
H314
H400
GHS06
GHS05
GHS09
Dgr
H311
H302
H314
H400
016-010-00-3 sodium polysulphides 215-686-9 1344-08-7 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Gef.
H301
H314
H400
EUH031 016-011-00-9 sulphur dioxide 231-195-2 7446-09-5 Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
H331
H314
GHS04
GHS06
GHS05
Gef.
H331
H314
* U5 016-012-00-4 disulphur dichloride;
sulfur monochloride
233-036-2 10025-67-9 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H301
H332
H314
H400
GHS06
GHS05
GHS09
Gef.
H301
H332
H314
H400
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 % 016-013-00-X sulphur dichloride 234-129-0 10545-99-0 Skin Corr. 1B
STOT SE 3
Aquatic Acute 1
H314
H335
H400
GHS05
GHS07
GHS09
Gef.
H314
H335
H400
EUH014 STOT SE 3; H335: C ≥ 5 % 016-014-00-5 sulphur tetrachloride — 13451-08-6 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
EUH014 STOT SE 3; H335: C ≥ 5 % 016-015-00-0 thionyl dichloride;
thionyl chloride
231-748-8 7719-09-7 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H332
H302
H314
GHS05
GHS07
Gef.
H332
H302
H314
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 % 016-016-00-6 sulphuryl chloride 232-245-6 7791-25-5 Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
EUH014 016-017-00-1 chlorosulphonic acid 232-234-6 7790-94-5 Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
EUH014 016-018-00-7 fluorosulphonic acid 232-149-4 7789-21-1 Acute Tox. 4 *
Skin Corr. 1A
H332
H314
GHS05
GHS07
Gef.
H332
H314
016-019-00-2 oleum ... % SO3 — — Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
EUH014 B 016-020-00-8 sulphuric acid ... % 231-639-5 7664-93-9 Skin Corr. 1A H314 GHS05
Gef.
H314 Skin Corr. 1A; H314: C ≥ 15 %
Skin Irrit. 2; H315: 5 % ≤ C < 15 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %
B 016-021-00-3 methanethiol;
methyl mercaptan
200-822-1 74-93-1 Flam. Gas. 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Gef.
H220
H331
H410
U 016-022-00-9 ethanethiol;
ethyl mercaptan
200-837-3 75-08-1 Flam. Liq. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H400
H410
GHS02
GHS07
GHS09
Gef.
H225
H332
H410
016-023-00-4 dimethyl sulphate 201-058-1 77-78-1 Carc. 1B
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H350
H341
H330
H301
H314
H317
GHS06
GHS08
GHS05
Gef.
H350
H341
H330
H301
H314
H317
Carc. 1B; H350: C ≥ 0.01 %
Muta. 2; H341: C ≥ 0.01 %
STOT SE 3; H335: C ≥ 5 %
016-024-00-X dimexano(ISO);
bis(methoxythiocarbonyl) disulphide
215-993-8 1468-37-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
016-025-00-5 disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES
205-259-5 149-26-8 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Gef.
H302
H315
H318
016-026-00-0 sulphamidic acid;
sulphamic acid;
sulfamic acid
226-218-8 5329-14-6 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Achtg.
H319
H315
H412
016-027-00-6 diethyl sulphate 200-589-6 64-67-5 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H340
H332
H312
H302
H314
GHS05
GHS08
GHS07
Gef.
H350
H340
H332
H312
H302
H314
016-028-00-1 sodium dithionite;
sodium hydrosulphite
231-890-0 7775-14-6 Self-heat. 1
Acute Tox. 4 *
H251
H302
GHS02
GHS07
Gef.
H251
H302
EUH031 016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 — — Skin Corr. 1B H314 GHS05
Gef.
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 203-180-0 104-15-4 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Achtg.
H319
H335
H315
STOT SE 3; H335: C ≥ 20 % 016-031-00-8 tetrahydrothiophene-1,1-dioxide;
sulpholane
204-783-1 126-33-0 Acute Tox. 4 * H302 GHS07
Achtg.
H302 016-032-00-3 1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide
214-317-9 1120-71-4 Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H350
H312
H302
GHS08
GHS07
Gef.
H350
H312
H302
Carc. 1B; H350: C ≥ 0,01 % 016-033-00-9 dimethylsulfamoylchloride 236-412-4 13360-57-1 Carc. 1B
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H330
H312
H302
H314
GHS06
GHS05
GHS08
Gef.
H350
H330
H312
H302
H314
016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 400-010-9 81898-60-4 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate 400-120-7 — Eye Irrit. 2 H319 GHS07
Achtg.
H319 016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate 400-130-1 — Resp. Sens. 1
Aquatic Chronic 2
H334
H411
GHS08
GHS09
Gef.
H334
H411
016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 400-350-8 85153-93-1 Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 400-380-1 86393-35-3 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate 400-430-2 — Skin Sens. 1 H317 GHS07
Achtg.
H317 016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate 400-570-4 — Eye Irrit. 2 H319 GHS07
Achtg.
H319 016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate 400-710-4 — Acute Tox. 4 * H332 GHS07
Achtg.
H332 016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 400-790-0 85665-97-0 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Achtg.
H319
H315
H317
016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate 401-010-1 — Skin Sens. 1 H317 GHS07
Achtg.
H317 016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate 401-320-7 — Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 401-560-2 108624-00-6 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-046-00-X sodium hydrogensulphate 231-665-7 7681-38-1 Eye Dam. 1 H318 GHS05
Gef.
H318 016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 401-650-1 85665-96-9 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate 401-870-8 — Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
016-049-00-6 calcium octadecylxylenesulphonate 402-040-8 — Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Gef.
H314
H411
016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat 402-150-6 — Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Achtg.
H319
H317
016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 402-170-5 106359-91-5 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 402-240-5 102561-46-6 Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Achtg.
H332
H411
016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate 402-460-1 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Achtg.
H315
H317
H413
016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate 400-030-8 — Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Sens. 1
H331
H372 **
H302
H319
H335
H317
GHS06
GHS08
Gef.
H331
H372 **
H302
H319
H335
H317
016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) 400-510-7 — Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Gef.
H318
H317
016-056-00-4 potassium hydrogensulphate 231-594-1 7646-93-7 Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
016-057-00-X styrene-4-sulfonyl chloride 404-770-2 2633-67-2 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Gef.
H315
H318
H317
016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14—tert-alkylamine 404-820-3 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Achtg.
H315
H317
H412
016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 405-300-9 17339-60-5 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H317
H410
016-060-00-6 diammonium peroxodisulphate;
ammonium persulphate
231-786-5 7727-54-0 Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Gef.
H272
H302
H319
H335
H315
H334
H317
016-061-00-1 dipotassium peroxodisulphate;
potassium persulphate
231-781-8 7727-21-1 Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Gef.
H272
H302
H319
H335
H315
H334
H317
016-062-00-7 bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
— 17606-31-4 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
016-063-00-2 sodium metabisulphite 231-673-0 7681-57-4 Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Gef.
H302
H318
EUH031 016-064-00-8 sodium hydrogensulphite . . . %;
sodium bisulphite . . . %
231-548-0 7631-90-5 Acute Tox. 4 * H302 GHS07
Achtg.
H302 EUH031 B 016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 400-100-8 84057-97-6 Aquatic Chronic 2 H411 GHS09 H411 016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 404-070-7 116912-62-0 Aquatic Chronic 3 H412 — H412 016-067-00-4 (4-methylphenyl)mesitylene sulfonate 407-530-5 67811-06-7 Aquatic Chronic 4 H413 — H413 016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 407-720-8 155160-86-4 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 407-990-7 141915-64-2 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone 408-220-2 — Aquatic Chronic 4 H413 — H413 016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 410-130-3 136248-03-8 Skin Sens. 1 H317 GHS07
Achtg.
H317 016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 411-520-6 112195-27-4 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H318
H317
H411
016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 404-310-0 10591-85-2 Aquatic Chronic 4 H413 — H413 016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene 405-410-7 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H315
H318
H317
H411
016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 411-570-9 41481-66-7 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 411-290-7 131538-00-6 Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Achtg.
H302
H373 **
H410
016-077-00-9 2-chloro-p-toluenesulfochloride 412-890-1 42413-03-6 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H314
H317
H412
GHS05
GHS07
Gef.
H314
H317
H412
016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 413-300-5 56187-04-3 Aquatic Chronic 4 H413 — 016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 412-920-3 16695-22-0 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Achtg.
H317
H413
016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 412-320-1 31361-99-6 Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide 418-350-1 — Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H302
H319
H317
H411
GHS08
GHS07
GHS09
Achtg.
H341
H302
H319
H317
H411
016-082-00-6 ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
— 126801-58-9 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 016-083-00-1 acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0 135158-54-2 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H319
H335
H315
H317
H410
016-084-00-7 prosulfuron (ISO);
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
— 94125-34-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=100 016-085-00-2 flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
— 104040-78-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 402-590-9 109125-56-6 Eye Dam. 1 H318 GHS05
Gef.
H318 016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate
403-490-8 104558-95-4 Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H317
H400
H410
GHS07
GHS09
Achtg.
H319
H317
H410
016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 407-280-7 71297-11-5 Aquatic Chronic 3 H412 — H412 016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene 413-840-1 — Self-react. C ****
Aquatic Chronic 4
H242
H413
GHS02
Gef.
H242
H413
016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 415-040-8 14653-91-9 Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Gef.
H302
H335
H318
016-091-00-5 C12-14—tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate 414-110-5 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Gef.
H318
H410
016-092-00-0 reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1 — Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f
H315
H317
H410
016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4 140698-96-0 Self-react. C****
Carc. 2
H242
H351
GHS02
GHS08
Gef.
H242
H351
016-094-00-1 sulfur 231-722-6 7704-34-9 Skin Irrit. 2 H315 GHS07
Wng
H315 016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4 — Self-react. C****
Carc. 2
H242
H351
GHS02
GHS08
Gef.
H242
H351
016-096-00-2 thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
— 79277-27-3 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 434-480-1 32047-53-3 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412
017-001-00-7 chlorine 231-959-5 7782-50-5 Ox. Gas 1
Press. Gas
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H270
H331
H319
H335
H315
H400
GHS03
GHS04
GHS06
GHS09
Dgr
H270
H331
H319
H335
H315
H400
M = 100 U 017-002-00-2 hydrogen chloride 231-595-7 7647-01-0 Press. Gas
Acute Tox. 3 *
Skin Corr. 1A
H331
H314
GHS04
GHS06
GHS05
Gef.
H331
H314
U5 017-002-01-X hydrochloric acid ... % 231-595-7 — Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 %
B 017-003-00-8 barium chlorate 236-760-7 13477-00-4 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Gef.
H271
H332
H302
H411
017-004-00-3 potassium chlorate 223-289-7 3811-04-9 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Gef.
H271
H332
H302
H411
017-005-00-9 sodium chlorate 231-887-4 7775-09-9 Ox. Sol. 1
Acute Tox. 4 *
Aquatic Chronic 2
H271
H302
H411
GHS03
GHS07
GHS09
Gef.
H271
H302
H411
017-006-00-4 perchloric acid ... % 231-512-4 7601-90-3 Ox. Liq. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Gef.
H271
H314
Skin Corr. 1A; H314: C ≥ 50 %
Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 10 %
Ox. Liq. 1; H271: C > 50 %:
Ox. Liq. 2; H272: C ≤ 50 %:
B 017-007-00-X barium perchlorate 236-710-4 13465-95-7 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
H271
H332
H302
GHS03
GHS07
Gef.
H271
H332
H302
017-008-00-5 potassium perchlorate 231-912-9 7778-74-7 Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Gef.
H271
H302
017-009-00-0 ammonium perchlorate 232-235-1 7790-98-9 Expl. 1,1
Ox. Sol. 1
H201
H271
GHS01
Dgr
H201
H271
T 017-010-00-6 sodium perchlorate 231-511-9 7601-89-0 Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Gef.
H271
H302
017-011-00-1 sodium hypochlorite, solution ... % Cl active 231-668-3 7681-52-9 Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
EUH031 EUH031: C ≥ 5 % B 017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H272
H302
H314
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H400
EUH031 Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
M = 10
T 017-013-00-2 calcium chloride 233-140-8 10043-52-4 Eye Irrit. 2 H319 GHS07
Achtg.
H319 017-014-00-8 ammonium chloride 235-186-4 12125-02-9 Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Achtg.
H302
H319
017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 417-410-4 61807-67-8 Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Gef.
H302
H314
H317
017-016-00-9 methyltriphenylphosphonium chloride 418-400-2 1031-15-8 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Gef.
H312
H302
H315
H318
H411
017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 426-210-6 120086-58-0 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Gef.
H314
H410
017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride 405-660-7 — Aquatic Chronic 2 H411 GHS09 H411 017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 415-110-8 54417-53-7 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
017-020-00-0 ethyl propoxy aluminium chloride 421-790-7 13014-29-4 Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Gef.
H260
H314
EUH014 017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 423-420-1 136920-10-0 Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Gef.
H318
H317
H410
017-023-00-7 [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides 425-520-9 197179-61-6 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
017-026-00-3 chlorine dioxide 233-162-8 10049-04-4 Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H270
H330
H314
H400
GHS04
GHS03
GHS06
GHS05
GHS09
Dgr
H270
H330
H314
H400
M = 10 5 017-026-01-0 chlorine dioxide … % 233-162-8 10049-04-4 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 3 %
STOT SE 3; H335: C ≥ 3 %
M = 10
B 019-001-00-2 potassium 231-119-8 7440-09-7 Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Gef.
H260
H314
EUH014 019-002-00-8 potassium hydroxide;
caustic potash
215-181-3 1310-58-3 Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Gef.
H302
H314
Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
019-003-00-3 Kalium-(E,E)-hexa-2,4-dienoat 246-376-1 24634-61-5 Eye Irrit. 2 H319 GSH07
Wng
H319 020-001-00-X calcium 231-179-5 7440-70-2 Water-react. 2 H261 GHS02
Gef.
H261 020-002-00-5 calcium cyanide 209-740-0 592-01-8 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Gef.
H300
H410
EUH032 020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4 — Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Achtg.
H319
H315
H317
022-001-00-5 titanium tetrachloride 231-441-9 7550-45-0 Skin Corr. 1B H314 GHS05
Gef.
H314 EUH014 022-002-00-0 titanium(4+) oxalate 403-260-7 — Eye Dam. 1 H318 GHS05
Gef.
H318 022-003-00-6 bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 412-000-1 125051-32-3 Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H228
H361f ***
H373 **
H411
GHS02
GHS08
GHS09
Gef.
H228
H361f ***
H373 **
H411
T 022-004-00-1 potassium titanium oxide (K2Ti6O13) 432-240-0 12056-51-8 Carc. 2 H351 GHS08
Wng
H351 022-005-00-7 [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium 419-840-8 169104-71-6 Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H228
H314
H317
H413
GHS02
GHS05
GHS07
Dgr
H228
H314
H317
H413
023-001-00-8 divanadium pentaoxide;
vanadium pentoxide
215-239-8 1314-62-1 Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2
H341
H361d ***
H372 **
H332
H302
H335
H411
GHS08
GHS07
GHS09
Gef.
H341
H361d ***
H372 **
H332
H302
H335
H411
024-001-00-0 chromium (VI) trioxide 215-607-8 1333-82-0 Ox. Sol. 1
Carc. 1A
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Gef.
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 1 % 024-002-00-6 potassium dichromate 231-906-6 7778-50-9 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Gef.
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 5 % 3 024-003-00-1 ammonium dichromate 232-143-1 7789-09-5 Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Gef.
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
G3 024-004-00-7 sodium dichromate 234-190-3 10588-01-9 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H400
H410
GHS03
GHS06
GHS05
GHS08
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H410
Resp. Sens. 1; H334: C ≥ 0,2 %
Skin Sens. 1; H317: C ≥ 0,2 %
STOT SE 3; H335: C ≥ 5 %
3 024-004-01-4 sodium dichromate, dihydrate 234-190-3 7789-12-0 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
3 024-005-00-2 chromyl dichloride;
chromic oxychloride
239-056-8 14977-61-8 Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350i
H340
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Gef.
H271
H350i
H340
H314
H317
H410
Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 5 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: 0,5 % ≤ C < 5 %
Skin Sens. 1; H317: C ≥ 0,5 %
T3 024-006-00-8 potassium chromate 232-140-5 7789-00-6 Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H340
H319
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Gef.
H350i
H340
H319
H335
H315
H317
H410
Skin Sens. 1; H317: C ≥ 0.5 % 3 024-007-00-3 zinc chromates including zinc potassium chromate — — Carc. 1A
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H302
H317
H410
A 024-008-00-9 calcium chromate 237-366-8 13765-19-0 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H302
H410
024-009-00-4 strontium chromate 232-142-6 7789-06-2 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H302
H400
H410
024-010-00-X dichromium tris(chromate);
chromium III chromate;
chromic chromate
246-356-2 24613-89-6 Ox. Sol. 1
Carc. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Gef.
H271
H350
H314
H317
H410
T 024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 400-110-2 109125-51-1 Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Gef.
H242
H410
024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) 400-810-8 — Muta. 2 H341 GHS08
Achtg.
H341 024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) 402-500-8 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 402-870-0 93952-24-0 Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) 404-930-1 — Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H332
H318
H411
GHS05
GHS07
GHS09
Gef.
H332
H318
H411
024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 405-110-6 88377-66-6 STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Achtg.
H373 **
H413
024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex — — Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H317
H400
H410
GHS08
GHS07
GHS09
Gef.
H350i
H317
H410
A 024-018-00-3 sodium chromate 231-889-5 7775-11-3 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
3 024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-230-1 — Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) 418-220-4 — Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
024-021-00-X potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) 425-830-4 — Eye Dam. 1 H318 GHS05
Dgr
H318 025-001-00-3 manganese dioxide 215-202-6 1313-13-9 Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Achtg.
H332
H302
025-002-00-9 potassium permanganate 231-760-3 7722-64-7 Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H400
H410
GHS03
GHS07
GHS09
Gef.
H272
H302
H410
025-003-00-4 manganese sulphate 232-089-9 7785-87-7 STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Achtg.
H373 **
H411
025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 411-760-1 116633-53-5 Aquatic Chronic 2 H411 GHS09 H411 025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)
417-660-4 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 026-001-00-6 (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate 407-840-0 100011-37-8 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Gef.
H302
H318
H412
026-002-00-1 (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate 407-880-9 117549-13-0 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
026-003-00-7 iron(II) sulfate 231-753-5 7720-78-7 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
026-003-01-4 iron (II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-5 7782-63-0 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
Skin Irrit. 2; H315: C ≥ 25 % 026-004-00-2 potassium ferrite 430-010-4 12160-44-0 Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
027-001-00-9 cobalt 231-158-0 7440-48-4 Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Gef.
H334
H317
H413
027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=10 027-003-00-X cobalt sulfide 215-273-3 1317-42-6 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10 027-004-00-5 cobalt dichloride 231-589-4 7646-79-9 Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F***
H302
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1 027-005-00-0 cobalt sulfate 233-334-2 10124-43-3 Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F***
H302
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1 027-006-00-6 cobalt di(acetate) 200-755-8 71-48-7 Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1 027-007-00-1 zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex 425-240-7 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
027-008-00-7 complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3) 427-390-9 — Skin Sens. 1 H317 GHS07
Wng
H317 027-009-00-2 cobalt dinitrate 233-402-1 10141-05-6 Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1 027-010-00-8 cobalt carbonate 208-169-4 513-79-1 Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M=10
1 028-001-00-1 tetracarbonylnickel;
nickel tetracarbonyl
236-669-2 13463-39-3 Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H351
H360D ***
H330
H400
H410
GHS02
GHS06
GHS08
GHS09
Gef.
H225
H351
H360D ***
H330
H410
028-002-00-7 nickel 231-111-4 7440-02-0 Carc. 2
STOT RE 1
Skin Sens. 1
H351
H372**
H317
GHS08
GHS07
Dgr
H351
H372**
H317
S7 028-002-01-4 nickel powder;
[particle diameter < 1 mm]
231-111-4 7440-02-0 Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H351
H372**
H317
H412
GHS08
GHS07
Dgr
H351
H372**
H317
H412
028-003-00-2 nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
215-215-7 [1]
234-323-5 [2]
- [3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-004-00-8 nickel dioxide 234-823-3 12035-36-8 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-005-00-3 dinickel trioxide 215-217-8 1314-06-3 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-006-00-9 nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
240-841-2 [1]
234-349-7 [2]
- [3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372**
H317
H410
028-007-00-4 trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
234-829-6 [1]
- [2]
12035-72-2 [1]
12035-71-1 [2]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372**
H317
H410
028-008-00-X nickel dihydroxide; [1]
nickel hydroxide [2]
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H410
028-009-00-5 nickel sulfate 232-104-9 7786-81-4 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-010-00-0 nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[μ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]
222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]
3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410
028-011-00-6 nickel dichloride 231-743-0 7718-54-9 Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-012-00-1 nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-013-00-7 nickel matte 273-749-6 69012-50-6 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-014-00-2 slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate 295-859-3 92129-57-2 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-015-00-8 slimes and sludges, copper electrolyte refining, decopperised 305-433-1 94551-87-8 Carc. 1A
Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
H 028-016-00-3 nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-1 13637-71-3 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-017-00-9 nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-018-00-4 nickel bis(sulfamidate);
nickel sulfamate
237-396-1 13770-89-3 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-019-00-X nickel bis(tetrafluoroborate) 238-753-4 14708-14-6 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-021-00-0 nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-022-00-6 nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-024-00-7 nickel dibenzoate 209-046-8 553-71-9 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-025-00-2 nickel bis(4-cyclohexylbutyrate) 223-463-2 3906-55-6 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-026-00-8 nickel(II) stearate;
nickel(II) octadecanoate
218-744-1 2223-95-2 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-027-00-3 nickel dilactate — 16039-61-5 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-028-00-9 nickel(II) octanoate 225-656-7 4995-91-9 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-029-00-4 nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-030-00-X nickel hexafluorosilicate 247-430-7 26043-11-8 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-031-00-5 nickel selenate 239-125-2 15060-62-5 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-032-00-0 nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H 028-033-00-6 diammonium nickel hexacyanoferrate — 74195-78-1 Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H 028-034-00-1 nickel dicyanide 209-160-8 557-19-7 Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
EUH032 H 028-035-00-7 nickel chromate 238-766-5 14721-18-7 Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H 028-036-00-2 nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-037-00-8 dinickel hexacyanoferrate 238-946-3 14874-78-3 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-038-00-3 trinickel bis(arsenate);
nickel(II) arsenate
236-771-7 13477-70-8 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H372**
H317
H410
H 028-039-00-9 nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-040-00-4 nickel telluride 235-260-6 12142-88-0 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-041-00-X trinickel tetrasulfide — 12137-12-1 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-042-00-5 trinickel bis(arsenite) — 74646-29-0 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-043-00-0 cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H 028-044-00-6 nickel tin trioxide;
nickel stannate
234-824-9 12035-38-0 Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H 028-045-00-1 nickel triuranium decaoxide 239-876-6 15780-33-3 Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H 028-046-00-7 nickel dithiocyanate 237-205-1 13689-92-4 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
EUH032 STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-047-00-2 nickel dichromate 239-646-5 15586-38-6 Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-048-00-8 nickel(II) selenite 233-263-7 10101-96-9 Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H 028-049-00-3 nickel selenide 215-216-2 1314-05-2 Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-050-00-9 silicic acid, lead nickel salt — 68130-19-8 Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360Df
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360Df
H372**
H317
H410
H 028-051-00-4 nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-052-00-X nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-6 68610-24-2 Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
028-053-00-5 nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-054-00-0 nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O 1,O 2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H 028-055-00-6 nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
H 028-056-00-1 nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410
H 028-057-00-7 dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
H 028-058-00-2 cobalt lithium nickel oxide 442-750-5 — Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H330
H372**
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H330
H372**
H317
H410
029-001-00-4 copper chloride;
copper (I) chloride;
cuprous chloride
231-842-9 7758-89-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H400
H410
029-002-00-X Dikupferoxid;
Kupfer(I)-oxid
215-270-7 1317-39-1 Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H332
H302
H318
H410
M = 100 029-003-00-5 Naphthenic acids, copper salts;
copper naphthenate
215-657-0 1338-02-9 Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H400
H410
GHS02
GHS07
GHS09
Achtg.
H226
H302
H410
029-004-00-0 copper sulphate 231-847-6 7758-98-7 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H315
H410
029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid 401-260-1 — Eye Irrit. 2 H319 GHS07
Achtg.
H319 029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) 403-210-4 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 404-670-9 89797-01-3 Skin Sens. 1 H317 GHS07
Achtg.
H317 G 029-008-00-2 copper(II) methanesulfonate 405-400-2 54253-62-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H318
H410
029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 413-650-9 93971-95-0 Aquatic Chronic 3 H412 — H412 029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 407-700-9 101408-30-4 Skin Sens. 1 H317 GHS07
Achtg.
H317 029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 412-730-0 150522-10-4 Skin Corr. 1B H314 GHS05
Gef.
H314 029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 407-340-2 124719-24-0 Eye Dam. 1 H318 GHS05
Gef.
H318 029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Eye Dam. 1 H318 GHS05
Dgr
H318 029-014-00-5 reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex
419-610-7 171866-24-3 STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
029-015-00-0 Kupferthiocyanat 214-183-1 1111-67-7 Aquatic Acute 1 Aquatic Chronic 1 H400
H410
GHS09
Wng
H410 EUH032 M = 10 029-016-00-6 Kupfer(II)-oxid 215-269-1 1317-38-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M = 100 029-017-00-1 Dikupferchloridtrihydroxid 215-572-9 1332-65-6 Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H301
H400
H410
GHS06
GHS09
Dgr
H332
H301
H410
M = 10 029-018-00-7 Tetrakupferhexahydroxidsulfat; [1]
Tetrakupferhexahydroxidsulfathydrat; [2]
215-582-3 [1]
215-582-3 [2]
1333-22-8 [1]
12527-76-3 [2]
Acute Tox. 4
Aquatic Acute 1 Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 10 029-019-01-X Kupferflocken (mit einem Überzug aus aliphatischer Säure) — — Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H319
H400
H410
GHS06
GHS09
Dgr
H331
H302
H319
H410
M = 10 029-020-00-8 Kupfer(II)-carbonat — Kupfer(II)-hydroxid (1:1) 235-113-6 12069-69-1 Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H319
H400
H410
GHS07
GHS09
Wng
H332
H302
H319
H410
M = 10 029-021-00-3 Kupferdihydroxid;
Kupfer(II)-hydroxid
243-815-9 20427-59-2 Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H302
H318
H410
M = 10 029-022-00-9 Kupferkalkbrühe (Bordeauxbrühe);
Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid
— 8011-63-0 Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H332
H318
H410
M = 10 029-023-00-4 Kupfersulfat-Pentahydrat 231-847-6 7758-99-8 Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS07
GHS05
GHS09
Dgr
H302
H318
H410
M = 10 030-001-00-1 zinc powder — zinc dust (pyrophoric) 231-175-3 7440-66-6 Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H400
H410
GHS02
GHS09
Gef.
H260
H250
H410
T 030-001-01-9 zinc powder — zinc dust (stabilised) 231-175-3 7440-66-6 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 030-003-00-2 zinc chloride 231-592-0 7646-85-7 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H314
H410
STOT SE 3; H335: C ≥ 5 % 030-004-00-8 dimethylzinc; [1]
diethylzinc [2]
208-884-1 [1]
209-161-3 [2]
544-97-8 [1]
557-20-0 [2]
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H260
H314
H400
H410
GHS02
GHS05
GHS09
Gef.
H250
H260
H314
H410
EUH014 030-005-00-3 diamminediisocyanatozinc 401-610-3 — Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H302
H318
H334
H317
H400
GHS05
GHS08
GHS07
GHS09
Gef.
H302
H318
H334
H317
H400
030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2]
231-793-3 [1]
231-793-3 [2]
7446-19-7 [1]
7733-02-0 [2]
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H318
H410
030-007-00-4 bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc 403-360-0 42405-40-3 Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Gef.
H228
H302
H410
T 030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 403-750-0 113036-91-2 Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Achtg.
H332
H411
030-009-00-5 zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate 417-130-2 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
030-010-00-0 2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt 430-740-3 — Aquatic Chronic 2 H411 GHS09 H411 030-011-00-6 trizinc bis(orthophosphate) 231-944-3 7779-90-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 423-570-6 169314-88-9 Aquatic Chronic 4 H413 H413 030-013-00-7 zinc oxide 215-222-5 1314-13-2 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate 440-060-9 — Aquatic Chronic 2 H411 GHS09 H411 031-001-00-4 Galliumarsenid 215-114-8 1303-00-0 Repr. 1B
Carc. 1B
STOT RE 1
H360F
H350
H372 (Atmungssystem und hämatopoetisches System)
GHS08
Dgr
H360F
H350
H372 (Atmungssystem und hämatopoetisches System)
033-001-00-X arsenic 231-148-6 7440-38-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Gef.
H331
H301
H410
033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Gef.
H331
H301
H410
* A1 033-003-00-0 diarsenic trioxide;
arsenic trioxide
215-481-4 1327-53-3 Carc. 1A
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H300
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H350
H300
H314
H410
033-004-00-6 diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide
215-116-9 1303-28-2 Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H331
H301
H410
033-005-00-1 arsenic acid and its salts with the exception of those specified elsewhere in this Annex — — Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
A 033-006-00-7 arsine 232-066-3 7784-42-1 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H330
H373 **
H400
H410
GHS02
GHS04
GHS06
GHS08
GHS09
Gef.
H220
H330
H373 **
H410
U 033-007-00-2 tert-butylarsine 423-320-6 4262-43-5 Pyr. Liq. 1
Acute Tox. 2 *
H250
H330
GHS02
GHS06
Gef.
H250
H330
034-001-00-2 selenium 231-957-4 7782-49-2 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4
H331
H301
H373 **
H413
GHS06
GHS08
Gef.
H331
H301
H373 **
H413
034-002-00-8 selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H373**
H410
A 034-003-00-3 sodium selenite 233-267-9 10102-18-8 Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2
H300
H331
H317
H411
GHS06
GHS09
Gef.
H300
H331
H317
H411
EUH031 035-001-00-5 bromine 231-778-1 7726-95-6 Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H330
H314
H400
GHS06
GHS05
GHS09
Gef.
H330
H314
H400
035-002-00-0 hydrogen bromide 233-113-0 10035-10-6 Press. Gas
Skin Corr. 1A
STOT SE 3
H314
H335
GHS04
GHS05
GHS07
Gef.
H314
H335
U 035-002-01-8 hydrobromic acid ... % — — Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Gef.
H314
H335
Skin Corr. 1B; H314: C ≥ 40 %
Skin Irrit. 2; H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319: 10 % ≤ C < 40 %
STOT SE 3; H335: C ≥ 10 %
B 035-003-00-6 potassium bromate 231-829-8 7758-01-2 Ox. Sol. 1
Carc. 1B
Acute Tox. 3 *
H271
H350
H301
GHS03
GHS06
GHS08
Gef.
H271
H350
H301
035-004-00-1 2-hydroxyethylammonium perbromide 407-440-6 — Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H272
H302
H314
H317
H400
GHS03
GHS05
GHS07
GHS09
Gef.
H272
H302
H314
H317
H400
040-001-00-3 zirconium powder (pyrophoric) 231-176-9 7440-67-7 Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Gef.
H260
H250
T 040-002-00-9 zirconium powder, dry (non pyrophoric) — — Self-heat. 1 H251 GHS02
Gef.
H251 T 040-003-00-4 reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5 430-610-6 226996-19-6 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 042-001-00-9 molybdenum trioxide 215-204-7 1313-27-5 Carc. 2
Eye Irrit. 2
STOT SE 3
H351
H319
H335
GHS08
GHS07
Wng
H351
H319
H335
042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) 404-760-8 117342-25-3 Acute Tox. 3 *
Eye Dam. 1
H331
H318
GHS06
GHS05
Dgr
H331
H318
042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 404-860-1 116810-46-9 Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H228
H318
H400
H410
GHS02
GHS05
GHS09
Gef.
H228
H318
H410
T 042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) 412-780-3 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Achtg.
H315
H317
H411
042-005-00-0 reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex
434-240-6 — Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
046-001-00-X tetraammine palladium(II) hydrogen carbonate 425-270-0 134620-00-1 Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H318
H317
H410
047-001-00-2 silver nitrate 231-853-9 7761-88-8 Ox. Sol. 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H272
H314
H400
H410
GHS03
GHS05
GHS09
Dgr
H272
H314
H410
047-002-00-8 polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt 416-850-4 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 047-003-00-3 Silber-Zink-Zeolith (Zeolith, Linde Typ A, Oberfläche mit Silber- und Zinkionen modifiziert)
[Dieser Eintrag betrifft Zeolith vom Typ LTA (Linde Typ A), dessen Oberfläche mit Silber- und Zinkionen mit einem Gehalt von Ag+ 0,5 %-6 %, Zn2 + 5 %-16 % und möglicherweise Phospor, NH4 +, Mg2 + und/oder Ca2 + jeweils < 3 % modifiziert wurde.]
— 130328-20-0 Repr. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H315
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H361d
H315
H318
H410
M = 100
M = 100
048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),
reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
— — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
* A1 048-002-00-0 cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]
215-146-2 [2]
7440-43-9 [1]
1306-19-0 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361fd
H330
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H341
H361fd
H330
H372 **
H410
048-003-00-6 cadmium diformate;
cadmiumformate
224-729-0 4464-23-7 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H331
H301
H351
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,25 %
048-004-00-1 cadmium cyanide 208-829-1 542-83-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H310
H300
H351
H373 **
H410
EUH032 STOT RE 2; H373: C ≥ 0,1 %
EUH032: C ≥ 1 %
048-005-00-7 cadmiumhexafluorosilicate(2-);
cadmium fluorosilica
241-084-0 17010-21-8 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H331
H301
H351
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,1 %
048-006-00-2 cadmium fluoride 232-222-0 7790-79-6 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H340
H360FD
H330
H301
H372 **
H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2: 0,1 % ≤ C < 7 %
048-007-00-8 cadmium iodide 232-223-6 7790-80-9 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H331
H301
H351
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,1 %
048-008-00-3 cadmium chloride 233-296-7 10108-64-2 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H340
H360FD
H330
H301
H372 **
H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %
048-009-00-9 cadmium sulphate 233-331-6 10124-36-4 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H340
H360FD
H330
H301
H372 **
H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %
048-010-00-4 cadmium sulphide 215-147-8 1306-23-6 Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4
H350
H341
H361fd
H372 **
H302
H413
GHS08
GHS07
Gef.
H350
H341
H361fd
H372 **
H302
H413
*
STOT RE 1; H372: C ≥ 10 %
STOT RE 2; H373: 0,1 % ≤ C < 10 %
1 048-011-00-X cadmium (pyrophoric) 231-152-8 7440-43-9 Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H250
H350
H341
H361fd
H330
H372 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Gef.
H250
H350
H341
H361fd
H330
H372 **
H410
048-012-00-5 Cadmiumcarbonat 208-168-9 513-78-0 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410
A1 048-013-00-0 Cadmiumhydroxid; Cadmiumdihydroxid 244-168-5 21041-95-2 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410
A1 048-014-00-6 Cadmiumnitrat;
Cadmiumdinitrat
233-710-6 10325-94-7 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410
Carc. 1B; H350:
C ≥ 0,01 %
A1 050-001-00-5 tin tetrachloride;
stannic chloride
231-588-9 7646-78-8 Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Gef.
H314
H412
STOT SE 3; H335: C ≥ 5 % 050-002-00-0 cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide
236-049-1 13121-70-5 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
M=1000 050-003-00-6 fentin acetate (ISO);
triphenyltin acetate
212-984-0 900-95-8 Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410
M=10 050-004-00-1 fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-6 76-87-9 Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410
M=10 050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Gef.
H330
H310
H300
H410
* A1 050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Gef.
H330
H310
H300
H410
* A1 050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Gef.
H331
H311
H301
H410
* A1 050-008-00-3 Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführt — — Repr. 1B
Acute Tox. 3
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H301
H312
H372**
H315
H319
H400
H410
GHS08
GHS06
GHS09
Dgr
H360FD
H301
H312
H372**
H315
H319
H410
*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
Skin Irrit. 2; H315:C ≥ 1 %
Eye Irrit. 2; H319:C ≥ 1 %
M = 10
A
1
050-009-00-9 fluorotripentylstannane; [1]
hexapentyldistannoxane [2]
243-546-7 [1]
247-143-7 [2]
20153-49-5 [1]
25637-27-8 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
* 1 050-010-00-4 fluorotrihexylstannane 243-547-2 20153-50-8 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
* 1 050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
*
M=100
A1 050-012-00-5 tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3]
215-910-5 [1]
221-437-5 [2]
230-358-5 [3]
1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
* A1 050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4
H319
H335
H315
H413
GHS07
Achtg.
H319
H335
H315
H413
Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %
A1 050-017-00-2 fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-7 13356-08-6 Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H319
H315
H400
H410
GHS06
GHS09
Gef.
H330
H319
H315
H410
050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H411
050-019-00-3 azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H—1,2,4-triazole
255-209-1 41083-11-8 Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Gef.
H330
H301
H335
H315
H318
H410
050-020-00-9 trioctylstannane 413-320-4 869-59-0 STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4
H372 **
H315
H413
GHS08
GHS07
Gef.
H372 **
H315
H413
050-021-00-4 dichlorodioctyl stannane 222-583-2 3542-36-7 Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H331
H372**
H412
GHS06
GHS08
Dgr
H331
H372**
H412
050-022-00-X dibutyltin dichloride;
(DBTC)
211-670-0 683-18-1 Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H360FD
H330
H301
H312
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H360FD
H330
H301
H312
H372**
H314
H410
Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %
M=10
050-023-00-5 reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5 — STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
M=10 050-024-00-0 reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6 — STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H315
H318
H317
H410
050-025-00-6 trichloromethylstannane 213-608-8 993-16-8 Repr. 2 H361d GHS08
Wng
H361d 050-026-00-1 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-828-5 57583-34-3 Repr. 2 H361d GHS08
Wng
H361d 050-027-00-7 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 239-622-4 15571-58-1 Repr. 1B H360D GHS08
Dgr
H360D 050-028-00-2 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-829-0 57583-35-4 Repr. 2
Acute Tox. 4
STOT RE 1
Skin Sens. 1A
H361d
H302
H372 (Nervensystem, Immunsystem)
H317
GHS08
GHS07
Dgr
H361d
H302
H372 (Nervensystem, Immunsystem)
H317
050-029-00-8 dimethyltin dichloride 212-039-2 753-73-1 Repr. 2
Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 1
Skin Corr. 1B
H361d
H330
H301
H311
H372 (Nervensystem, Immunsystem)
H314
GHS08
GHS06
GHS05
Dgr
H361d
H330
H301
H311
H372 (Nervensystem, Immunsystem)
H314
EUH071 050-030-00-3 Dibutylzinndilaurat; Dibutyl[bis(dodecanoyloxy)]-stannan 201-039-8 77-58-7 Muta. 2
Repr. 1B
STOT RE 1
H341
H360FD
H372 (Immunsystem)
GHS08
Dgr
H341
H360FD
H372 (Immunsystem)
051-001-00-8 antimony trichloride 233-047-2 10025-91-9 Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Gef.
H314
H411
STOT SE 3; H335: C ≥ 5 % 051-002-00-3 antimony pentachloride 231-601-8 7647-18-9 Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Gef.
H314
H411
STOT SE 3; H335: C ≥ 5 % 051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Achtg.
H332
H302
H411
* A1 051-004-00-4 antimony trifluoride 232-009-2 7783-56-4 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Gef.
H331
H311
H301
H411
051-005-00-X antimony trioxide 215-175-0 1309-64-4 Carc. 2 H351 GHS08
Achtg.
H351 051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate 403-500-0 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 404-420-9 71786-70-4 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
053-001-00-3 iodine 231-442-4 7553-56-2 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H312
H400
GHS07
GHS09
Achtg.
H332
H312
H400
053-002-00-9 hydrogen iodide 233-109-9 10034-85-2 Press. Gas
Skin Corr. 1A
H314 GHS04
GHS05
Gef.
H314 Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %
Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %
STOT SE 3; H335: C ≥ 0,02 %
U5 053-002-01-6 hydriodic acid ... % — — Skin Corr. 1B H314 GHS05
Gef.
Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B 053-003-00-4 iodoxybenzene — 696-33-3 Expl. **** **** **** **** 053-004-00-X calcium iodoxybenzoate — — Expl. **** **** **** **** C 053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 422-960-3 178233-72-2 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Achtg.
H312
H302
H373 **
H410
056-001-00-1 barium peroxide 215-128-4 1304-29-6 Ox. Sol. 2
Acute Tox. 4 *
Acute Tox. 4 *
H272
H332
H302
GHS03
GHS07
Gef.
H272
H332
H302
056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Achtg.
H332
H302
* A1 056-003-00-2 barium carbonate 208-167-3 513-77-9 Acute Tox. 4 * H302 GHS07
Achtg.
H302 056-004-00-8 barium chloride 233-788-1 10361-37-2 Acute Tox. 3 *
Acute Tox. 4 *
H301
H332
GHS06
Gef.
H301
H332
064-001-00-8 gadolinium(III)sulfite trihydrate 456-900-2 51285-81-5 Aquatic Chronic 2 H411 GHS09 H411 072-001-00-4 hafnium tetra-n-butoxide 411-740-2 22411-22-9 Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Gef.
H318
H317
074-001-00-X hexasodium tungstate hydrate 412-770-9 12141-67-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Gef.
H302
H318
H412
074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione 408-250-6 — Flam. Liq. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H314
H317
H400
H410
GHS02
GHS05
GHS07
GHS09
Gef.
H225
H332
H314
H317
H410
076-001-00-5 osmium tetraoxide;
osmic acid
244-058-7 20816-12-0 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
H330
H310
H300
H314
GHS06
GHS05
Gef.
H330
H310
H300
H314
078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H318
H334
H317
A 078-002-00-6 diammonium tetrachloroplatinate 237-499-1 13820-41-2 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H315
H318
H334
H317
078-003-00-1 disodium tetrachloroplatinate 233-051-4 10026-00-3 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H315
H318
H334
H317
078-004-00-7 dipotassium tetrachloroplatinate 233-050-9 10025-99-7 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H315
H318
H334
H317
078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H318
H334
H317
A 078-006-00-8 disodium hexachloroplatinate 240-983-5 16923-58-3 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H318
H334
H317
078-007-00-3 dipotassium hexachloroplatinate 240-979-3 16921-30-5 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H318
H334
H317
078-008-00-9 diammonium hexachloroplatinate 240-973-0 16919-58-7 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H318
H334
H317
078-009-00-4 hexachloroplatinic acid 241-010-7 16941-12-1 Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H301
H314
H334
H317
GHS06
GHS05
GHS08
Gef.
H301
H314
H334
H317
078-010-00-X tetraammine platinum(II) hydrogen carbonate 426-730-3 123439-82-7 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
078-011-00-5 hydroxydisulfito platinum(II) acid 423-310-1 61420-92-6 Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373
H314
H334
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373
H314
H334
H317
H412
078-012-00-0 platinum(IV) nitrate/nitric acid solution 432-400-1 — Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
080-001-00-0 mercury 231-106-7 7439-97-6 Repr. 1B
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H330
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D***
H330
H372**
H410
080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H310
H300
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,1 %
A1 080-003-00-1 dimercury dichloride;
mercurous chloride;
calomel
233-307-5 10112-91-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H335
H315
H410
080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H310
H300
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,1 %
A1 080-005-00-2 mercury difulminate;
mercuric fulminate;
fulminate of mercury
211-057-8 628-86-4 Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Gef.
H200
H331
H311
H301
H373 **
H400
H410
080-005-01-X mercury difulminate;
mercuric fulminate;
fulminate of mercury [> 20 % phlegmatiser]
211-057-8 628-86-4 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Gef.
H201
H331
H311
H301
H373 **
H400
H410
080-006-00-8 dimercury dicyanide oxide;
mercuric oxycyanide
215-629-8 1335-31-5 Expl. 1,1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373**
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373**
H410
080-007-00-3 dimethylmercury; [1]
diethylmercury [2]
209-805-3 [1]
211-000-7 [2]
593-74-8 [1]
627-44-1 [2]
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H330
H310
H300
H373 **
H410
*
STOT RE 2; H373: C ≥ 0,05 %
1 080-008-00-9 phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3]
200-242-9 [1]
202-866-7 [2]
[3]
55-68-5 [1]
100-57-2 [2]
8003-05-2 [3]
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H301
H372 **
H314
H410
080-009-00-4 2-methoxyethylmercury chloride 204-659-7 123-88-6 Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H301
H372 **
H314
H410
080-010-00-X mercury dichloride;
mercuric chloride
231-299-8 7487-94-7 Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H361f***
H300
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H361f***
H300
H372**
H314
H410
080-011-00-5 phenylmercury acetate 200-532-5 62-38-4 Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H301
H372 **
H314
H410
081-001-00-3 thallium 231-138-1 7440-28-0 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Gef.
H330
H300
H373 **
H413
081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H300
H373 **
H411
GHS06
GHS08
GHS09
Gef.
H330
H300
H373 **
H411
A 081-003-00-4 dithallium sulphate;
thallic sulphate
231-201-3 7446-18-6 Acute Tox. 2 *
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 2
H300
H372 **
H315
H411
GHS06
GHS08
GHS09
Gef.
H300
H372 **
H315
H411
082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex — — Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Gef.
H360Df
H332
H302
H373 **
H410
Repr. 2; H361f: C ≥ 2,5 %
*
STOT RE 2; H373: C ≥ 0,5 %
A1 082-002-00-1 lead alkyls — — Repr. 1A
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H360Df
H330
H310
H300
H373 **
H410
Repr. 1A; H360D: C ≥ 0,1 %
*
STOT RE 2; H373: C ≥ 0,05 %
A1 082-003-00-7 lead diazide;
lead azide
236-542-1 13424-46-9 Unst. Expl.
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Gef.
H200
H360Df
H332
H302
H373 **
H410
1 082-003-01-4 lead diazide;
lead azide [> 20 % phlegmatiser]
236-542-1 13424-46-9 Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Gef.
H201
H360Df
H332
H302
H373 **
H410
1 082-004-00-2 lead chromate 231-846-0 7758-97-6 Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410
1 082-005-00-8 lead di(acetate) 206-104-4 301-04-2 Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Gef.
H360Df
H373 **
H410
1 082-006-00-3 trilead bis(orthophosphate) 231-205-5 7446-27-7 Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Gef.
H360Df
H373 **
H410
1 082-007-00-9 lead acetate, basic 215-630-3 1335-32-6 Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H360Df
H373 **
H400
H410
GHS08
GHS09
Gef.
H351
H360Df
H373 **
H410
1 082-008-00-4 lead(II) methanesulphonate 401-750-5 17570-76-2 Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H360Df
H332
H302
H373 **
H315
H318
GHS08
GHS05
GHS07
Gef.
H360Df
H332
H302
H373 **
H315
H318
1 082-009-00-X lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-7 1344-37-2 Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410
1 082-010-00-5 lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-9 12656-85-8 Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410
1 082-011-00-0 lead hydrogen arsenate 232-064-2 7784-40-9 Carc. 1A
Repr. 1A
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H331
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H360Df
H331
H301
H373 **
H410
1 082-012-00-6 barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped 431-780-4 199876-46-5 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411
082-013-00-1 Bleipulver;
[Partikeldurchmesser < 1 mm]
231-100-4 7439-92-1 Repr. 1 A
Lakt.
H360FD
H362
GHS08
Dgr
H360FD
H362
Repr. 1 A; H360D: C ≥ 0,03 % 082-014-00-7 Blei, massiv:
[Partikeldurchmesser ≥ 1 mm]
231-100-4 7439-92-1 Repr. 1 A
Lakt.
H360FD
H362
GHS08
Dgr
H360FD
H362
092-001-00-8 uranium 231-170-6 7440-61-1 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Gef.
H330
H300
H373 **
H413
092-002-00-3 uranium compounds with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H373**
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H373**
H411
A 601-001-00-4 methane 200-812-7 74-82-8 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 601-002-00-X ethane 200-814-8 74-84-0 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 601-003-00-5 propane 200-827-9 74-98-6 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 601-004-00-0 butane; [1]
and isobutane [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 C U 601-004-01-8 butane (containing ≥ 0.1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0.1 % butadiene (203-450-8)) [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Gef.
H220
H350
H340
C S U 601-005-00-6 2,2-dimethylpropane;
neopentane
207-343-7 463-82-1 Flam. Gas 1
Press. Gas
Aquatic Chronic 2
H220
H411
GHS02
GHS04
GHS09
Gef.
H220
H411
U 601-006-00-1 pentane 203-692-4 109-66-0 Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H225
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H304
H336
H411
EUH066 C 601-007-00-7 hexane (containing < 5 % n-hexane (203-777-6));
2-methylpentane; [1]
3-methylpentane; [2]
2,2-dimethylbutane; [3]
2,3-dimethylbutane [4]
203-523-4 [1]
202-481-4 [2]
200-906-8 [3]
201-193-6 [4]
107-83-5 [1]
96-14-0 [2]
75-83-2 [3]
79-29-8 [4]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411
C 601-008-00-2 heptane;
n-heptane; [1]
2,4-dimethylpentane; [2]
2,2,3-trimethylbutane; [3]
3,3-dimethylpentane; [4]
2,3-dimethylpentane; [5]
3-methylhexane; [6]
2,2-dimethylpentane; [7]
2-methylhexane; [8]
3-ethylpentane; [9]
isoheptane; [10]
205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10]
142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410
C 601-009-00-8 octane;
n-octane; [1]
2,2,4-trimethylpentane; [2]
2,3,3-trimethylpentane; [3]
3,3-dimethylhexane; [4]
2,2,3-trimethylpentane; [5]
2,3,4-trimethylpentane; [6]
3,4-dimethylhexane; [7]
2,3-dimethylhexane; [8]
2,4-dimethylhexane; [9]
4-methylheptane; [10]
3-methylheptane; [11]
2,2-dimethylhexane; [12]
2,5-dimethylhexane; [13]
2-methylheptane; [14]
2,2,3,3-tetramethylbutane; [15]
3-ethyl-2-methylpentane; [16]
3-ethylhexane; [17]
3-ethyl-3-methylpentane; [18]
isooctane; [19]
203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19]
111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410
C 601-010-00-3 ethylene 200-815-3 74-85-1 Flam. Gas 1
Press. Gas
STOT SE 3
H220
H336
GHS02
GHS04
GHS07
Gef.
H220
H336
U 601-011-00-9 propene;
propylene
204-062-1 115-07-1 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 601-012-00-4 but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5]
203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5]
106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5]
Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 C U 601-013-00-X 1,3-butadiene;
buta-1,3-diene
203-450-8 106-99-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Gef.
H220
H350
H340
D U 601-014-00-5 isoprene (stabilised)
2-methyl-1,3-butadiene
201-143-3 78-79-5 Flam. Liq. 1
Carc. 1B
Muta. 2
Aquatic Chronic 3
H224
H350
H341
H412
GHS02
GHS08
Gef.
H224
H350
H341
H412
D 601-015-00-0 acetylene;
ethyne
200-816-9 74-86-2 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 EUH006 U 601-016-00-6 cyclopropane 200-847-8 75-19-4 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 601-017-00-1 cyclohexane 203-806-2 110-82-7 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H304
H315
H336
H410
601-018-00-7 methylcyclohexane 203-624-3 108-87-2 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H304
H315
H336
H411
601-019-00-2 1,4-dimethylcyclohexane 209-663-2 589-90-2 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H304
H315
H336
H411
601-020-00-8 benzene 200-753-7 71-43-2 Flam. Liq. 2
Carc. 1A
Muta. 1B
STOT RE 1
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
H225
H350
H340
H372 **
H304
H319
H315
GHS02
GHS08
GHS07
Gef.
H225
H350
H340
H372 **
H304
H319
H315
E 601-021-00-3 toluene 203-625-9 108-88-3 Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
H225
H361d ***
H304
H373 **
H315
H336
GHS02
GHS08
GHS07
Gef.
H225
H361d ***
H304
H373 **
H315
H336
601-022-00-9 o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4]
202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4]
95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4]
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H312
H315
GHS02
GHS07
Achtg.
H226
H332
H312
H315
* C 601-023-00-4 ethylbenzene 202-849-4 100-41-4 Flam. Liq. 2
Acute Tox. 4*
STOT RE 2
Asp. Tox. 1
H225
H332
H373 (Hörorgane)
H304
GHS02
GHS07
GHS08
Dgr
H225
H332
H373 (Hörorgane)
H304
601-024-00-X cumene; [1]
propylbenzene [2]
202-704-5 [1]
203-132-9 [2]
98-82-8 [1]
103-65-1 [2]
Flam. Liq. 3
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H226
H304
H335
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H226
H304
H335
H411
C 601-025-00-5 mesitylene;
1,3,5-trimethylbenzene
203-604-4 108-67-8 Flam. Liq. 3
STOT SE 3
Aquatic Chronic 2
H226
H335
H411
GHS02
GHS07
GHS09
Achtg.
H226
H335
H411
STOT SE 3; H335: C ≥ 25 % 601-026-00-0 styrene 202-851-5 100-42-5 Flam. Liq. 3
Repr. 2
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
H226
H361d
H332
H372 (Hörorgane)
H315
H319
GHS02
GHS08
GHS07
Dgr
H226
H361d
H332
H372 (Hörorgane)
H315
H319
* D 601-027-00-6 2-phenylpropene;
α-methylstyrene
202-705-0 98-83-9 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2
H226
H319
H335
H411
GHS02
GHS07
GHS09
Achtg.
H226
H319
H335
H411
STOT SE 3; H335: C ≥ 25 % 601-028-00-1 2-methylstyrene;
2-vinyltoluene
210-256-7 611-15-4 Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Achtg.
H332
H411
601-029-00-7 dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5]
138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5]
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H315
H317
H400
H410
GHS02
GHS07
GHS09
Achtg.
H226
H315
H317
H410
C 601-030-00-2 cyclopentane 206-016-6 287-92-3 Flam. Liq. 2
Aquatic Chronic 3
H225
H412
GHS02
Gef.
H225
H412
601-031-00-8 2,4,4-trimethylpent-1-ene 203-486-4 107-39-1 Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Gef.
H225
H411
601-032-00-3 benzo[a]pyrene;
benzo[def]chrysene
200-028-5 50-32-8 Carc. 1B
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H317
H400
H410
GHS08
GHS07
GHS09
Gef.
H350
H340
H360FD
H317
H410
Carc. 1B; H350: C ≥ 0,01 % 601-033-00-9 benz[a]anthracene 200-280-6 56-55-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
M=100 601-034-00-4 benz[e]acephenanthrylene 205-911-9 205-99-2 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Gef.
H350
H410
601-035-00-X benzo[j]fluoranthene 205-910-3 205-82-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Gef.
H350
H410
601-036-00-5 benzo[k]fluoranthene 205-916-6 207-08-9 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Gef.
H350
H410
601-037-00-0 n-hexane 203-777-6 110-54-3 Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H361f ***
H304
H373 **
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H361f ***
H304
H373 **
H315
H336
H411
STOT RE 2; H373: C ≥ 5 % 601-041-00-2 dibenz[a,h]anthracene 200-181-8 53-70-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
Carc. 1B; H350: C ≥ 0,01 %
M=100
601-042-00-8 biphenyl;
diphenyl
202-163-5 92-52-4 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H335
H315
H410
601-043-00-3 1,2,4-trimethylbenzene 202-436-9 95-63-6 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H332
H319
H335
H315
H411
GHS02
GHS07
GHS09
Achtg.
H226
H332
H319
H335
H315
H411
601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 201-052-9 77-73-6 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H225
H332
H302
H319
H335
H315
H411
GHS02
GHS07
GHS09
Gef.
H225
H332
H302
H319
H335
H315
H411
601-045-00-4 1,2,3,4-tetrahydronaphthalene 204-340-2 119-64-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Achtg.
H319
H315
H411
EUH019 601-046-00-X 7-methylocta-1,6-diene 404-210-7 42152-47-6 Flam. Liq. 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H400
H410
GHS02
GHS09
Achtg.
H226
H410
601-047-00-5 m-mentha-1,3(8)-diene 404-150-1 17092-80-7 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
601-048-00-0 chrysene 205-923-4 218-01-9 Carc. 1B
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H400
H410
GHS08
GHS09
Gef.
H350
H341
H410
601-049-00-6 benzo[e]pyrene 205-892-7 192-97-2 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Gef.
H350
H410
601-051-00-7 4-phenylbut-1-ene 405-980-7 768-56-9 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
601-052-00-2 naphthalene 202-049-5 91-20-3 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS07
GHS08
GHS09
Achtg.
H351
H302
H410
601-053-00-8 nonylphenol; [1]
4-nonylphenol, branched [2]
246-672-0 [1]
284-325-5 [2]
25154-52-3 [1]
84852-15-3 [2]
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Gef.
H361fd
H302
H314
H410
601-054-00-3 reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene
405-570-8 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes
410-190-0 132983-41-6 Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Achtg.
H319
H413
601-056-00-4 reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane
405-470-4 73807-39-3 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Achtg.
H315
H410
601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 421-130-8 156679-41-3 Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Gef.
H318
H317
H410
601-058-00-5 di-L-para-menthene 417-870-6 83648-84-4 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H315
H317
H410
601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 420-940-9 15768-07-7 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Achtg.
H319
H315
H411
601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 417-610-1 155522-09-1 Skin Sens. 1 H317 GHS07
Achtg.
H317 601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) 418-960-8 — Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Gef.
H314
H317
H411
601-062-00-7 reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane
417-030-9 151006-59-6 Aquatic Chronic 4 H413 — H413 601-063-00-2 reaction mass of isomers of branched tetracosane 417-060-2 151006-61-0 Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Achtg.
H332
H413
601-064-00-8 branched hexatriacontane 417-070-7 151006-62-1 Aquatic Chronic 4 H413 — H413 601-065-00-3 reaction mass of: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9 — Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone 426-820-2 78531-60-9 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Achtg.
H317
H413
601-067-00-4 triethyl arsenate 427-700-2 15606-95-8 Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Gef.
H350
H331
H301
H410
601-068-00-X 1,2-diacetoxybut-3-ene 421-720-5 18085-02-4 Acute Tox. 4 * H302 GHS07
Achtg.
H302 601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 422-680-1 287933-44-2 Aquatic Chronic 3 H412 — H412 601-070-00-0 reaction mass of: branched icosane;
branched docosane;
branched tetracosane
417-050-8 151006-58-5 Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 423-830-9 20627-73-0 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
601-072-00-1 reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane
430-690-2 52783-21-8 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
601-073-00-7 1-bromo-3,5-difluorobenzene 416-710-2 461-96-1 Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373 **
H315
H317
H400
H410
GHS02
GHS08
GHS07
GHS09
Achtg.
H226
H302
H373 **
H315
H317
H410
601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1 — Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Achtg.
H319
H315
H411
601-075-00-8 4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane 418-770-5 151882-81-4 Carc. 2 H351 GHS08
Wng
H351 601-076-00-3 ethynyl cyclopropane 425-430-1 6746-94-7 Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H315
H318
H412
GHS02
GHS05
Dgr
H225
H315
H318
H412
601-077-00-9 reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
426-510-7 196965-91-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 601-078-00-4 reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane
427-040-5 — Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
601-079-00-X reaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene
429-620-3 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-080-00-5 reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 601-081-00-0 cyclohexadeca-1,9-diene 431-730-1 4277-06-9 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-082-00-6 reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
601-083-00-1 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene 435-000-3 22094-83-3 Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4
H304
H315
H413
GHS08
GHS07
Dgr
H304
H315
H413
601-084-00-7 reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3 — Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H304
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H304
H315
H410
601-085-00-2 isopentane;
2-methylbutane
201-142-8 78-78-4 Flam. Liq. 1
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H224
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Gef.
H224
H304
H336
H411
EUH066 601-087-00-3 2,4,4-trimethylpentene 246-690-9 25167-70-8 Flam. Liq. 2 H225 GHS02 H225 D Asp. Tox. 1 H304 GHS07 H304 STOT SE 3 H336 GHS08
Dgr
H336 601-088-00-9 4-vinylcyclohexene 202-848-9 100-40-3 Carc. 2 H351 GHS08
Wng
H351 601-089-00-4 muscalure; cis-tricos-9-ene 248-505-7 27519-02-4 Skin Sens. 1B H317 GHS07
Wng
H317 602-001-00-7 chloromethane;
methyl chloride
200-817-4 74-87-3 Flam. Gas 1
Press. Gas
Carc. 2
STOT RE 2 *
H220
H351
H373 **
GHS02
GHS04
GHS08
Gef.
H220
H351
H373 **
U 602-002-00-2 bromomethane;
methylbromide
200-813-2 74-83-9 Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone 1
H341
H331
H301
H373
**
H319
H335
H315
H400
H420
GHS04
GHS06
GHS08
GHS09
Dgr
H341
H331
H301
H373 **
H319
H335
H315
H400
H420
U 602-003-00-8 dibromomethane 200-824-2 74-95-3 Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Achtg.
H332
H412
* 602-004-00-3 dichloromethane;
methylene chloride
200-838-9 75-09-2 Carc. 2 H351 GHS08
Achtg.
H351 602-005-00-9 methyl iodide;
iodomethane
200-819-5 74-88-4 Carc. 2
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
H351
H312
H331
H301
H335
H315
GHS06
GHS08
Gef.
H351
H312
H331
H301
H335
H315
602-006-00-4 chloroform;
trichloromethane
200-663-8 67-66-3 Carc. 2 H351 GHS06 H351 Repr. 2 H361d GHS08 H361d Acute Tox. 3 H331 Dgr H331 Acute Tox. 4 H302 H302 STOT RE 1 H372 H372 Eye Irrit. 2 H319 H319 Skin Irrit. 2 H315 H315 602-007-00-X bromoform;
tribromomethane
200-854-6 75-25-2 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H331
H302
H319
H315
H411
GHS06
GHS09
Dgr
H331
H302
H319
H315
H411
602-008-00-5 carbon tetrachloride;
tetrachloromethane
200-262-8 56-23-5 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic
Chronic 3
Ozone 1
H351
H331
H311
H301
H372
**
H412
H420
GHS06
GHS08
Dgr
H351
H331
H311
H301
H372 **
H412
H420
*
STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,2 % ≤ C
< 1 %
602-009-00-0 chloroethane 200-830-5 75-00-3 Flam. Gas 1
Press. Gas
Carc. 2
Aquatic Chronic 3
H220
H351
H412
GHS02
GHS04
GHS08
Gef.
H220
H351
H412
U 602-010-00-6 1,2-dibromoethane 203-444-5 106-93-4 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H350
H331
H311
H301
H319
H335
H315
H411
GHS06
GHS08
GHS09
Gef.
H350
H331
H311
H301
H319
H335
H315
H411
* 602-011-00-1 1,1-dichloroethane 200-863-5 75-34-3 Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
H225
H302
H319
H335
H412
GHS02
GHS07
Gef.
H225
H302
H319
H335
H412
* 602-012-00-7 1,2-dichloroethane;
ethylene dichloride
203-458-1 107-06-2 Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H302
H319
H335
H315
GHS02
GHS08
GHS07
Gef.
H225
H350
H302
H319
H335
H315
602-013-00-2 1,1,1-trichloroethane;
methyl chloroform
200-756-3 71-55-6 Acute Tox. 4 *
Ozone 1
H332
H420
GHS07
Wng
H332
H420
F 602-014-00-8 1,1,2-trichloroethane 201-166-9 79-00-5 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H351
H332
H312
H302
GHS08
GHS07
Achtg.
H351
H332
H312
H302
EUH066 * 602-015-00-3 1,1,2,2-tetrachloroethane 201-197-8 79-34-5 Acute Tox. 2 *
Acute Tox. 1
Aquatic Chronic 2
H330
H310
H411
GHS06
GHS09
Gef.
H330
H310
H411
602-016-00-9 1,1,2,2-tetrabromoethane 201-191-5 79-27-6 Acute Tox. 2 *
Eye Irrit. 2
Aquatic Chronic 3
H330
H319
H412
GHS06
Gef.
H330
H319
H412
602-017-00-4 pentachloroethane 200-925-1 76-01-7 Carc. 2
STOT RE 1
Aquatic Chronic 2
H351
H372 **
H411
GHS08
GHS09
Gef.
H351
H372 **
H411
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %
602-018-00-X 1-chloropropane; [1]
2-chloropropane [2]
208-749-7 [1]
200-858-8 [2]
540-54-5 [1]
75-29-6 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Gef.
H225
H332
H312
H302
C 602-019-00-5 1-bromopropane;
n-propyl bromide
203-445-0 106-94-5 Flam. Liq. 2
Repr. 1B
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
STOT SE 3
H225
H360FD
H373 **
H319
H335
H315
H336
GHS02
GHS08
GHS07
Gef.
H225
H360FD
H373 **
H319
H335
H315
H336
602-020-00-0 1,2-Dichlorpropan;
Propylendichlorid
201-152-2 78-87-5 Flam. Liq. 2
Carc. 1B
Acute Tox. 4*
Acute Tox. 4*
H225
H350
H332
H302
GHS02
GHS08
GHS07
Dgr
H225
H350
H332
H302
602-021-00-6 1,2-dibromo-3-chloropropane 202-479-3 96-12-8 Carc. 1B
Muta. 1B
Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H340
H360F ***
H301
H373 **
H412
GHS06
GHS08
Gef.
H350
H340
H360F ***
H301
H373 **
H412
602-022-00-1 1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3]
208-846-4 [1]
210-885-7 [2]
210-467-4 [3]
543-59-9 [1]
625-29-6 [2]
616-20-6 [3]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Gef.
H225
H332
H312
H302
C 602-023-00-7 vinyl chloride;
chloroethylene
200-831-0 75-01-4 Press. Gas
Flam. Gas 1
Carc. 1A
H220
H350
GHS02
GHS08
Gef.
H220
H350
D U 602-024-00-2 bromoethylene 209-800-6 593-60-2 Press. Gas
Flam. Gas 1
Carc. 1B
H220
H350
GHS02
GHS08
Gef.
H220
H350
U 602-025-00-8 1,1-dichloroethylene;
vinylidene chloride
200-864-0 75-35-4 Flam. Liq. 1
Carc. 2
Acute Tox. 4 *
H224
H351
H332
GHS02
GHS08
GHS07
Gef.
H224
H351
H332
* D 602-026-00-3 1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3]
208-750-2 [1]
205-859-7 [2]
205-860-2 [3]
540-59-0 [1]
156-59-2 [2]
156-60-5 [3]
Flam. Liq. 2
Acute Tox. 4 *
Aquatic Chronic 3
H225
H332
H412
GHS02
GHS07
Gef.
H225
H332
H412
* C 602-027-00-9 trichloroethylene;
trichloroethene
201-167-4 79-01-6 Carc. 1B
Muta. 2
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 3
H350
H341
H319
H315
H336
H412
GHS08
GHS07
Gef.
H350
H341
H319
H315
H336
H412
602-028-00-4 tetrachloroethylene 204-825-9 127-18-4 Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Achtg.
H351
H411
602-029-00-X 3-chloropropene;
allyl chloride
203-457-6 107-05-1 Flam. Liq. 2
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400
GHS02
GHS08
GHS07
GHS09
Gef.
H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400
D 602-030-00-5 1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]
208-826-5 [1]
233-195-8 [2]
542-75-6 [1]
10061-01-5 [2]
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H311
H301
H332
H304
H319
H335
H315
H317
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H226
H311
H301
H332
H304
H319
H335
H315
H317
H410
C D 602-031-00-0 1,1-dichloropropene 209-253-3 563-58-6 Flam. Liq. 2
Acute Tox. 3 *
Aquatic Chronic 3
H225
H301
H412
GHS02
GHS06
Gef.
H225
H301
H412
602-032-00-6 3-chloro-2-methylpropene 209-251-2 563-47-3 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Gef.
H225
H332
H302
H314
H317
H411
602-033-00-1 Chlorbenzol 203-628-5 108-90-7 Flam. Liq. 3
Acute Tox. 4
Skin Irrit. 2
Aquatic Chronic 2
H226
H332
H315
H411
GHS02
GHS07
GHS09
Wng
H226
H332
H315
H411
602-034-00-7 1,2-dichlorobenzene;
o-dichlorobenzene
202-425-9 95-50-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H335
H315
H410
* 602-035-00-2 1,4-dichlorobenzene;
p-dichlorobenzene
203-400-5 106-46-7 Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H400
H410
GHS08
GHS09
Achtg.
H351
H319
H410
602-036-00-8 chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised)
204-818-0 126-99-8 Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H332
H302
H373 **
H319
H335
H315
GHS02
GHS08
GHS07
Gef.
H225
H350
H332
H302
H373 **
H319
H335
H315
D 602-037-00-3 α-chlorotoluene;
benzyl chloride
202-853-6 100-44-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H373 **
H335
H315
H318
GHS06
GHS08
GHS05
Gef.
H350
H331
H302
H373 **
H335
H315
H318
602-038-00-9 α, α,α-trichlorotoluene;
benzotrichloride
202-634-5 98-07-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Gef.
H350
H331
H302
H335
H315
H318
602-039-00-4 polychlorobiphenyls;
PCB
215-648-1 1336-36-3 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Achtg.
H373 **
H410
STOT RE 2; H373: C ≥ 0,005 % C 602-040-00-X 2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4]
202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4]
95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4]
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Achtg.
H332
H411
C 602-041-00-5 penthachloronaphthalene 215-320-8 1321-64-8 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H319
H315
H410
C 602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex — — Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H301
H312
H410
A C 602-043-00-6 lindane (ISO);
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane
200-401-2 58-89-9 Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H373 **
H362
H400
H410
GHS06
GHS08
GHS09
Gef.
H301
H332
H312
H373 **
H362
H410
M=10 602-044-00-1 camphechlor (ISO);
toxaphene;
232-283-3 8001-35-2 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H335
H315
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H301
H312
H335
H315
H410
602-045-00-7 DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane
200-024-3 50-29-3 Carc. 2
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H301
H372 **
H410
602-046-00-2 heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-3 76-44-8 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H311
H301
H373 **
H410
602-047-00-8 chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-0 57-74-9 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H312
H302
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H312
H302
H410
602-048-00-3 aldrin (ISO) 206-215-8 309-00-2 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H311
H301
H372 **
H410
602-049-00-9 dieldrin (ISO) 200-484-5 60-57-1 Carc. 2
Acute Tox. 1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H310
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H310
H301
H372 **
H410
602-050-00-4 isodrin;
(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
207-366-2 465-73-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
M=100 602-051-00-X endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-7 72-20-8 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Gef.
H300
H311
H410
602-052-00-5 endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;
1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite
204-079-4 115-29-7 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H312
H400
H410
GHS06
GHS09
Dgr
H330
H300
H312
H410
602-053-00-0 isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4 297-78-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Gef.
H310
H300
H400
602-054-00-6 3-iodpropene;
allyl iodide
209-130-4 556-56-9 Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
602-055-00-1 bromoethane;
ethyl bromide
200-825-8 74-96-4 Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H351
H332
H302
GHS02
GHS08
GHS07
Gef.
H225
H351
H332
H302
602-056-00-7 α, α,α-trifluorotoluene;
benzotrifluoride
202-635-0 98-08-8 Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Gef.
H225
H411
602-057-00-2 α-bromotoluene;
benzyl bromide
202-847-3 100-39-0 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Achtg.
H319
H335
H315
602-058-00-8 α, α-dichlorotoluene;
benzylidene chloride;
benzal chloride
202-709-2 98-87-3 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H351
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Gef.
H351
H331
H302
H335
H315
H318
602-059-00-3 1-chlorobutane;
butyl chloride
203-696-6 109-69-3 Flam. Liq. 2 H225 GHS02
Gef.
H225 602-060-00-9 bromobenzene 203-623-8 108-86-1 Flam. Liq. 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H315
H411
GHS02
GHS07
GHS09
Achtg.
H226
H315
H411
602-061-00-4 hexafluoropropene;
hexafluoropropylene
204-127-4 116-15-4 Press. Gas
Acute Tox. 4 *
STOT SE 3
H332
H335
GHS07
Achtg.
H332
H335
U 602-062-00-X 1,2,3-trichloropropane 202-486-1 96-18-4 Carc. 1B
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H360F ***
H332
H312
H302
GHS08
GHS07
Gef.
H350
H360F ***
H332
H312
H302
D 602-063-00-5 heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-0 1024-57-3 Carc. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H301
H373 **
H410
602-064-00-0 1,3-dichloro-2-propanol 202-491-9 96-23-1 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
H350
H301
H312
GHS06
GHS08
Gef.
H350
H301
H312
602-065-00-6 hexachlorobenzene 204-273-9 118-74-1 Carc. 1B
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372 **
H400
H410
GHS08
GHS09
Gef.
H350
H372 **
H410
602-066-00-1 tetrachloro-p-benzoquinone 204-274-4 118-75-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H315
H410
602-067-00-7 1,3-dichlorbenzene 208-792-1 541-73-1 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
602-068-00-2 ethylene bis(trichloroacetate) 219-732-9 2514-53-6 Skin Irrit. 2 H315 GHS07
Achtg.
H315 602-069-00-8 dichloroacetylene — 7572-29-4 Unst. Expl.
Carc. 2
STOT RE 2 *
H200
H351
H373 **
GHS01
GHS08
Achtg.
H200
H351
H373 **
602-070-00-3 3-chloro-4,5,α, α,α-pentafluorotoluene 401-930-3 77227-99-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H226
H332
H302
H400
GHS02
GHS07
GHS09
Achtg.
H226
H332
H302
H400
602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 402-210-1 99688-47-8 STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H373 **
H317
H410
602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-3 76253-60-6 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 602-073-00-X 1,4-dichlorobut-2-ene 212-121-8 764-41-0 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H330
H311
H301
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Gef.
H350
H330
H311
H301
H314
H410
Carc. 1B; H350: C ≥ 0,01 %
STOT SE 3; H335: C ≥ 5 %
602-074-00-5 pentachlorobenzene 210-172-0 608-93-5 Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Gef.
H228
H302
H410
T 602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 404-060-2 22432-68-4 Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
H330
H302
H314
GHS06
GHS05
Gef.
H330
H302
H314
602-076-00-6 2,3,4-trichlorobut-1-ene 219-397-9 2431-50-7 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H302
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H331
H302
H319
H335
H315
H410
Carc. 2; H351: C ≥ 0,1 % 602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex
219-196-6 2385-85-5 Carc. 2
Repr. 2
Lact.
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361fd
H362
H312
H302
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H361fd
H362
H312
H302
H410
602-078-00-7 hexachlorocyclopentadiene 201-029-3 77-47-4 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H302
H314
H400
H410
GHS06
GHS05
GHS09
Gef.
H330
H311
H302
H314
H410
602-079-00-2 2,3-dichloropropene;
2,3-dichloropropylene
201-153-8 78-88-6 Flam. Liq. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H341
H332
H312
H302
H335
H315
H318
H412
GHS02
GHS08
GHS05
GHS07
Gef.
H225
H341
H332
H312
H302
H335
H315
H318
H412
602-080-00-8 alkanes, C10-13, chloro;
chlorinated paraffins, C10-13
287-476-5 85535-84-8 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
EUH066 602-081-00-3 2-chloro-4,5-difluorobenzoic acid 405-380-5 — Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H312
H302
H318
H317
GHS05
GHS07
Gef.
H312
H302
H318
H317
602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 408-020-5 109678-33-3 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 251-084-2 32534-81-9 STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H362
H400
H410
GHS08
GHS09
Achtg.
H373 **
H362
H410
602-084-00-X 1,1-dichloro-1-fluoroethane 404-080-1 1717-00-6 Aquatic
Chronic 3
Ozone 1
H412
H420
GHS07
Wng
H412
H420
602-085-00-5 2-bromopropane 200-855-1 75-26-3 Flam. Liq. 2
Repr. 1A
STOT RE 2 *
H225
H360F ***
H373 **
GHS02
GHS08
Gef.
H225
H360F ***
H373 **
EUH066 602-086-00-0 trifluoroiodomethane;
trifluoromethyl iodide
219-014-5 2314-97-8 Muta. 2 H341 GHS08
Achtg.
H341 602-087-00-6 1,2,4-trichlorobenzene 204-428-0 120-82-1 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H315
H410
602-088-00-1 2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol
202-480-9 96-13-9 Carc. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H350
H361f ***
H311
H332
H302
H412
GHS08
GHS07
Gef.
H350
H361f ***
H311
H332
H302
H412
602-089-00-7 4-bromo-2-chlorofluorobenzene 405-580-2 60811-21-4 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H315
H410
602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 406-630-6 121626-73-1 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
602-091-00-8 1,3-dichloro-4-fluorobenzene 406-160-1 1435-48-9 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
H302
H373 **
H315
H411
GHS08
GHS07
Achtg.
H302
H373 **
H315
H411
602-092-00-3 1-bromo-3,4,5-trifluorobenzene 418-480-9 138526-69-9 Flam. Liq. 3
Carc. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H351
H315
H318
H411
GHS02
GHS08
GHS05
GHS09
Gef.
H226
H351
H315
H318
H411
602-093-00-9 α, α,α,4-tetrachlorotoluene;
p-chlorobenzotrichloride
226-009-1 5216-25-1 Carc. 1B
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H350
H361f ***
H372 **
H312
H302
H335
H315
GHS08
GHS07
Gef.
H350
H361f ***
H372 **
H312
H302
H335
H315
602-094-00-4 diphenylether; octabromo derivate 251-087-9 32536-52-0 Repr. 1B H360Df GHS08
Gef.
H360Df 602-095-00-X alkanes, C14-17, chloro;
chlorinated paraffins, C14-17
287-477-0 85535-85-9 Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
EUH066 602-096-00-5 malachite green hydrochloride; [1]
malachite green oxalate [2]
209-322-8 [1]
219-441-7 [2]
569-64-2 [1]
2437-29-8 [2]
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Gef.
H361d ***
H302
H318
H410
602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 422-850-5 148757-89-5 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
602-098-00-6 2-(3-bromophenoxy)tetrahydro-2H-pyran 429-030-6 57999-49-2 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
602-099-00-1 3-(4-fluorophenyl)-2-methylpropionylchloride 426-370-7 — Skin Corr. 1A
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
EUH014
EUH029
602-100-00-5 reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
420-640-8 — Aquatic Chronic 3 H412 — H412 602-101-00-0 2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate 427-020-6 141772-37-4 STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373**
H317
H410
602-102-00-6 1,1,1,3,3-pentafluorobutane 430-250-1 406-58-6 Flam. Liq. 2 H225 GHS02
Dgr
H225 602-103-00-1 1-(chlorophenylmethyl)-2-methylbenzene 431-450-1 41870-52-4 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
602-104-00-7 1,1,2,2,3,3,4-heptafluorocyclopentane 430-710-1 15290-77-4 Aquatic Chronic 3 H412 — H412 602-105-00-2 sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate 422-100-7 102061-82-5 Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
602-106-00-8 2-bromo-4,6-difluoroaniline 429-430-0 444-14-4 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
602-107-00-3 3,3,4,4-tetrafluoro-4-iodo-1-butene 439-500-2 33831-83-3 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411
602-108-00-9 (2,3,5,6-tetrafluorophenyl)methanol 443-840-7 4084-38-2 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
602-109-00-4 Hexabromocyclododecane [1] 247-148-4 [1] 25637-99-4[1] Repr. 2
Lact.
H361
H362
GHS08
Wng
H361
H362
1,2,5,6,9,10-hexabromocyclododecane [2] 221-695-9[2] 3194-55-6[2] 603-001-00-X methanol 200-659-6 67-56-1 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
H225
H331
H311
H301
H370 **
GHS02
GHS06
GHS08
Gef.
H225
H331
H311
H301
H370 **
*
STOT SE 1; H370: C ≥ 10 %
STOT SE 2; H371: 3 % ≤ C < 10 %
603-002-00-5 ethanol;
ethyl alcohol
200-578-6 64-17-5 Flam. Liq. 2 H225 GHS02
Gef.
H225 603-003-00-0 propan-1-ol;
n-propanol
200-746-9 71-23-8 Flam. Liq. 2
Eye Dam. 1
STOT SE 3
H225
H318
H336
GHS02
GHS05
GHS07
Gef.
H225
H318
H336
603-004-00-6 butan-1-ol;
n-butanol
200-751-6 71-36-3 Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H302
H335
H315
H318
H336
GHS02
GHS05
GHS07
Gef.
H226
H302
H335
H315
H318
H336
603-005-00-1 2-methylpropan-2-ol;
tert-butyl alcohol
200-889-7 75-65-0 Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335
603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex 250-378-8 Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
H226
H332
H335
GHS02
GHS07
Achtg.
H226
H332
H335
EUH066 C 603-007-00-2 2-methylbutan-2-ol;
tert-pentanol
200-908-9 75-85-4 Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H225
H332
H335
H315
GHS02
GHS07
Gef.
H225
H332
H335
H315
603-008-00-8 4-methylpentan-2-ol;
methyl isobutyl carbinol
203-551-7 108-11-2 Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Achtg.
H226
H335
STOT SE 3; H335: C ≥ 25 % 603-009-00-3 cyclohexanol 203-630-6 108-93-0 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H332
H302
H335
H315
GHS07
Achtg.
H332
H302
H335
H315
603-010-00-9 2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3]
209-512-0 [1]
231-187-9 [2]
231-186-3 [3]
583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3]
Acute Tox. 4 * H332 GHS07
Achtg.
H332 C 603-011-00-4 2-methoxyethanol;
ethylene glycol monomethyl ether
203-713-7 109-86-4 Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Gef.
H226
H360FD
H332
H312
H302
603-012-00-X 2-ethoxyethanol;
ethylene glycol monoethyl ether
203-804-1 110-80-5 Flam. Liq. 3
Repr. 1B
Acute Tox. 3
Acute Tox. 4
H226
H360FD
H331
H302
GHS02
GHS08
GHS06
Dgr
H226
H360FD
H331
H302
603-013-00-5 2-isopropoxyethanol;
ethylene glycol monoisopropyl ether
203-685-6 109-59-1 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H332
H312
H319
GHS07
Achtg.
H332
H312
H319
603-014-00-0 2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve
203-905-0 111-76-2 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H332
H312
H302
H319
H315
GHS07
Achtg.
H332
H312
H302
H319
H315
603-015-00-6 allyl alcohol 203-470-7 107-18-6 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H331
H311
H301
H319
H335
H315
H400
GHS02
GHS06
GHS09
Gef.
H225
H331
H311
H301
H319
H335
H315
H400
603-016-00-1 4-hydroxy-4-methylpentan-2-one;
diacetone alcohol
204-626-7 123-42-2 Eye Irrit. 2 H319 GHS07
Achtg.
H319 Eye Irrit. 2; H319: C ≥ 10 % 603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
H351
H331
H312
H302
H373**
H319
H335
GHS06
GHS08
Dgr
H351
H331
H312
H302
H373**
H319
H335
603-019-00-8 dimethyl ether 204-065-8 115-10-6 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 603-020-00-3 ethyl methyl ether — 540-67-0 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 U 603-021-00-9 methyl vinyl ether 203-475-4 107-25-5 Flam. Gas 1
Press. Gas
H220 GHS02
GHS04
Gef.
H220 D U 603-022-00-4 diethyl ether;
ether
200-467-2 60-29-7 Flam. Liq. 1
Acute Tox. 4 *
STOT SE 3
H224
H302
H336
GHS02
GHS07
Gef.
H224
H302
H336
EUH019
EUH066
603-023-00-X ethylene oxide;
oxirane
200-849-9 75-21-8 Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H220
H350
H340
H331
H319
H335
H315
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H350
H340
H331
H319
H335
H315
U 603-024-00-5 1,4-dioxane 204-661-8 123-91-1 Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3
H225
H351
H319
H335
GHS02
GHS08
GHS07
Gef.
H225
H351
H319
H335
EUH019
EUH066
D 603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3
H225
H351
H319
H335
GHS02
GHS07
GHS08
Dgr
H225
H351
H319
H335
EUH019 STOT SE 3;
H335: C ≥ 25 %
Eye Irrit.2;
H319: C ≥ 25 %
603-026-00-6 1-chloro-2,3-epoxypropane;
epichlorhydrin
203-439-8 106-89-8 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Gef.
H226
H350
H331
H311
H301
H314
H317
* 603-027-00-1 ethanediol;
ethylene glycol
203-473-3 107-21-1 Acute Tox. 4 * H302 GHS07
Achtg.
H302 603-028-00-7 2-chloroethanol;
ethylene chlorohydrin
203-459-7 107-07-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Gef.
H330
H310
H300
603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 Carc. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H351
H330
H310
H300
GHS06
GHS08
Dgr
H351
H330
H310
H300
603-030-00-8 2-aminoethanol;
ethanolamine
205-483-3 141-43-5 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H332
H312
H302
H314
GHS05
GHS07
Gef.
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 5 % 603-031-00-3 1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME
203-794-9 110-71-4 Flam. Liq. 2
Repr. 1B
Acute Tox. 4 *
H225
H360FD
H332
GHS02
GHS08
GHS07
Gef.
H225
H360FD
H332
EUH019 603-032-00-9 ethylene dinitrate;
ethylene glycol dinitrate
211-063-0 628-96-6 Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
H200
H330
H310
H300
H373**
GHS01
GHS06
GHS08
Dgr
H200
H330
H310
H300
H373**
603-033-00-4 oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate
211-745-8 693-21-0 Unst. Expl
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H200
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Gef.
H200
H330
H310
H300
H373 **
H412
603-033-01-1 oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate;
[>25 % phlegmatiser]
211-745-8 693-21-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H201
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Gef.
H201
H330
H310
H300
H373 **
H412
603-034-00-X glycerol trinitrate;
nitroglycerine
200-240-8 55-63-0 Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H200
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Gef.
H200
H330
H310
H300
H373 **
H411
603-034-01-7 glycerol trinitrate;
nitroglycerine;
[>40 % phlegmatiser]
200-240-8 55-63-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H201
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Gef.
H201
H330
H310
H300
H373 **
H411
603-035-00-5 pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.
201-084-3 78-11-5 Unst. Expl. H200 GHS01
Gef.
H200 603-035-01-2 pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.;
[>20 % phlegmatiser]
201-084-3 78-11-5 Expl. 1.1 H201 GHS01
Gef.
H201 T 603-036-00-0 mannitol hexanitrate;
nitromannite
239-924-6 15825-70-4 Unst. Expl. H200 GHS01
Gef.
H200 603-036-01-8 mannitol hexanitrate;
nitromannite;
[>40 % phlegmatiser]
239-924-6 15825-70-4 Expl. 1.1 H201 GHS01
Gef.
H201 603-037-00-6 cellulose nitrate;
nitrocellulose
— — Expl. 1.1 H201 GHS01
Dgr
H201 T 603-038-00-1 allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4 106-92-3 Flam. Liq. 3
Carc. 2
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412
GHS02
GHS08
GHS05
GHS07
Gef.
H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412
603-039-00-7 butyl glycidyl ether;
butyl 2,3-epoxypropyl ether
219-376-4 2426-08-6 Flam. Liq. 3
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H332
H302
H335
H317
H412
GHS02
GHS08
GHS07
Achtg.
H226
H351
H341
H332
H302
H335
H317
H412
603-040-00-2 sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3]
204-699-5 [1]
212-736-1 [2]
212-737-7 [3]
124-41-4 [1]
865-33-8 [2]
865-34-9 [3]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Gef.
H251
H314
EUH014 T 603-041-00-8 potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2]
213-029-0 [1]
205-487-5 [2]
917-58-8 [1]
141-52-6 [2]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Gef.
H251
H314
EUH014 T 603-042-00-3 aluminium-tri-isopropoxide 209-090-8 555-31-7 Flam. Sol. 1 H228 GHS02
Gef.
H228 T 603-043-00-9 triarimol (ISO);
2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol
— 26766-27-8 Acute Tox. 4 * H302 GHS07
Achtg.
H302 603-044-00-4 dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0 115-32-2 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H315
H317
H410
603-045-00-X diisopropyl ether; [1]
dipropyl ether [2]
203-560-6 [1]
203-869-6 [2]
108-20-3 [1]
111-43-3 [2]
Flam. Liq. 2
STOT SE 3
H225
H336
GHS02
GHS07
Gef.
H225
H336
EUH019
EUH066
C 603-046-00-5 bis(chloromethyl) ether;
oxybis(chloromethane)
208-832-8 542-88-1 Flam. Liq. 2
Carc. 1A
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
H225
H350
H330
H311
H302
GHS02
GHS06
GHS08
Dgr
H225
H350
H330
H311
H302
Carc. 1A; H350: C ≥ 0,001 % 603-047-00-0 2-dimethylaminoethanol;
N,N-dimethylethanolamine
203-542-8 108-01-0 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Gef.
H226
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 5 % 603-048-00-6 2-diethylaminoethanol;
N,N-diethylethanolamine
202-845-2 100-37-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07 GHS09
Gef.
H226
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 5 % 603-049-00-1 chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol
201-246-3 80-06-8 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
603-050-00-7 1-(2-butoxypropoxy)propan-2-ol 246-011-6 24083-03-2 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
603-051-00-2 2-ethylbutan-1-ol 202-621-4 97-95-0 Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Achtg.
H312
H302
603-052-00-8 3-butoxypropan-2-ol;
propylene glycol monobutyl ether
225-878-4 5131-66-8 Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Achtg.
H319
H315
603-053-00-3 2-methylpentane-2,4-diol 203-489-0 107-41-5 Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Achtg.
H319
H315
603-054-00-9 di-n-butyl ether;
dibutyl ether
205-575-3 142-96-1 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H226
H319
H335
H315
H412
GHS02
GHS07
Achtg.
H226
H319
H335
H315
H412
STOT SE 3; H335: C ≥ 10 % 603-055-00-4 Propylenoxid;
1,2-Epoxypropan; Methyloxiran
200-879-2 75-56-9 Flam. Liq. 1
Carc. 1B
Muta. 1B
Acute Tox. 3
Acute Tox. 3
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
H224
H350
H340
H331
H311
H302
H335
H319
GHS02
GHS08
GHS06
Dgr
H224
H350
H340
H331
H311
H302
H335
H319
603-056-00-X [(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropyl o-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4]
218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4]
2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4]
Muta. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H315
H317
H411
GHS08
GHS07
GHS09
Achtg.
H341
H315
H317
H411
C 603-057-00-5 benzyl alcohol 202-859-9 100-51-6 Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Achtg.
H332
H302
603-058-00-0 1,3-propylene oxide 207-964-3 503-30-0 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Gef.
H225
H332
H312
H302
603-059-00-6 hexan-1-ol 203-852-3 111-27-3 Acute Tox. 4 * H302 GHS07
Achtg.
H302 603-060-00-1 2,2'-bioxirane;
1,2:3,4-diepoxybutane
215-979-1 1464-53-5 Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H350
H340
H330
H311
H301
H314
GHS06
GHS08
GHS05
Gef.
H350
H340
H330
H311
H301
H314
603-061-00-7 tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol
202-625-6 97-99-4 Repr. 1B
Eye Irrit. 2
H360Df
H319
GHS08
GHS07
Dgr
H360Df
H319
603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 203-239-0 104-80-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Achtg.
H319
H335
H315
STOT SE 3; H335: C ≥ 10 % 603-063-00-8 2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol
209-128-3 556-52-5 Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H341
H360F ***
H331
H312
H302
H319
H335
H315
GHS06
GHS08
Gef.
H350
H341
H360F ***
H331
H312
H302
H319
H335
H315
603-064-00-3 1-methoxy-2-propanol;
monopropylene glycol methyl ether
203-539-1 107-98-2 Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
603-065-00-9 resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene
202-987-5 101-90-6 Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H351
H341
H312
H302
H319
H315
H317
H412
GHS08
GHS07
Achtg.
H351
H341
H312
H302
H319
H315
H317
H412
603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide
203-437-7 106-87-6 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H351
H331
H311
H301
GHS06
GHS08
Dgr
H351
H331
H311
H301
* 603-067-00-X phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane
204-557-2 122-60-1 Carc. 1B
Muta. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H332
H335
H315
H317
H412
GHS08
GHS07
Gef.
H350
H341
H332
H335
H315
H317
H412
603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether
— 130014-35-6 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Achtg.
H319
H315
H317
603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 202-013-9 90-72-2 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Achtg.
H302
H319
H315
603-070-00-6 2-amino-2-methylpropanol 204-709-8 124-68-5 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Achtg.
H319
H315
H412
603-071-00-1 2,2'-iminodiethanol;
diethanolamine
203-868-0 111-42-2 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H302
H373 **
H315
H318
GHS08
GHS05
GHS07
Gef.
H302
H373 **
H315
H318
603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether
219-371-7 2425-79-8 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H312
H319
H315
H317
GHS07
Achtg.
H332
H312
H319
H315
H317
603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 216-823-5 1675-54-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Achtg.
H319
H315
H317
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700)
500-033-5 25068-38-6 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Achtg.
H319
H315
H317
H411
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
603-075-00-3 chlormethyl methyl ether;
chlorodimethyl ether
203-480-1 107-30-2 Flam. Liq. 2
Carc. 1A
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H350
H332
H312
H302
GHS02
GHS08
GHS07
Gef.
H225
H350
H332
H312
H302
603-076-00-9 but-2-yne-1,4-diol;
2-butyne-1,4-diol
203-788-6 110-65-6 Skin Corr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H331
H301
H312
H373 **
H317
GHS06
GHS05
GHS08
Gef.
H314
H331
H301
H312
H373 **
H317
Skin Corr. 1B; H314: C ≥ 50 %
Skin Irrit. 2; H315: 25 % ≤ C < 50 %
Eye Irrit. 2; H319: 25 % ≤ C < 50 %
D 603-077-00-4 1-dimethylaminopropan-2-ol;
dimepranol (INN)
203-556-4 108-16-7 Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
H226
H302
H314
GHS02
GHS05
GHS07
Gef.
H226
H302
H314
603-078-00-X prop-2-yn-1-ol;
propargyl alcohol
203-471-2 107-19-7 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H311
H301
H314
H411
GHS02
GHS06
GHS05
GHS09
Gef.
H226
H331
H311
H301
H314
H411
603-079-00-5 2,2'-(methylimino)diethanol;
N-methyldiethanolamine
203-312-7 105-59-9 Eye Irrit. 2 H319 GHS07
Achtg.
H319 603-080-00-0 2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol
203-710-0 109-83-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05 GHS07
Gef.
H312
H302
H314
STOT SE 3; H335: C ≥ 5 % 603-081-00-6 2,2'-thiodiethanol;
thiodiglycol
203-874-3 111-48-8 Eye Irrit. 2 H319 GHS07
Achtg.
H319 603-082-00-1 1-aminopropan-2-ol;
isopropanolamine
201-162-7 78-96-6 Skin Corr. 1B H314 GHS05
Gef.
H314 603-083-00-7 1,1'-iminodipropan-2-ol;
di-isopropanolamine
203-820-9 110-97-4 Eye Irrit. 2 H319 GHS07
Achtg.
H319 603-084-00-2 styrene oxide;
(epoxyethyl)benzene;
phenyloxirane
202-476-7 96-09-3 Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
H350
H312
H319
GHS08
GHS07
Gef.
H350
H312
H319
603-085-00-8 bronopol (INN);
2-bromo-2-nitropropane-1,3-diol
200-143-0 52-51-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H312
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H335
H315
H318
H400
M=10 603-086-00-3 ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-3 23947-60-6 Acute Tox. 4 * H312 GHS07
Achtg.
H312 603-087-00-9 2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol
202-377-9 94-96-2 Eye Dam. 1 H318 GHS05
Gef.
H318 603-088-00-4 2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide
222-598-4 3547-33-9 Eye Dam. 1 H318 GHS05
Gef.
H318 603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol 400-390-6 — Skin Corr. 1A
Acute Tox. 4 *
H314
H302
GHS05
GHS07
Gef.
H314
H302
603-090-00-5 2-(2-bromoethoxy)anisole 402-010-4 4463-59-6 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 402-470-6 87172-89-2 Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Gef.
H302
H318
603-092-00-6 2-methyl-4-phenylpentanol 402-770-7 92585-24-5 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
603-093-00-1 cinmethylin (ISO);
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-9 87818-31-3 Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Gef.
H332
H411
603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 241-536-7 17557-23-2 Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Achtg.
H315
H317
603-095-00-2 2-(propyloxy)ethanol;
EGPE
220-548-6 2807-30-9 Acute Tox. 4 *
Eye Irrit. 2
H312
H319
GHS07
Achtg.
H312
H319
603-096-00-8 2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether
203-961-6 112-34-5 Eye Irrit. 2 H319 GHS07
Achtg.
H319 603-097-00-3 1,1′,1″-nitrilotripropan-2-ol;
triisopropanolamine
204-528-4 122-20-3 Eye Irrit. 2 H319 GHS07
Wng
H319 603-098-00-9 2-phenoxyethanol 204-589-7 122-99-6 Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Achtg.
H302
H319
603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 403-440-5 93633-79-5 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
603-100-00-8 1,2-dimethoxypropane 404-630-0 7778-85-0 Flam. Liq. 2 H225 GHS02
Gef.
H225 EUH019 603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Eye Irrit. 2 H319 GHS07
Achtg.
H319 603-102-00-9 1,2-Epoxybutan 203-438-2 106-88-7 Flam. Liq. 2
Carc. 2
Acute Tox. 4*
Acute Tox. 4*
Acute Tox. 4*
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
H225
H351
H302
H312
H332
H335
H315
H319
GHS02
GHS08
GHS07
Dgr
H225
H351
H302
H312
H332
H335
H315
H319
603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Achtg.
H315
H317
603-104-00-X fenarimol (ISO);
2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-7 60168-88-9 Repr. 2
Lact.
Aquatic Chronic 2
H361fd
H362
H411
GHS08 GHS09
Achtg.
H361fd
H362
H411
603-105-00-5 furan 203-727-3 110-00-9 Flam. Liq. 1
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3
H224
H350
H341
H332
H302
H373 **
H315
H412
GHS02
GHS08
GHS07
Gef.
H224
H350
H341
H332
H302
H373 **
H315
H412
EUH019 603-106-00-0 2-methoxypropanol 216-455-5 1589-47-5 Flam. Liq. 3
Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H226
H360D ***
H335
H315
H318
GHS02
GHS08
GHS05
GHS07
Gef.
H226
H360D ***
H335
H315
H318
603-107-00-6 2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether
203-906-6 111-77-3 Repr. 2 H361d *** GHS08
Achtg.
H361d *** 603-108-00-1 2-methylpropan-1-ol;
iso-butanol
201-148-0 78-83-1 Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H335
H315
H318
H336
GHS02
GHS05
GHS07
Gef.
H226
H335
H315
H318
H336
603-109-00-7 reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane
425-340-0 — Aquatic Chronic 4 H413 — H413 603-110-00-2 reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane
426-130-1 166301-21-9 Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-111-00-8 reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane
426-530-6 — Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-112-00-3 cyclopentyl 2-phenylethyl ether 428-340-9 — Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-113-00-9 6-glycidyloxynapht-1-yl oxymethyloxirane 429-960-2 27610-48-6 Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H341
H312
H315
H317
H412
GHS08
GHS07
Wng
H341
H312
H315
H317
H412
603-114-00-4 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene 430-830-2 26912-64-1 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-115-00-X reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) 423-580-0 — STOT RE 2 *
Aquatic Chronic 4
H373**
H413
GHS08
Wng
H373**
H413
603-116-00-5 (Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride 424-740-2 138271-16-6 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
603-117-00-0 propan-2-ol;
isopropyl alcohol;
isopropanol
200-661-7 67-63-0 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
603-118-00-6 6-dimethylaminohexan-1-ol 404-680-3 1862-07-3 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Gef.
H302
H314
H412
603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) 405-840-5 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
603-120-00-7 2-methyl-5-phenylpentanol 405-890-8 25634-93-9 Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Achtg.
H319
H315
603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 406-057-1 114565-66-1 Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Achtg.
H351
H317
H413
603-122-00-8 sodium 2-ethylhexanolate 406-150-7 38411-13-1 Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3
H228
H314
H412
GHS02
GHS05
Gef.
H228
H314
H412
T 603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 406-330-5 122760-84-3 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Achtg.
H315
H317
H411
603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 406-900-3 84563-49-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol 407-850-5 89544-40-1 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H411
603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 408-090-7 100418-33-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Achtg.
H302
H317
H412
603-127-00-5 butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4]
201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]
78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3
H226
H319
H335
H336
GHS02
GHS07
Wng
H226
H319
H335
H336
C 603-128-00-0 2-(phenylmethoxy)naphthalene 405-490-3 613-62-7 Aquatic Chronic 4 H413 — H413 603-129-00-6 1-tert-butoxypropan-2-ol 406-180-0 57018-52-7 Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Gef.
H226
H318
603-130-00-1 reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) 406-325-8 — Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1 — Eye Dam. 1 H318 GHS05
Gef.
H318 603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 408-200-3 63187-91-7 Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Gef.
H315
H318
H412
603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1 — Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. 410-450-3 — Aquatic Chronic 4 H413 — H413 603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium 410-500-4 — Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 410-910-3 104226-19-9 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6 — Eye Dam. 1 H318 GHS05
Gef.
H318 603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4 103694-68-4 Aquatic Chronic 3 H412 — H412 603-139-00-0 bis(2-methoxyethyl) ether 203-924-4 111-96-6 Flam. Liq. 3
Repr. 1B
H226
H360FD
GHS02
GHS08
Gef.
H226
H360FD
EUH019 603-140-00-6 2,2' -oxybisethanol;
diethylene glycol
203-872-2 111-46-6 Acute Tox. 4 * H302 GHS07
Achtg.
H302 603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6 — Aquatic Chronic 3 H412 — H412 603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 407-360-1 116230-20-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H373 **
H315
H318
GHS06
GHS08
GHS05
Gef.
H312
H302
H373 **
H315
H318
603-143-00-2 R—2,3-epoxy-1-propanol 404-660-4 57044-25-4 Self-react. C ****
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H242
H350
H341
H360F ***
H331
H312
H302
H314
GHS02
GHS06
GHS08
GHS05
Gef.
H242
H350
H341
H360F ***
H331
H312
H302
H314
603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6 111850-00-1 Aquatic Chronic 2 H411 GHS09 H411 603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 406-970-5 129228-11-1 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 406-080-7 83016-70-0 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Gef.
H302
H314
H412
603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 406-030-4 105812-81-5 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H411
603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 413-370-7 17351-75-6 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07 GHS09
Achtg.
H317
H411
603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 407-640-3 63767-86-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07 GHS09
Achtg.
H319
H315
H411
603-150-00-0 (±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 411-580-3 107898-54-4 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Achtg.
H315
H410
603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H—1,2,4-triazol-1-yl)propan-1-ol 413-570-4 — Aquatic Chronic 3 H412 — H412 603-152-00-1 2-(4-tert-butylphenyl)ethanol 410-020-5 5406-86-0 Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H361f ***
H373 **
H318
H411
GHS08
GHS05
GHS09
Gef.
H361f ***
H373 **
H318
H411
603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 410-010-0 104333-00-8 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Achtg.
H302
H412
603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 412-300-2 139504-68-0 Aquatic Chronic 2 H411 GHS09 H411 603-155-00-8 Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane 410-560-1 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 411-210-0 89544-48-9 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H315
H317
H410
603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 411-450-6 143747-72-2 Aquatic Chronic 4 H413 — H413 603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene 412-460-3 — Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07 GHS09
Achtg.
H315
H411
603-159-00-X 2-cyclododecylpropan-1-ol 411-410-8 118562-73-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 603-160-00-5 1,2-diethoxypropane 412-180-1 10221-57-5 Flam. Liq. 2 H225 GHS02
Gef.
H225 EUH019 603-161-00-0 1,3-diethoxypropane 413-140-6 3459-83-4 Flam. Liq. 3 H226 GHS02
Achtg.
H226 603-162-00-6 α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 413-420-8 144736-29-8 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Gef.
H314
H317
H411
603-163-00-1 2-phenyl-1,3-propanediol 411-810-2 1570-95-2 Eye Dam. 1 H318 GHS05
Gef.
H318 603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 412-420-5 133909-99-6 Aquatic Chronic 4 H413 — H413 603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1 — Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Achtg.
H341
H317
603-166-00-8 R-1-chloro-2,3-epoxypropane 424-280-2 51594-55-9 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Gef.
H226
H350
H331
H311
H301
H314
H317
603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 407-920-5 6390-69-8 Aquatic Chronic 4 H413 GHS05
Gef.
H413 603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 408-080-2 70445-33-9 Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 415-550-0 109887-53-8 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H411
603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-3 67739-11-1 Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Achtg.
H319
H411
603-171-00-5 5-thiazolylmethanol 414-780-9 38585-74-9 Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Gef.
H318
H412
603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 415-180-1 773058-82-5 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H411
603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 421-750-9 57280-22-5 Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Achtg.
H319
H317
603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 420-630-3 83926-73-2 Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
603-175-00-7 2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol
203-988-3 112-59-4 Acute Tox. 4 *
Eye Dam. 1
H312
H318
GHS05
GHS07
Gef.
H312
H318
603-176-00-2 1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme
203-977-3 112-49-2 Repr. 1B H360Df GHS08
Gef.
H360Df EUH019 603-177-00-8 1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2]
216-374-5 [1]
259-370-9 [2]
1569-02-4 [1]
54839-24-6 [2]
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Achtg.
H226
H336
603-178-00-3 2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol
203-951-1 112-25-4 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Gef.
H312
H302
H314
603-179-00-9 ergocalciferol (ISO);
Vitamin D2
200-014-9 50-14-6 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Gef.
H330
H311
H301
H372 **
603-180-00-4 colecalciferol;
Vitamin D3
200-673-2 67-97-0 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Gef.
H330
H311
H301
H372 **
603-181-00-X tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane
216-653-1 1634-04-4 Flam. Liq. 2
Skin Irrit. 2
H225
H315
GHS02
GHS07
Gef.
H225
H315
603-182-00-5 reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide 428-630-5 — Skin Sens. 1 H317 GHS07
Wng
H317 603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol
205-592-6 143-22-6 Eye Dam. 1 H318 GHS05
Gef.
H318 Eye Dam. 1; H318: C ≥ 30 %
Eye Irrit. 2; H319: 20 % ≤ C < 30 %
603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 416-380-1 146925-83-9 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 420-740-1 99817-36-4 Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Gef.
H301
H318
H317
H410
603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 419-050-3 79944-37-9 Skin Sens. 1 H317 GHS07
Achtg.
H317 603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 419-360-9 163661-77-6 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 603-188-00-8 reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene
426-970-9 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol 405-250-8 — Aquatic Chronic 2 H411 GHS09 H411 603-190-00-9 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane 424-030-2 62406-73-9 Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 419-740-4 137658-79-8 Aquatic Chronic 4 H413 — H413 603-192-00-X (E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol 423-240-1 125474-34-2 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-193-00-5 disodium 9,10-anthracenedioxide 426-030-8 46492-07-3 Skin Corr. 1A H314 GHS05
Dgr
H314 603-194-00-0 2-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5 111-41-1 Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Df
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Df
H314
H317
STOT SE 3; H335: C ≥ 5 % 603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 430-810-3 154825-62-4 Aquatic Chronic 3 H412 — H412 603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Achtg.
H302
H373 **
H411
603-197-00-7 Tebuconazol (ISO); 1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H361d***
H302
H410
M = 1
M = 10
603-199-00-8 etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
— 153233-91-1 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 M=100 603-200-00-1 1-pentanol; [1]
3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H226
H332
H335
H315
GHS02
GHS07
Wng
H226
H332
H335
H315
603-201-00-7 (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol 416-120-5 — Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
603-202-00-2 4,4,5,5,5-pentafluoropentan-1-ol 421-360-9 148043-73-6 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-203-00-8 (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane 427-580-1 — Skin Irrit. 2 H315 GHS07
Wng
H315 603-204-00-3 reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane
428-110-8 — Aquatic Chronic 3 H412 — H412 603-205-00-9 (1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride 426-200-1 172015-79-1 STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H372**
H302
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318
H317
H412
603-206-00-4 2,2-dichloro-1,3-benzodioxol 426-850-6 2032-75-9 Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1
H226
H314
H302
H317
GHS02
GHS05
GHS07
Dgr
H226
H314
H302
H317
EUH014 603-207-00-X 2-isobutyl-2-isopropyl-1,3-dimethoxypropane 430-800-9 129228-21-3 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-208-00-5 1,2-diethoxyethane 211-076-1 629-14-1 Flam. Liq. 2
Repr. 1A
Eye Irrit. 2
H225
H360Df
H319
GHS02
GHS08
GHS07
Dgr
H225
H360Df
H319
EUH019 603-209-00-0 spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]
- [1]
- [2]
- [3]
- [1]
131929-60-7 [2]
131929-63-0 [3]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 M=10 603-210-00-6 2,4-diethyl-1,5-pentanediol 429-310-8 57987-55-0 Eye Dam. 1 H318 GHS05
Dgr
H318 603-211-00-1 2,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … %
221-221-0 3033-77-0 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412
B 603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-9 1222-05-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 603-213-00-2 2-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4 994-05-8 Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
H225
H302
H336
GHS02
GHS07
Dgr
H225
H302
H336
603-214-00-8 1,1-diisopropoxycyclohexane 413-740-8 1132-95-2 Skin Corr. 1B H314 GHS05
Dgr
H314 603-215-00-3 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 418-330-2 162241-33-0 Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H302
H373**
H318
H317
H400
H410
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H201
H302
H373**
H318
H317
H410
603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol 422-660-2 7480-35-5 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
603-217-00-4 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite 423-560-1 161717-32-4 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
603-220-00-0 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol 432-890-5 72955-94-3 Aquatic Chronic 4 H413 — H413 603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2 214353-17-0 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2 214353-17-0 Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H350
H302
H314
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H350
H302
H314
H411
603-222-00-1 (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane 433-820-6 118058-74-5 Eye Irrit. 2 H319 GHS07
Wng
H319 603-223-00-7 2-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol
434-270-1 6261-30-9 Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
603-224-00-2 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane 435-790-1 297730-93-9 Aquatic Chronic 4 H413 — H413 603-225-00-8 erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0 13127-18-9 Aquatic Chronic 2 H411 GHS09 H411 603-226-00-3 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol 444-500-0 1440-00-2 Aquatic Chronic 3 H412 — H412 603-227-00-9 α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2 203574-04-3 ****
Aquatic Acute 1
Aquatic Chronic 1
****
H400
H410
****
GHS09
Wng
****
H410
603-228-00-4 (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1 — Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
603-229-00-X sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate 420-800-7 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-230-00-5 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan 440-030-5 — Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4
H315
H318
H413
GHS05
Dgr
H315
H318
H413
603-231-00-0 (S)-1,1-diphenyl-1,2-propanediol 443-220-6 — Aquatic Chronic 3 H412 — H412 603-232-00-6 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane 444-420-6 — Aquatic Chronic 4 H413 — H413 603-233-00-1 reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0 — Aquatic Chronic 2 H411 GHS09 H411 603-234-00-7 (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene 444-480-3 — Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-235-00-2 Linalool: 3,7-Dimethyl-1,6-octadien-3-ol; DL-Linalool; [1]
Coriandrol; (S)-3,7-Dimethyl-1,6-octadien-3-ol; D-Linalool; [2]
Licareol; (R)-3,7-Dimethyl-1,6-octadien-3-ol; L-Linalool [3]
201-134-4 [1]
204-810-7 [2]
204-811-2 [3]
78-70-6 [1]
126-90-9 [2]
126-91-0 [3]
Skin Sens. 1B H317 GHS07
Wng
H317 604-001-00-2 phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol
203-632-7 108-95-2 Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
H341
H331
H311
H301
H373 **
H314
GHS06
GHS08 GHS05
Gef.
H341
H331
H311
H301
H373 **
H314
*
Skin Corr. 1B; H314: C ≥ 3 %
Skin Irrit. 2; H315: 1 % ≤ C < 3 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %
604-002-00-8 pentachlorophenol 201-778-6 87-86-5 Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H330
H311
H301
H319
H335
H315
H410
604-003-00-3 sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2]
205-025-2 [1]
231-911-3 [2]
131-52-2 [1]
7778-73-6 [2]
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H330
H311
H301
H319
H335
H315
H410
604-004-00-9 m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4]
203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4]
108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4]
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Gef.
H311
H301
H314
* C 604-005-00-4 1,4-dihydroxybenzene;
hydroquinone;
quinol
204-617-8 123-31-9 Carc. 2
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H302
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H341
H302
H318
H317
H400
M=10 604-006-00-X 3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7]
202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7]
95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7]
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H301
H314
H411
GHS06
GHS05
GHS09
Gef.
H311
H301
H314
H411
C 604-007-00-5 2-naphthol 205-182-7 135-19-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Achtg.
H332
H302
H400
604-008-00-0 2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4]
202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4]
95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H312
H302
H411
GHS07 GHS09
Achtg.
H332
H312
H302
H411
C 604-009-00-6 pyrogallol;
1,2,3-trihydroxybenzene
201-762-9 87-66-1 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H341
H332
H312
H302
H412
GHS08
GHS07
Achtg.
H341
H332
H312
H302
H412
* 604-010-00-1 resorcinol;
1,3-benzenediol
203-585-2 108-46-3 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H302
H319
H315
H400
GHS07
GHS09
Achtg.
H302
H319
H315
H400
* 604-011-00-7 2,4-dichlorophenol 204-429-6 120-83-2 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H302
H314
H411
GHS06
GHS05
GHS09
Gef.
H311
H302
H314
H411
604-012-00-2 4-chloro-o-cresol;
4-chloro-2-methyl phenol
216-381-3 1570-64-5 Acute Tox. 3 *
Skin Corr. 1A
Aquatic Acute 1
H331
H314
H400
GHS06
GHS05
GHS09
Gef.
H331
H314
H400
STOT SE 3; H335: C ≥ 1 % 604-013-00-8 2,3,4,6-tetrachlorophenol 200-402-8 58-90-2 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H315
H400
H410
GHS06
GHS09
Gef.
H301
H319
H315
H410
*
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
604-014-00-3 chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol
200-431-6 59-50-7 Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H312
H302
H318
H317
H400
GHS05
GHS07
GHS09
Gef.
H312
H302
H318
H317
H400
* 604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene
200-733-8 70-30-4 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Gef.
H311
H301
H410
* 604-016-00-4 1,2-dihydroxybenzene;
pyrocatechol
204-427-5 120-80-9 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H312
H302
H319
H315
GHS07
Achtg.
H312
H302
H319
H315
604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H315
H410
*
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
604-018-00-5 2,4,6-trichlorophenol 201-795-9 88-06-2 Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H319
H315
H400
H410
GHS08
GHS07
GHS09
Achtg.
H351
H302
H319
H315
H410
604-019-00-0 dichlorophen (ISO) 202-567-1 97-23-4 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H410
604-020-00-6 2-phenylphenol (ISO)
biphenyl-2-ol;
2-hydroxybiphenyl;
201-993-5 90-43-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Achtg.
H319
H335
H315
H400
604-021-00-1 sodium 2-biphenylate;
2-phenylphenol, sodium salt
205-055-6 132-27-4 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Achtg.
H302
H335
H315
H318
H400
604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 400-900-7 22961-82-6 Eye Dam. 1 H318 GHS05
Gef.
H318 604-023-00-2 2,4-dichloro-3-ethylphenol 401-060-4 — Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Gef.
H314
H410
604-024-00-8 4,4-isobutylethylidenediphenol 401-720-1 6807-17-6 Repr. 1B
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360F ***
H319
H400
H410
GHS08
GHS09
Gef.
H360F ***
H319
H410
604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone 400-220-0 — Aquatic Chronic 2 H411 GHS09 H411 604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) 400-270-3 — Aquatic Chronic 2 H411 GHS09 H411 604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone 400-530-6 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H318
H317
H411
604-028-00-X 4-amino-3-fluorophenol 402-230-0 399-95-1 Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H350
H302
H317
H411
GHS08
GHS07
GHS09
Gef.
H350
H302
H317
H411
604-029-00-5 1-naphtol 201-969-4 90-15-3 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H312
H302
H335
H315
H318
GHS05
GHS07
Gef.
H312
H302
H335
H315
H318
604-030-00-0 Bisphenol A;
4,4′-Isopropylidendiphenol
201-245-8 80-05-7 Repr. 1B
STOT SE 3
Eye Dam. 1
Skin Sens. 1
H360F
H335
H318
H317
GHS08
GHS05 GHS07
Dgr
H360F
H335
H318
H317
604-031-00-6 guaiacol 201-964-7 90-05-1 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Achtg.
H302
H319
H315
604-032-00-1 thymol 201-944-8 89-83-8 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Gef.
H302
H314
H411
604-033-00-7 isobutyl but-3-enoate 401-170-2 24342-03-8 Flam. Liq. 3 H226 GHS02
Achtg.
H226 604-034-00-2 4,4'-thiodi-o-cresol 403-330-7 24197-34-0 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Gef.
H318
H410
604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol 404-160-6 — Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Achtg.
H317
H413
604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 404-590-4 90884-29-0 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
604-037-00-9 3,5-xylenol;
3,5-dimethylphenol
203-606-5 108-68-9 Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Gef.
H311
H301
H314
604-038-00-4 4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2]
201-793-8 [1]
215-316-6 [2]
88-04-0 [1]
1321-23-9 [2]
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H302
H319
H315
H317
GHS07
Achtg.
H302
H319
H315
H317
604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl
266-362-9 66441-23-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
604-040-00-5 fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-9 72178-02-0 Acute Tox. 4 * H302 GHS07
Achtg.
H302 604-041-00-0 acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2]
256-634-5 [1]
263-560-7 [2]
50594-66-6 [1]
62476-59-9 [2]
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H315
H318
H410
604-042-00-6 4-nitrosophenol 203-251-6 104-91-6 Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H341
H302
H318
H411
GHS08
GHS05
GHS07
GHS09
Gef.
H341
H302
H318
H411
604-043-00-1 monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether
203-083-3 103-16-2 Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Achtg.
H319
H317
604-044-00-7 mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether
205-769-8 150-76-5 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Achtg.
H302
H319
H317
604-045-00-2 2,3,5-trimethylhydroquinone 211-838-3 700-13-0 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H335
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Gef.
H332
H335
H315
H318
H317
H410
604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 405-520-5 95235-30-6 Aquatic Chronic 2 H411 GHS09 H411 604-047-00-3 4-(4-tolyloxy)biphenyl 405-730-7 51601-57-1 STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Achtg.
H373 **
H413
604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 405-800-7 27955-94-8 Aquatic Chronic 2 H411 GHS09 H411 604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 407-480-4 93589-69-6 Aquatic Chronic 2 H411 GHS09 H411 604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 401-110-5 87113-78-8 Aquatic Chronic 3 H412 — H412 604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 403-800-1 103597-45-1 Aquatic Chronic 4 H413 — H413 604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 410-760-9 157661-93-3 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H315
H317
H410
604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0 — Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 413-900-7 85954-11-6 Carc. 2
Skin Sens. 1
H351
H317
GHS08
GHS07
Wng
H351
H317
604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 412-520-9 99610-72-7 Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
H228
H361f ***
H302
GHS02
GHS07
GHS08
Gef.
H228
H361f ***
H302
604-057-00-8 Reaktionsmasse aus Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; Isomeren von 2-(2H-Benzotriazol-2-yl)-4-methyl-5,6-didodecylphenol; n = 5 oder 6 401-680-5 — Aquatic Chronic 4 H413 H413 604-058-00-3 1,2-bis(3-methylphenoxy)ethane 402-730-9 54914-85-1 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 604-059-00-9 2-n-hexadecylhydroquinone 406-400-5 — STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H373 **
H315
H317
H413
GHS08
GHS07
Achtg.
H373 **
H315
H317
H413
604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 406-950-6 3236-71-3 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H315
H410
604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl= 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl
407-740-7 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Achtg.
H315
H317
H412
604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol 411-220-5 — Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Achtg.
H315
H317
H410
604-063-00-0 5,6-dihydroxyindole 412-130-9 3131-52-0 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05 GHS07
GHS09
Gef.
H302
H318
H411
604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 411-380-6 147315-50-2 Aquatic Chronic 4 H413 — H413 604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 407-460-5 111850-25-0 Aquatic Chronic 2 H411 GHS09 H411 604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Gef.
H315
H318
H410
604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 415-170-5 90274-24-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
H332
H302
H317
GHS07
Achtg.
H332
H302
H317
604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 421-740-4 51390-14-8 Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Gef.
H314
H411
604-070-00-9 triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-2 3380-34-5 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H319
H315
H410
M=100 604-071-00-4 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol 425-600-3 110726-28-8 Aquatic Chronic 4 H413 — H413 604-072-00-X 1,2-bis(phenoxymethyl)benzene 428-620-0 10403-74-4 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 604-073-00-5 (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol 428-010-4 82413-20-5 Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H360F***
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H351
H360F***
H317
H410
604-074-00-0 tetrabromobisphenol-A;
2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol
201-236-9 79-94-7 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol
205-426-2 140-66-9 Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
M=10 604-076-00-1 phenolphthalein 201-004-7 77-09-8 Carc. 1B
Muta. 2
Repr. 2
H350
H341
H361f***
GHS08
Dgr
H350
H341
H361f***
Carc. 1B; H350: C ≥ 1 % 604-077-00-7 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol 419-750-9 98809-58-6 Aquatic Chronic 4 H413 — H413 604-079-00-8 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol 428-970-4 13595-25-0 Repr. 2
Skin Sens. 1
Aquatic Chronic 2
H361f***
H317
H411
GHS08
GHS07
GHS09
Wng
H361f***
H317
H411
604-080-00-3 4-fluoro-3-trifluoromethylphenol 432-560-0 61721-07-1 Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Chronic 2
H332
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H314
H317
H411
604-081-00-9 1,1-bis(4-hydroxyphenyl)-1-phenylethane 433-130-5 1571-75-1 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 604-082-00-4 2-chloro-6-fluoro-phenol 433-890-8 2040-90-6 Muta. 1B
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H340
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H340
H361f***
H302
H314
H317
H411
604-083-00-X 4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH4Cl), pentachlorophosphorane and phenol 439-270-3 260408-02-4 Aquatic Chronic 4 H413 — H413 604-084-00-5 1-ethoxy-2,3-difluorobenzene 441-000-4 121219-07-6 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
604-087-00-1 reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8 — Pyr. Sol. 1
Aquatic Chronic 4
H250
H413
GHS02
Dgr
H250
H413
EUH044 604-089-00-2 2-methyl-5-tert-butylthiophenol 444-970-7 — Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H361d***
H373**
H304
H319
H315
H317
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H361d***
H373**
H304
H319
H315
H317
H336
H410
604-090-00-8 4-tert-butylphenol 202-679-0 98-54-4 Repr. 2
Skin Irrit. 2
Eye Dam. 1
H361f
H315
H318
GHS08
GHS05
Dgr
H361f
H315
H318
604-091-00-3 etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether 407-980-2 80844-07-1 Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
M = 100
M = 1000
604-092-00-9 Phenol, dodecyl-, verzweigt; [1]
Phenol, 2-dodecyl-, verzweigt; [2]
Phenol, 3-dodecyl-, verzweigt; [3]
Phenol, 4-dodecyl-, verzweigt; [4]
Phenol, (tetrapropenyl) Derivate [5]
310-154-3 [1]
[2]
[3]
[4]
[5]
121158-58-5 [1]
[2]
[3]
210555-94-5 [4]
74499-35-7 [5]
Repr. 1B
Skin Corr. 1C
Eye Dam. 1
Aquatic Acute 1 Aquatic Chronic 1
H360F
H314
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H360F
H314
H410
M = 10
M = 10
604-093-00-4 Clorofen;
Chlorophen;
2-Benzyl-4-chlorphenol
204-385-8 120-32-1 Carc. 2
Repr. 2
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1
Eye Dam. 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H361f
H332
H315
H317
H318
H373 (Nieren)
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H361f
H332
H315
H317
H318
H373 (Nieren)
H410
M = 1
M = 100
605-001-00-5 formaldehyde ...% 200-001-8 50-00-0 Carc. 1B
Muta. 2
Acute Tox. 3*
Acute Tox. 3*
Acute Tox. 3*
Skin Corr. 1B
Skin Sens. 1
H350
H341
H301
H311
H331
H314
H317
GHS08
GHS06
GHS05
Dgr
H350
H341
H301
H311
H331
H314
H317
*
Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 5 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 5 %
Skin Sens. 1; H317: C ≥ 0,2 %
B, D 605-002-00-0 1,3,5-trioxan;
trioxymethylene
203-812-5 110-88-3 Flam. Sol. 1
Repr. 2
STOT SE 3
H228
H361d ***
H335
GHS02
GHS08
GHS07
Gef.
H228
H361d ***
H335
T 605-003-00-6 acetaldehyde;
ethanal
200-836-8 75-07-0 Flam. Liq. 1
Carc. 2
Eye Irrit. 2
STOT SE 3
H224
H351
H319
H335
GHS02
GHS08
GHS07
Gef.
H224
H351
H319
H335
605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde
204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02
Wng
H226 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde
203-600-2 108-62-3 Flam. Sol. 2
Acute Tox. 4 *
H228
H302
GHS02
GHS07
Wng
H228
H302
605-006-00-2 butyraldehyde 204-646-6 123-72-8 Flam. Liq. 2 H225 GHS02
Gef.
H225 605-007-00-8 1,1-dimethoxyethane;
dimethyl acetal
208-589-8 534-15-6 Flam. Liq. 2 H225 GHS02
Gef.
H225 605-008-00-3 acrolein;
prop-2-enal;
acrylaldehyde
203-453-4 107-02-8 Flam. Liq. 2
Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H225
H330
H300
H311
H314
H400
H410
GHS02
GHS06
GHS05
GHS09
Dgr
H225
H330
H300
H311
H314
H410
EUH071 Skin Corr. 1B;
H314: C ≥ 0,1 %
M = 100
M = 1
D 605-009-00-9 crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2]
224-030-0 [1]
204-647-1 [2]
4170-30-3 [1]
123-73-9 [2]
Flam. Liq. 2
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400
GHS02
GHS06
GHS08
GHS05
GHS09
Gef.
H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400
605-010-00-4 2-furaldehyde 202-627-7 98-01-1 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H331
H301
H312
H319
H335
H315
GHS06
GHS08
Dgr
H351
H331
H301
H312
H319
H335
H315
605-011-00-X 2-chlorobenzaldehyde;
o-chlorobenzaldehyde
201-956-3 89-98-5 Skin Corr. 1B H314 GHS05
Gef.
H314 605-012-00-5 benzaldehyde 202-860-4 100-52-7 Acute Tox. 4 * H302 GHS07
Achtg.
H302 605-013-00-0 Chloralose (INN);
(R)-1,2-O-(2,2,2-Trichlorethyliden)-α-D-glucofuranose; Glucochloralose; Anhydroglucochloral
240-016-7 15879-93-3 Acute Tox. 4*
Acute Tox. 3
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H301
H336
H400
H410
GHS06
GHS09
Dgr
H332
H301
H336
H410
M = 10
M = 10
C 605-014-00-6 chloral hydrate;
2,2,2-trichloroethane-1,1-diol
206-117-5 302-17-0 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Gef.
H301
H319
H315
605-015-00-1 1,1-diethoxyethane;
acetal
203-310-6 105-57-7 Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2
H225
H319
H315
GHS02
GHS07
Gef.
H225
H319
H315
605-016-00-7 glyoxal...%;
ethandial...%
203-474-9 107-22-2 Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H341
H332
H319
H315
H317
GHS07
GHS08
Achtg.
H341
H332
H319
H315
H317
* B 605-017-00-2 1,3-dioxolane 211-463-5 646-06-0 Flam. Liq. 2 H225 GHS02
Gef.
H225 605-018-00-8 propanal;
propionaldehyde
204-623-0 123-38-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Gef.
H225
H319
H335
H315
605-019-00-3 citral 226-394-6 5392-40-5 Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Achtg.
H315
H317
605-020-00-9 safrole;
5-allyl-1,3-benzodioxole
202-345-4 94-59-7 Carc. 1B
Muta. 2
Acute Tox. 4 *
H350
H341
H302
GHS08
GHS07
Gef.
H350
H341
H302
605-021-00-4 formaldehyde, reaction products with butylphenol 294-145-9 91673-30-2 Skin Sens. 1 H317 GHS07
Achtg.
H317 605-022-00-X Glutaral; Glutaraldehyd;
1,5-Pentandial
203-856-5 111-30-8 Acute Tox. 2
Acute Tox. 3
STOT SE 3
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1 A
Aquatic Acute 1
Aquatic Chronic 2
H330
H301
H335
H314
H334
H317
H400
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H301
H335
H314
H334
H317
H410
EUH071 STOT SE 3; H335: 0,5 % ≤ C < 5 %
M = 1
605-023-00-5 5-Chlor-2-(4-chlorphenoxy)phenol;
[DCPP]
429-290-0 3380-30-1 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
M = 10
M = 10
605-024-00-0 2-bromo-5-hydroxy-4-methoxybenzaldehyde 426-540-0 2973-59-3 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-025-00-6 chloroacetaldehyde 203-472-8 107-20-0 Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H351
H330
H311
H301
H314
H400
GHS06
GHS08
GHS05
GHS09
Gef.
H351
H330
H311
H301
H314
H400
STOT SE 3; H335: C ≥ 5 % 605-026-00-1 2,5,7,7-tetramethyloctanal 405-690-0 114119-97-0 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07 GHS09
Achtg.
H315
H317
H411
605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7 — Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
605-028-00-2 β-methyl-3-(1-methylethyl)-benzenepropanal 412-050-4 125109-85-5 Aquatic Chronic 2 H411 GHS09 H411 605-029-00-8 2-cyclohexylpropanal 412-270-0 2109-22-0 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Achtg.
H317
H411
605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 411-510-1 3353-51-3 Skin Sens. 1 H317 GHS07
Achtg.
H317 605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0 — Skin Sens. 1 H317 GHS07
Achtg.
H317 605-032-00-4 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal 425-370-4 93957-50-7 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
605-033-00-X reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal
425-910-9 32480-08-3 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
605-034-00-5 reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
429-860-9 — Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-035-00-0 (E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal 426-330-9 177964-68-0 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H319
H317
H413
GHS07
Wng
H319
H317
H413
605-036-00-6 2-bromomalonaldehyde 430-470-6 2065-75-0 Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1 120578-03-2 Aquatic Chronic 4 H413 — H413 605-038-00-7 3-methyl-5-phenylpentan-1-al 433-900-0 55066-49-4 Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H315
H317
H411
GHS07
GHS09
Wng
H302
H315
H317
H411
605-039-00-2 3,4-dihydroxy-5-nitrobenzaldehyde 441-810-8 116313-85-0 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
605-040-00-8 Hydroxyisohexyl-3-cyclohexencarboxaldehyd (INCI); Reaktionsmasse von 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd und 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [1]
4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [2]
3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [3]
- [1]
250-863-4 [2]
257-187-9 [3]
130066-44-3 [1]
31906-04-4 [2]
51414-25-6 [3]
Skin Sens. 1 A H317 GHS07
Wng
H317 606-001-00-8 acetone;
propan-2-one;
propanone
200-662-2 67-64-1 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
EUH066 606-002-00-3 butanone;
ethyl methyl ketone
201-159-0 78-93-3 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
EUH066 606-003-00-9 heptan-3-one;
butyl ethyl ketone
203-388-1 106-35-4 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
H226
H332
H319
GHS02
GHS07
Achtg.
H226
H332
H319
606-004-00-4 4-methylpentan-2-one;
isobutyl methyl ketone
203-550-1 108-10-1 Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Gef.
H225
H332
H319
H335
EUH066 606-005-00-X 2,6-dimethylheptan-4-one;
di-isobutyl ketone
203-620-1 108-83-8 Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Achtg.
H226
H335
STOT SE 3; H335: C ≥ 10 % 606-006-00-5 pentan-3-one;
diethyl ketone
202-490-3 96-22-0 Flam. Liq. 2
STOT SE 3
STOT SE 3
H225
H335
H336
GHS02
GHS07
Gef.
H225
H335
H336
EUH066 606-007-00-0 3-methylbutan-2-one;
methyl isopropyl ketone
209-264-3 563-80-4 Flam. Liq. 2 H225 GHS02
Gef.
H225 606-009-00-1 4-methylpent-3-en-2-one;
mesityl oxide
205-502-5 141-79-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Achtg.
H226
H332
H312
H302
* 606-010-00-7 cyclohexanone 203-631-1 108-94-1 Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Achtg.
H226
H332
606-011-00-2 2-methylcyclohexanone 209-513-6 583-60-8 Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Achtg.
H226
H332
606-012-00-8 3,5,5-trimethylcyclohex-2-enone;
isophorone
201-126-0 78-59-1 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H351
H312
H302
H319
H335
GHS08
GHS07
Achtg.
H351
H312
H302
H319
H335
STOT SE 3; H335: C ≥ 10 % 606-013-00-3 p-benzoquinone;
quinone
203-405-2 106-51-4 Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H331
H301
H319
H335
H315
H400
GHS06
GHS09
Dgr
H331
H301
H319
H335
H315
H400
M=10 606-014-00-9 Chlorphacinon (ISO);
2-[(4-Chlorphenyl)(phenyl)acetyl]-1H-inden-1,3(2H)-dion
223-003-0 3691-35-8 Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D
H330
H310
H300
H372 (Blut)
H400
H410
GHS08
GHS06
GHS09
Dgr
H360D
H330
H310
H300
H372 (Blut)
H410
Repr. 1B; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut): C ≥ 0,1 %
STOT RE 2; H373 (Blut):
0,01 % ≤ C < 0,1 %
M = 1
M = 1
606-016-00-X pindone (ISO);
2-pivaloylindan-1,3-dione
201-462-8 83-26-1 Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Gef.
H301
H372 **
H410
606-017-00-5 diketene;
diketen
211-617-1 674-82-8 Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Achtg.
H226
H332
D 606-018-00-0 dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone
204-210-5 117-80-6 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H315
H410
606-019-00-6 chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3 143-50-0 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H400
H410
GHS06
GHS08
GHS09
Gef.
H351
H311
H301
H410
606-020-00-1 5-methylheptan-3-one 208-793-7 541-85-5 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Achtg.
H226
H319
H335
STOT SE 3; H335: C ≥ 10 % 606-021-00-7 N-Methyl-2-pyrrolidon; 1-Methyl-2-pyrrolidon 212-828-1 872-50-4 Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
H360D***
H335
H315
H319
GHS08
GHS07
Dgr
H360D***
H335
H315
H319
STOT SE 3; H335: C ≥ 10 % 606-022-00-2 1-phenyl-3-pyrazolidone 202-155-1 92-43-3 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
606-023-00-8 4-methoxy-4-methylpentan-2-one 203-512-4 107-70-0 Flam. Liq. 3
Acute Tox. 4 ((*))
H226
H332
GHS02
GHS07
Achtg.
H226
H332
606-024-00-3 heptan-2-one;
methyl amyl ketone
203-767-1 110-43-0 Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H226
H332
H302
GHS02
GHS07
Achtg.
H226
H332
H302
606-025-00-9 cyclopentanone 204-435-9 120-92-3 Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2
H226
H319
H315
GHS02
GHS07
Achtg.
H226
H319
H315
606-026-00-4 5-methylhexan-2-one;
isoamyl methyl ketone
203-737-8 110-12-3 Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Achtg.
H226
H332
606-027-00-X heptan-4-one;
di-n-propyl ketone
204-608-9 123-19-3 Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Achtg.
H226
H332
606-028-00-5 2,4-dimethylpentan-3-one;
di-isopropyl ketone
209-294-7 565-80-0 Flam. Liq. 2
Acute Tox. 4 (*)
H225
H332
GHS02
GHS07
Gef.
H225
H332
606-029-00-0 pentane-2,4-dione;
acetylacetone
204-634-0 123-54-6 Flam. Liq. 3
Acute Tox. 4 (*)
H226
H302
GHS02
GHS07
Achtg.
H226
H302
606-030-00-6 hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone
209-731-1 591-78-6 Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3
H226
H361f (*)(*)(*)
H372 (*)(*)
H336
GHS02
GHS08
GHS07
Gef.
H226
H361f (*)(*)(*)
H372 (*)(*)
H336
606-031-00-1 3-propanolide;
1,3-propiolactone
200-340-1 57-57-8 Carc. 1B
Acute Tox. 2 (*)
Eye Irrit. 2
Skin Irrit. 2
H350
H330
H319
H315
GHS06
GHS08
Gef.
H350
H330
H319
H315
606-032-00-7 hexachloroacetone 204-129-5 116-16-5 Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole
243-761-6 20354-26-1 Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Achtg.
H312
H302
H319
H315
H411
606-034-00-8 metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-7 21087-64-9 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10 606-035-00-3 chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon
216-920-2 1698-60-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Achtg.
H317
H410
606-036-00-9 quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-3 2439-01-2 Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f (*)(*)(*)
H332
H312
H302
H373 (*)(*)
H319
H317
H400
H410
GHS08
GHS07
GHS09
Achtg.
H361f (*)(*)(*)
H332
H312
H302
H373 (*)(*)
H319
H317
H410
606-037-00-4 triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-8 43121-43-3 Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Achtg.
H302
H317
H411
606-038-00-X diphacinone (ISO);
2-diphenylacetylindan-1,3-dione
201-434-5 82-66-6 Acute Tox. 2 (*)
STOT RE 1
H300
H372 (*)(*)
GHS06
GHS08
Gef.
H300
H372 (*)(*)
606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one 400-680-2 — Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H400
H410
GHS07
GHS09
Achtg.
H332
H410
606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 401-840-4 55845-90-4 Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Gef.
H318
H411
606-041-00-6 2-Methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-on 400-600-6 71868-10-5 Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H360FD
H302
H411
GHS08
GHS07
GHS09
Dgr
H360FD
H302
H411
606-042-00-1 acetophenone 202-708-7 98-86-2 Acute Tox. 4 (*)
Eye Irrit. 2
H302
H319
GHS07
Achtg.
H302
H319
606-043-00-7 2,4-di-tert-butylcyclohexanone 405-340-7 13019-04-0 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
606-044-00-2 2,4,6-trimethylbenzophenone 403-150-9 954-16-5 Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H410
606-045-00-8 oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-7 19666-30-9 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — Aquatic Chronic 4 H413 — H413 606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Achtg.
H317
H413
606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 412-480-2 72453-58-8 Aquatic Chronic 2 H411 GHS09 H411 606-051-00-0 4-pentylcyclohexanone 406-670-4 61203-83-6 Aquatic Chronic 2 H411 GHS09 H411 606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 410-410-5 54574-82-2 Aquatic Chronic 3 H412 — H412 606-053-00-1 flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one
— 96525-23-4 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-054-00-7 Isoxaflutol (ISO); 5-Cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluor-2-mesyl-p-tolyl keton — 141112-29-0 Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H400
H410
GHS08
GHS09
Wng
H361d***
H410
M = 10
M = 100
606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H302
H373 (*)(*)
H411
GHS08
GHS07
GHS09
Achtg.
H302
H373 (*)(*)
H411
606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-057-00-3 4-propylcyclohexanone 406-810-4 40649-36-3 Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Achtg.
H315
H412
606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 407-500-1 21983-80-2 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
606-059-00-4 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 412-390-3 86386-75-6 Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Gef.
H302
H318
H317
606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 423-290-4 66938-41-8 Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H400
H410
GHS08
GHS09
Achtg.
H341
H410
606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 407-330-8 61571-06-0 Repr. 1B
Eye Dam. 1
Aquatic Chronic 3
H360D (*)(*)(*)
H318
H412
GHS08
GHS05
Gef.
H360D (*)(*)(*)
H318
H412
606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 410-980-5 112704-51-5 Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Achtg.
H319
H317
606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 407-450-0 7093-55-2 Aquatic Chronic 4 H413 — H413 606-065-00-7 1-(4-morpholinophenyl)butan-1-one 413-790-0 — Aquatic Chronic 2 H411 GHS09 H411 606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 410-440-9 164058-20-2 Aquatic Chronic 2 H411 GHS09 H411 606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-8 96792-67-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 415-770-7 1638-05-7 STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3
H373 (*)(*)
H317
H412
GHS08
GHS07
Achtg.
H373 (*)(*)
H317
H412
606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 415-460-1 154171-76-3 Aquatic Chronic 2 H411 GHS09 H411 606-070-00-4 butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3 138164-12-2 Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H315
H400
H410
GHS08
GHS07
GHS09
Achtg.
H361fd
H302
H315
H410
606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 421-050-3 13258-43-0 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 421-600-2 719-86-8 STOT RE 2 (*)
Aquatic Chronic 2
H373 (*)(*)
H411
GHS08
GHS09
Achtg.
H373 (*)(*)
H411
606-073-00-0 4,4'-bis(dimethylamino)benzophenone;
Michler's ketone
202-027-5 90-94-8 Carc. 1B
Muta. 2
Eye Dam. 1
H350
H341
H318
GHS08
GHS05
Gef.
H350
H341
H318
606-074-00-6 reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
425-570-1 — Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 417-340-4 65855-02-9 Acute Tox. 4 (*) H302 GHS07
Achtg.
H302 606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 418-630-3 136465-99-1 Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Gef.
H318
H317
606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 418-650-2 104872-06-2 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-078-00-8 1-octylazepin-2-one 420-040-6 59227-88-2 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Gef.
H314
H317
H411
606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Gef.
H314
H317
H410
606-080-00-9 Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene 417-100-9 — Aquatic Chronic 4 H413 H413 606-081-00-4 (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 419-790-7 4229-69-0 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Achtg.
H317
H412
606-082-00-X reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7 STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H372 (*)(*)
H317
H412
GHS08
GHS07
Gef.
H372 (*)(*)
H317
H412
606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 407-750-1 137193-60-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Achtg.
H319
H315
H317
H412
606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 414-540-3 484-33-3 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 418-530-1 79200-56-9 Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Gef.
H302
H318
H317
606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 422-330-8 56973-87-6 Aquatic Chronic 2 H411 GHS09 H411 606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 422-460-5 137234-87-8 Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 422-520-0 74338-72-0 Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Achtg.
H315
H411
606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-2 12223-77-7 Aquatic Chronic 4 H413 — H413 606-090-00-3 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone 430-920-1 73096-98-7 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 421-320-0 118289-55-7 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a)(Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 606-093-00-X 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one 414-470-3 95885-13-5 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-094-00-5 N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one 417-460-7 — Aquatic Chronic 4 H413 — H413 606-095-00-0 (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one 421-830-3 49805-30-3 Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
606-096-00-6 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one 424-170-4 130603-71-3 Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
606-097-00-1 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone 424-210-0 23911-85-5 Aquatic Chronic 4 H413 — H413 606-098-00-7 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione 431-220-9 158574-65-3 Aquatic Chronic 4 H413 — H413 606-099-00-2 5-methoxy-4'-(trifluoromethyl)valerophenone 425-000-1 61718-80-7 Aquatic Chronic 2 H411 GHS09 H411 606-100-00-6 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one 425-150-8 94723-86-1 Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H360F***
H302
H317
H412
GHS08
GHS07
Dgr
H360F***
H302
H317
H412
606-101-00-1 reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione
426-050-7 165038-51-7 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 606-102-00-7 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone 431-490-8 79876-59-8 Aquatic Chronic 2 H411 GHS09 H411 606-103-00-2 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone 426-460-6 — Skin Sens. 1 H317 GHS07
Wng
H317 606-104-00-8 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone 426-830-7 78531-59-6 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-105-00-3 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione 431-500-0 226065-73-2 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-106-00-9 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone 427-320-7 83626-30-6 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-107-00-4 8-azaspiro[4.5]decane-7,9-dione 427-770-4 1075-89-4 Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
606-108-00-X 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone 436-710-6 756-13-8 Aquatic Chronic 3 H412 — H412 606-109-00-5 2-(4-methyl-3-pentenyl)anthraquinone 428-320-1 71308-16-2 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H413
GHS07
Wng
H302
H317
H413
606-110-00-0 5-ethoxy-5H-furan-2-one 428-330-4 2833-30-9 Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H312
H302
H373**
H317
GHS05
GHS08
GHS07
Dgr
H314
H312
H302
H373**
H317
606-111-00-6 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one 428-410-9 67014-36-2 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
606-112-00-1 (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one 428-690-2 1668-86-6 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
606-113-00-7 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one 429-040-0 272460-97-6 Eye Dam. 1
Aquatic Chronic 4
H318
H413
GHS05
Dgr
H318
H413
606-114-00-2 4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone 429-150-9 67887-47-2 Aquatic Chronic 4 H413 — H413 606-115-00-8 profoxydim (ISO);
2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
— 139001-49-3 Carc. 2
Repr. 2
Skin Sens. 1
H351
H361d
H317
GHS08
GHS07
Wng
H351
H361d
H317
606-116-00-3 tepraloxydim (ISO);
(RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
— 149979-41-9 Carc. 2
Repr. 2
H351
H361fd
GHS08
Wng
H351
H361fd
606-117-00-9 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one 429-460-4 7078-98-0 Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-118-00-4 N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine 429-640-2 52870-46-9 Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
606-119-00-X (E)-3-methyl-5-cyclopentadecen-1-one 429-900-5 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
606-120-00-5 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one 430-170-5 114625-74-0 Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-121-00-0 (+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) 430-460-1 133636-82-5 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
606-122-00-6 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one 430-820-8 114341-88-7 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H315
H318
H317
H410
606-123-00-1 4-hexadecyl-1-phenylpyrazolidin-3-one 430-840-7 — Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-124-00-7 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione 421-080-7 161462-35-7 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
606-125-00-2 1-benzylimidazolidine-2,4-dione 421-340-1 6777-05-5 Acute Tox. 4 * H302 GHS07
Wng
H302 606-126-00-8 1,4-bis(2,3-dihydroxypropylamino)anthraquinone 421-470-7 99788-75-7 Aquatic Chronic 2 H411 GHS09 H411 606-128-00-9 2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione 422-650-8 148935-94-8 Aquatic Chronic 4 H413 — H413 606-129-00-4 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7 156732-13-7 Aquatic Chronic 4 H413 — H413 606-130-00-X 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone 423-860-2 56309-94-5 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-131-00-5 cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione 427-230-8 5571-36-8 Repr. 1B
STOT RE 2 *
Aquatic Chronic 2
H360F***
H373**
H411
GHS08
GHS09
Dgr
H360F***
H373**
H411
606-132-00-0 (6β)-6,19-epoxyandrost-4-ene-3,17-dione 433-490-3 6563-83-3 Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-134-00-1 androsta-1,4,9(11)-triene-3,17-dione 433-560-3 15375-21-0 Repr. 2 H361f*** GHS08
Wng
H361f*** 606-135-00-7 cyclohexadecanone 438-930-8 2550-52-9 Aquatic Chronic 4 H413 — H413 606-136-00-2 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone 444-350-6 133413-70-4 Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
606-137-00-8 trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione 444-750-0 211387-26-7 Aquatic Chronic 4 H413 — H413 606-138-00-3 (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone 444-800-1 141645-23-0 Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373**
H315
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H226
H302
H373**
H315
H318
H317
H410
M=10 606-139-00-9 (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one 444-830-5 124379-29-9 Aquatic Chronic 4 H413 — H413 606-140-00-4 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one 444-860-9 474510-57-1 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
606-141-00-X sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate 418-410-7 — Eye Irrit. 2 H319 GHS07
Wng
H319 606-142-00-5 reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9 — Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
606-143-00-0 abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] _ [1] 71751-41-2 [1] Repr. 2
Acute Tox. 2
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H300
H330
H372 (Nervensystem)
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d
H300
H330
H372 (Nervensystem)
H410
STOT RE 1;
H372: C ≥ 5 %
STOT RE 2;
H373: 0,5 % ≤ C < 5 %
M = 10000
avermectin B1a (purity ≥ 80 %); [2] 265-610-3 [2] 65195-55-3 [2] 606-144-00-6 acequinocyl (ISO);
3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
— 57960-19-7 Skin Sens. 1
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H370 (Lunge)
(Einatmung)
H373 (Blutkreislauf)
H400
H410
GHS07
GHS08
GHS09
Dgr
H317
H370 (Lunge)
(Einatmung)
H373 (Blutkreislauf)
H410
M = 1000 606-145-00-1 sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8 Repr. 2 H361d GHS08 H361d M = 1
M = 10
STOT RE 2 H373 (Nieren) GHS07 H373 (Nieren) Skin Sens. 1A H317 HS09 H317 Aquatic Acute 1 H400 Wng Aquatic Chronic 1 H410 H410 606-146-00-7 tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one — 87820-88-0 Carc. 2
Acute Tox. 4
Aquatic Chronic 2
H351
H302
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H411
606-147-00-2 cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 405-230-9 101205-02-1 Repr. 2 H361d GHS08
Wng
H361d 606-148-00-8 Carvon (ISO);
2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1]
d-Carvon; (5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2]
l-Carvon; (5R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3]
202-759-5 [1]
218-827-2 [2]
229-352-5 [3]
99-49-0 [1]
2244-16-8 [2]
6485-40-1 [3]
Skin Sens. 1 H317 GHS07
Wng
H317 606-149-00-3 Tembotrion (ISO); 2-{2-Chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyclohexan-1,3-dion — 335104-84-2 Repr. 2
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H373 (Augen, Nieren, Leber)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H373 (Augen, Nieren, Leber)
H317
H410
M = 100
M = 10
606-150-00-9 Clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-Chlorallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on — 99129-21-2 Acute Tox. 4
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
EUH066 606-151-00-4 Anthrachinon 201-549-0 84-65-1 Carc. 1B H350 GHS08
Dgr
H350 607-001-00-0 formic acid ... % 200-579-1 64-18-6 Skin Corr. 1A H314 GHS05
Gef.
H314 Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 10 % ≤ C < 90 %
Skin Irrit. 2; H315: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 2 % ≤ C < 10 %
B 607-002-00-6 acetic acid ... % 200-580-7 64-19-7 Flam. Liq. 3
Skin Corr. 1A
H226
H314
GHS02
GHS05
Gef.
H226
H314
Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 25 % ≤ C < 90 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B 607-003-00-1 chloroacetic acid 201-178-4 79-11-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H331
H311
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H400
STOT SE 3; H335: C ≥ 5 % 607-004-00-7 TCA (ISO);
trichloroacetic acid
200-927-2 76-03-9 Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Gef.
H314
H410
STOT SE 3; H335: C ≥ 1 % 607-005-00-2 TCA-sodium (ISO);
sodium trichloroacetate
211-479-2 650-51-1 STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H335
H400
H410
GHS07
GHS09
Achtg.
H335
H410
607-006-00-8 oxalic acid 205-634-3 144-62-7 Acute Tox. 4 (*)
Acute Tox. 4 (*)
H312
H302
GHS07
Achtg.
H312
H302
(*) 607-007-00-3 salts of oxalic acid with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
* A 607-008-00-9 acetic anhydride 203-564-8 108-24-7 Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H226
H332
H302
H314
GHS02
GHS05
GHS07
Gef.
H226
H332
H302
H314
Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Dam. 1; H318: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 1 % ≤ C < 5 %
STOT SE 3; H335: C ≥ 5 %
607-009-00-4 phthalic anhydride 201-607-5 85-44-9 Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H335
H315
H318
H334
H317
GHS08
GHS05
GHS07
Gef.
H302
H335
H315
H318
H334
H317
607-010-00-X propionic anhydride 204-638-2 123-62-6 Skin Corr. 1B H314 GHS05
Gef.
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
607-011-00-5 acetyl chloride 200-865-6 75-36-5 Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Gef.
H225
H314
EUH014 607-012-00-0 benzoyl chloride 202-710-8 98-88-4 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H332
H312
H302
H314
H317
GHS05
GHS07
Dgr
H332
H312
H302
H314
H317
607-013-00-6 dimethyl carbonate 210-478-4 616-38-6 Flam. Liq. 2 H225 GHS02
Gef.
H225 607-014-00-1 methyl formate 203-481-7 107-31-3 Flam. Liq. 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
H224
H332
H302
H319
H335
GHS02
GHS07
Gef.
H224
H332
H302
H319
H335
607-015-00-7 ethyl formate 203-721-0 109-94-4 Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
H225
H332
H302
H319
H335
GHS02
GHS07
Gef.
H225
H332
H302
H319
H335
607-016-00-2 propyl formate; [1]
isopropyl formate [2]
203-798-0 [1]
210-901-2 [2]
110-74-7 [1]
625-55-8 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
H225
H319
H335
H336
GHS02
GHS07
Gef.
H225
H319
H335
H336
C 607-017-00-8 butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3]
209-772-5 [1]
212-105-0 [2]
208-818-1 [3]
592-84-7 [1]
762-75-4 [2]
542-55-2 [3]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Gef.
H225
H319
H335
C 607-018-00-3 isopentyl formate; [1]
2-methylbutyl formate [2]
203-769-2 [1]
252-343-2 [2]
110-45-2 [1]
35073-27-9 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Gef.
H225
H319
H335
C 607-019-00-9 methyl chloroformate 201-187-3 79-22-1 Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H225
H330
H312
H302
H314
GHS02
GHS06
GHS05
Gef.
H225
H330
H312
H302
H314
607-020-00-4 ethyl chloroformate 208-778-5 541-41-3 Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H225
H330
H302
H314
GHS02
GHS06
GHS05
Gef.
H225
H330
H302
H314
607-021-00-X methyl acetate 201-185-2 79-20-9 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
EUH066 607-022-00-5 ethyl acetate 205-500-4 141-78-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
EUH066 607-023-00-0 vinyl acetate 203-545-4 108-05-4 Flam. Liq. 2 H225 GHS02 H225 D Carc. 2 H351 GHS08 H351 Acute Tox. 4 H332 GHS07 H332 STOT SE 3 H335 Dgr H335 607-024-00-6 propyl acetate; [1]
isopropyl acetate [2]
203-686-1 [1]
203-561-1 [2]
109-60-4 [1]
108-21-4 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Gef.
H225
H319
H336
EUH066 C 607-025-00-1 n-butyl acetate 204-658-1 123-86-4 Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Achtg.
H226
H336
EUH066 607-026-00-7 sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3]
203-300-1 [1]
203-745-1 [2]
208-760-7 [3]
105-46-4 [1]
110-19-0 [2]
540-88-5 [3]
Flam. Liq. 2 H225 GHS02
Gef.
H225 EUH066 C 607-027-00-2 methyl propionate 209-060-4 554-12-1 Flam. Liq. 2
Acute Tox. 4 (*)
H225
H332
GHS02
GHS07
Gef.
H225
H332
607-028-00-8 ethyl propionate 203-291-4 105-37-3 Flam. Liq. 2 H225 GHS02
Gef.
H225 607-029-00-3 n-butyl propionate; [1]
sec-butyl propionate; [2]
iso-butyl propionate [3]
209-669-5 [1]
[2]
208-746-0 [3]
590-01-2 [1]
591-34-4 [2]
540-42-1 [3]
Flam. Liq. 3 H226 GHS02
Achtg.
H226 C 607-030-00-9 propyl propionate 203-389-7 106-36-5 Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Achtg.
H226
H332
607-031-00-4 butyl butyrate 203-656-8 109-21-7 Flam. Liq. 3 H226 GHS02
Achtg.
H226 C 607-032-00-X ethyl acrylate 205-438-8 140-88-5 Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Gef.
H225
H332
H312
H302
H319
H335
H315
H317
Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 %
D 607-033-00-5 n-butyl methacrylate 202-615-1 97-88-1 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Achtg.
H226
H319
H335
H315
H317
D 607-034-00-0 methyl acrylate;
methyl propenoate
202-500-6 96-33-3 Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Gef.
H225
H332
H312
H302
H319
H335
H315
H317
D 607-035-00-6 methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate
201-297-1 80-62-6 Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H335
H315
H317
GHS02
GHS07
Gef.
H225
H335
H315
H317
D 607-036-00-1 2-methoxyethyl acetate;
methylglycol acetate
203-772-9 110-49-6 Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H360FD
H332
H312
H302
GHS08
GHS07
Gef.
H360FD
H332
H312
H302
607-037-00-7 2-ethoxyethyl acetate;
ethylglycol acetate
203-839-2 111-15-9 Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD
H332
H312
H302
607-038-00-2 2-butoxyethyl acetate;
butylglycol acetate
203-933-3 112-07-2 Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
GHS07
Achtg.
H332
H312
607-039-00-8 2,4-D (ISO);
2,4-dichlorophenoxyacetic acid
202-361-1 94-75-7 Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H335
H318
H317
H412
GHS05
GHS07
Gef.
H302
H335
H318
H317
H412
607-040-00-3 salts of 2,4-D — — Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H317
H411
A 607-041-00-9 2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid
202-273-3 93-76-5 Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H335
H315
H410
607-042-00-4 salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid
— — Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H335
H315
H410
A 607-043-00-X dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid
217-635-6 1918-00-9 Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Gef.
H302
H318
H412
607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]
233-002-7 [2]
2300-66-5 [1]
10007-85-9 [2]
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Achtg.
H319
H412
607-045-00-0 dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid
204-390-5 120-36-5 Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
H312
H302
H315
H318
GHS05
GHS07
Gef.
H312
H302
H315
H318
607-046-00-6 salts of dichlorprop — — Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Achtg.
H332
H312
H302
A 607-047-00-1 fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid
202-271-2 93-72-1 Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H315
H410
607-048-00-7 salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid
— — Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H332
H312
H302
H410
A 607-049-00-2 mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]
202-264-4 [2]
7085-19-0 [1]
708519-0 [2]
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H315
H318
H410
M=100 607-050-00-8 salts of mecoprop — — Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Gef.
H302
H315
H318
H410
A 607-051-00-3 MCPA (ISO);
4-chloro-o-tolyloxyacetic acid
202-360-6 94-74-6 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
607-052-00-9 salts and esters of MCPA — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
A 607-053-00-4 MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid
202-365-3 94-81-5 Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Achtg.
H410 607-054-00-X salts and esters of MCPB — — Acute Tox. 4 (*) H302 GHS07
Achtg.
H302 A 607-055-00-5 endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8 129-67-9 Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Gef.
H301
H312
H319
H335
H315
607-056-00-0 Warfarin (ISO);
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-on; [1]
(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [2]
(R)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [3]
201-377-6
[1]
226-907-3
[2]
226-908-9
[3]
81-81-2 [1]
5543-57-7
[2]
5543-58-8
[3]
Repr. 1 A
Acute Tox. 1
Acute Tox. 1
Acute Tox. 2
STOT RE 1
Aquatic Chronic 2
H360D
H330
H310
H300
H372 (Blut)
H411
GHS08
GHS06
GHS09
Dgr
H360D
H330
H310
H300
H372 (Blut)
H411
Repr. 1 A; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut): C ≥ 0,5 %
STOT RE 2; H373 (Blut): 0,05 % ≤ C < 0,5 %
607-057-00-6 coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-1 81-82-3 STOT RE 2 (*)
Aquatic Chronic 3
H373 (*)(*)
H412
GHS08
Achtg.
H373 (*)(*)
H412
607-058-00-1 coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin
204-195-5 117-52-2 Acute Tox. 3 (*)
STOT RE 1
Aquatic Chronic 3
H301
H372 (*)(*)
H412
GHS06
GHS08
Gef.
H301
H372 (*)(*)
H412
607-059-00-7 Coumatetralyl (ISO); 4-Hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)cumarin 227-424-0 5836-29-3 Repr. 1B
Acute Tox. 2
Acute Tox. 3
Acute Tox. 2
STOT RE 1
Aquatic Chronic 1
H360D
H330
H311
H300
H372 (Blut)
H410
GHS08
GHS06
GHS09
Dgr
H360D
H330
H311
H300
H372 (Blut)
H410
Repr. 1B; H360D: C ≥ 0,003 %
STOT RE 1; H372 (Blut): C ≥ 1,0 %
STOT RE 2; H373 (Blut) 0,1 % ≤ C < 1,0 %
M = 10
607-060-00-2 dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-9 66-76-2 STOT RE 1
Acute Tox. 4 (*)
Aquatic Chronic 2
H372 (*)(*)
H302
H411
GHS08
GHS07
GHS09
Gef.
H372 (*)(*)
H302
H411
607-061-00-8 acrylic acid;
prop-2-enoic acid
201-177-9 79-10-7 Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
Aquatic Acute 1
H226
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Gef.
H226
H332
H312
H302
H314
H400
STOT SE 3; H335: C ≥ 1 % D 607-062-00-3 n-butyl acrylate 205-480-7 141-32-2 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Achtg.
H226
H319
H335
H315
H317
D 607-063-00-9 isobutyric acid 201-195-7 79-31-2 Acute Tox. 4 (*)
Acute Tox. 4 (*)
H312
H302
GHS07
Achtg.
H312
H302
607-064-00-4 benzyl chloroformate 207-925-0 501-53-1 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Gef.
H314
H410
STOT SE 3; H335: C ≥ 5 % 607-065-00-X bromoacetic acid 201-175-8 79-08-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H331
H311
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H400
607-066-00-5 dichloroacetic acid 201-207-0 79-43-6 Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
607-067-00-0 dichloroacetyl chloride 201-199-9 79-36-7 Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Gef.
H314
H400
607-068-00-6 iodoacetic acid 200-590-1 64-69-7 Acute Tox. 3 (*)
Skin Corr. 1A
H301
H314
GHS06
GHS05
Gef.
H301
H314
607-069-00-1 ethyl bromoacetate 203-290-9 105-36-2 Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
H330
H310
H300
GHS06
Gef.
H330
H310
H300
607-070-00-7 ethyl chloroacetate 203-294-0 105-39-5 Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
H331
H311
H301
H400
GHS06
GHS09
Gef.
H331
H311
H301
H400
607-071-00-2 ethyl methacrylate 202-597-5 97-63-2 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H319
H335
H315
H317
GHS02
GHS07
Gef.
H225
H319
H335
H315
H317
D 607-072-00-8 2-hydroxyethyl acrylate 212-454-9 818-61-1 Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H311
H314
H317
H400
GHS06
GHS05
GHS09
Gef.
H311
H314
H317
H400
(*)
Skin Sens. 1; H317: C ≥ 0,2 %
D 607-073-00-3 4-CPA (ISO);
4-chlorophenoxyacetic acid
204-581-3 122-88-3 Acute Tox. 4 (*) H302 GHS07
Achtg.
H302 607-074-00-9 chlorfenac(ISO);
2,3,6-trichlorophenylacetic acid
201-599-3 85-34-7 Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
607-075-00-4 chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-5 14437-17-3 Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Achtg.
H312
H302
H410
607-076-00-X dodine(ISO);
dodecylguanidinium acetate
219-459-5 2439-10-3 Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Achtg.
H302
H319
H315
H410
607-077-00-5 erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate
— 136-25-4 Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
607-078-00-0 fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate
— 4301-50-2 Acute Tox. 1
Acute Tox. 2 (*)
H310
H300
GHS06
Gef.
H310
H300
607-079-00-6 kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
— 4234-79-1 Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2
H311
H302
H411
GHS06
GHS09
Gef.
H311
H302
H411
607-080-00-1 chloroacetyl chloride 201-171-6 79-04-9 Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Skin Corr. 1A
Aquatic Acute 1
H331
H311
H301
H372 (*)(*)
H314
H400
GHS06
GHS08
GHS05
GHS09
Gef.
H331
H311
H301
H372 (*)(*)
H314
H400
EUH014
EUH029
607-081-00-7 fluoroacetic acid 205-631-7 144-49-0 Acute Tox. 2 (*)
Aquatic Acute 1
H300
H400
GHS06
GHS09
Gef.
H300
H400
607-082-00-2 fluoroacetates, soluble — — Acute Tox. 2 (*)
Aquatic Acute 1
H300
H400
GHS06
GHS09
Gef.
H300
H400
A 607-083-00-8 2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid
202-366-9 94-82-6 Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Achtg.
H302
H411
607-084-00-3 salts of 2,4-DB — — Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Gef.
H302
H318
H411
A 607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-086-00-4 diallyl phthalate 205-016-3 131-17-9 Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Achtg.
H302
H410
607-088-00-5 methacrylic acid;
2-methylpropenoic acid
201-204-4 79-41-4 Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Gef.
H312
H302
H314
STOT SE 3; H335: C ≥ 1 % D 607-089-00-0 propionic acid ... % 201-176-3 79-09-4 Skin Corr. 1B H314 GHS05
Gef.
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H319: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 %
B 607-090-00-6 thioglycolic acid 200-677-4 68-11-1 Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
H331
H311
H301
H314
GHS06
GHS05
Gef.
H331
H311
H301
H314
(*) 607-091-00-1 trifluoroacetic acid . . . % 200-929-3 76-05-1 Acute Tox. 4 (*) H332 GHS05 H332 * B Skin Corr. 1A
Aquatic Chronic 3
H314
H412
GHS07
Gef.
H314
H412
607-092-00-7 methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4]
208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4]
547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Achtg.
H226
H319
H335
C 607-093-00-2 propionyl chloride 201-170-0 79-03-8